ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001058.1|Zorbamycin_1 # 34 # 345 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.679	BGC0001058.1|Zorbamycin_1 	34	345	-	Loose	400	22.7126	vatD	31.71	3002843	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin A antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	ATGCGCTGTGTCATTGCCCGCTACCCGTTCGATCTGACCAAGGGCGGCGTGTGGGAATCGATGAAGGGCGTCACACCCGAACCGGTCACCGGCGAGTCCGTGATCATCGGACGGCGCCACTACCCCGCCAAGCAGGTCGGCCAGGTCATCACCCGCCAGGACCCCCGCGATTTCAGCGTCGGCGAGGTTCTGAGGGCGATGACCCTGCTCGGCTTCACCTGCCGCACCATCCCCGAGGGCGCTCCCGCACCCACCGAGAGTCCGTTGCAGCGGGCTTCCGCGATGCTCGGCGCCCCCCACCTGTCCGTCTGA	MRCVIARYPFDLTKGGVWESMKGVTPEPVTGESVIIGRRHYPAKQVGQVITRQDPRDFSVGEVLRAMTLLGFTCRTIPEGAPAPTESPLQRASAMLGAPHLSV	MKMYPIEGNKSVQFIKPILEKLENVEVGEYSYYDSKNGETFDKQILYHYPILNDKLKIGKFCSIGPGVTIIMNGANHRMDGSTYPFNLFGNGWEKHMPKLDQLPIKGDTIIGNDVWIGKDVVIMPGVKIGDGAIVAANSVVVKDIAPYMLAGGNPANEIKQRFDQDTINQLLDIKWWNWPIDIINENIDKILDNSIIREVIWKK	50.49	gnl|BL_ORD_ID|261|hsp_num:0	290			243	363	virginiamycin M1; madumycin II; griseoviridin; dalfopristin
BGC0001058.1|Zorbamycin_2 # 395 # 799 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=13bp;gc_cont=0.677	BGC0001058.1|Zorbamycin_2 	395	799	-	Loose	475	28.1054	cph	37.7	3007075	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	capreomycin phosphotransferase	ATGGGACAGTTGCAGGCTCGCTCCGTAAGCGCTCGACCATTGCACGGCACGCTGGTCGACGTCATGGACGCAGCCGGACCGCAGGTCTGGTATGACATGACCGTTGAGGTGGCGTTGTCCGTGATGGCCGCCTCAGGTGCGGAGCATCTGGTCGTCTGCGACGAAGACGCCCGGTGGGTCGGCCTGGTCACCCGGGCCCGCCTCACCGCAGTCCGTGACAGCTCCGAATACACCGACCGGCTTCGCCTGGGTGACATCACCGACGACAGCGGGCCCTTCATCTCAGCTCTGGCCACAAAGGGCGAAGCCGAGGACGCGATGCCCCACGGACGGCTCGGGCCCGTGCCCGTGCCCGTGGTCGACGAAGACGGCAGCGCCCTGGGCATCCTCGCTCTCTCCCGTTGA	MGQLQARSVSARPLHGTLVDVMDAAGPQVWYDMTVEVALSVMAASGAEHLVVCDEDARWVGLVTRARLTAVRDSSEYTDRLRLGDITDDSGPFISALATKGEAEDAMPHGRLGPVPVPVVDEDGSALGILALSR	MTLSHLVDVVRRAHPDVDLEGAGVHSGQFHDVLIARDRVFRFPKTAGAAAELPGRVAVLTAVDAVELGVGVPVPLSEVRDGGPHGFLVLSRLHGTPLERGDATSPEVIDVVAAEFARVLRAMAGADVEKLRLVLPVADAGRWRGFAGRVRATLFPLMSEDGRARAERELAAAVAMDHVATGLVHGDLGGENVLWQQVEELPRLTGIVDWDEAKVGDPAEDLAAVGASYGPELVERVVALLGAGDLWPRIRAYQGTFALQQALAGAEDGDDEELEDGLTAYR	47.69	gnl|BL_ORD_ID|4772|hsp_num:0	5768			273	456	capreomycin
BGC0001058.1|Zorbamycin_3 # 851 # 2347 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.719	BGC0001058.1|Zorbamycin_3 	851	2347	-	Loose	600	29.261	THIN-B	29.17	3000851	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	THIN-B beta-lactamase	ATGTACCGCACGCGCAAGAACGACCGCTTCGCCCGCACCCGTGATGGCAGCGCCGACTCCGGAAAGGGCGGCAACCGCTTCGCTTCGCCGGCGCCCCGCCGGTCGGCCGGCCCTGGCCGATCCGGCGGTCACGGCCGTCGGCCCGCCGCCGTCCACGGGGAGTTCGCGCTGCCCAGGACGATCACTCCCGCGCTTCCCGCAGTGGAGGGCTTCGCCGATCTCGACATGCCCGGGGAACTGCTGGCCGCGCTCGGCAAAGACGGTGTGACCGTGCCATTCCCGATTCAGGCCGCGACCCTGCCTAACTCCCTCGCCGGCCGCGACGTCCTCGGCCGCGGCCGCACCGGTTCCGGAAAGACCCTCGCCTTCGGGCTGGCCTTGCTGGCCCGCACGGCCGGACGGCGGGCCGAGCCCCGACAGCCGCTGGGACTGGTCCTCGTACCGACGCGGGAGCTGGCGCAGCAGGTCACCGACGCGCTCACCCCGTACGCCCGTTCCGTGAAGCTACGGCTGGCCACCGTCGTGGGCGGGATGTCCATCGGCAGGCAGGCATCGGCGCTGCGCGGTGGCGCCGAGATCGTCGTCGCCACCCCCGGACGCCTCAAGGACCTCATCGACCGCGGCGACTGCCGGCTGAACCAGATTTCCATCACCGTCCTCGACGAGGCCGACCAGATGGCCGACATGGGCTTCCTGCCGCAGGTCACCGCACTGCTCGACCAGGTTCGTCCCGAAGGCCAGCGCATGCTGTTCTCCGCCACCCTCGACCGCAACGTCGACCTGCTCGTACGCCGCTACCTGACAGATCCCGTCGTGCACTCCGTCGACCCCTCGGCGGGCGCCGTCACGACGATGGAGCACCACGTGCTGCACGTCCACGGTGCCGACAAGCACGCGGCCACCACCGAAATCGCCGCCCGCGACGGCCGAGTGATCATGTTCCTGGACACCAAGCACGCCGTCGACAGGCTCACCCGGGACCTGCTCAACAGCGGAGTACGGGCCGCCGCCCTGCACGGCGGCAAGTCCCAGCCGCAGCGCACCCGCACCCTGACGCAGTTCAAGACGGGCCACGTCACCGTGCTGGTGGCGACCAACGTCGCGGCGCGCGGCATCCACGTCGACAACCTCGACCTCGTCGTCAACGTCGATCCGCCGACCGATCACAAGGACTACCTCCACCGCGGCGGCCGCACGGCCCGCGCCGGCGAGTCCGGCAGCGTCGTCACGCTCGTCACACCGAGCCAGCGTCGCGGCATGGTCCGCCTCATGTCCAACGCCGGGATCCGGCCGCAGACCACCCAGGTCAACCCGGGCGACGAGGCCCTCAGCCGGATCACCGGCGCCCAAGCACCGACTGGCATCCCGGTCGTCATCACCGCACCGGTGGACGAACGCCCCAAGAAGCGCGGAGCCACCTCACGCGGCCGACGCCGCCCCGCCTCGGCGACCCGCCGCGCCCGCGCACTCCAGTCCCCTGCCGGTGCGGCCGCATAG	MYRTRKNDRFARTRDGSADSGKGGNRFASPAPRRSAGPGRSGGHGRRPAAVHGEFALPRTITPALPAVEGFADLDMPGELLAALGKDGVTVPFPIQAATLPNSLAGRDVLGRGRTGSGKTLAFGLALLARTAGRRAEPRQPLGLVLVPTRELAQQVTDALTPYARSVKLRLATVVGGMSIGRQASALRGGAEIVVATPGRLKDLIDRGDCRLNQISITVLDEADQMADMGFLPQVTALLDQVRPEGQRMLFSATLDRNVDLLVRRYLTDPVVHSVDPSAGAVTTMEHHVLHVHGADKHAATTEIAARDGRVIMFLDTKHAVDRLTRDLLNSGVRAAALHGGKSQPQRTRTLTQFKTGHVTVLVATNVAARGIHVDNLDLVVNVDPPTDHKDYLHRGGRTARAGESGSVVTLVTPSQRRGMVRLMSNAGIRPQTTQVNPGDEALSRITGAQAPTGIPVVITAPVDERPKKRGATSRGRRRPASATRRARALQSPAGAAA	MTLLAKLMLATVATMSAATVQAKTPAPKPDTPVDCDSCKAWNGEVTPFNVFGNTWYVGTAGLSAVLVTSPQGHVLLDGALPQSAPLIIANIAALGFRIEDVKFILNSHAHWDHAGGIAALQAASGATVVASASGALGLQSGTNGKDDPQFQAKPVVHVAKVEKVKVVGEGDAIKLGPLNLTAHMTPGHTPGATTWTWTSCEGQRCLDVVYADSLNPYSSGDFTYTGKGDGPDISASFAASIAKVAALPCDIILSVHPDSTGVLDKAAKRSGEHNPFIDANACRAYAATADAMLTKRLAKERGVALPAAAPAAQHAH	157.59	gnl|BL_ORD_ID|1352|hsp_num:0	1393			255	384	
BGC0001058.1|Zorbamycin_4 # 2697 # 2900 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.627	BGC0001058.1|Zorbamycin_4 	2697	2900	-	Loose	1900	23.0978	MexK	38.46	3003693	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCAGTGGCACCGTGAAGTGGTTCAACGCAGAAAAGGGATTCGGCTTCATCGAGCAGGACGGTGGCGGCGCTGACGTCTTCGCCCACTACTCGAACATTGCCGCCCAGGGCTTCCGCGAGCTGCTGGAGGGCCAGAAGGTGAGCTTCGACATCGCGCAGGGTCAGAAGGGCCCGACGGCCGAGAACATCGTTCCCGCCTGA	MASGTVKWFNAEKGFGFIEQDGGGADVFAHYSNIAAQGFRELLEGQKVSFDIAQGQKGPTAENIVPA	MSFNLSAWALQNRQIVLYLMILLGAVGALSYSKLGQSEDPPFTFKAMVVQTNWPGASAEEVARQVTERIEKKLMETGDYDRIVSFSRPGVSQVTFMAREDIHSSEIPELWYQIRKKISDIRATLPQSIQGPFFNDEFGTTYGNIYALTGKGFDYAVMKDYADRLQLQLQRIRNVGKVELIGLQDEKIWIDLSNTKLATLGLPLAAVQKALEEQNAVASSGFFETASDRVQLRVSGRFDSVEEIRDFPIRVGDRTFRIGDVAEVRRGFNDPPAPRMRFMGEDAIGLAVAMKPGGDILVLGKALETEFARLQQSLPAGLELRKVSDQPAAVRTGVGEFIRVLAEALVIVLLVSFFSLGLRTGLVVALSIPLVLAMTFAAMHYFGIGLHKISLGALVLALGLLVDDAIIAVEMMAVKMEQGYDRLKAASFAWTSTAFPMLTGTLITAAGFLPIATAQSGTGEYTRSLFQVVTIALVVSWFAAVVFVPYLGAKLLPDLARLHAQKHGGSADGYDPYATAFYQRFRRLVEWCVRYRKTVIVLTLAAFVGALLLFRLVPQQFFPPSARLELLLDIKLAEGASLRSTGEEVQRLEKMLQGHDGIDNYVAYVGTGSPRFYLPLDQQLPAASFAQVVVLAKDLESREALRKWLIERMNEDFPHLRSRISRLENGPPVGYPVQFRVSGEDIPQVRELARKVADKMRENPHVVNVHLDWEEPSKVVYLSIDQERARALGVSTASLSQFLQSALTGSHVSFFREDNELIEILLRGTEQERRDLSLLPSLAVPTENGRSVALSQIATLEYGFEEGIIWHRNRLPTVTVRADIYDDSLPATLVAQIAPTLEPIRAELPDGYLLEVGGTVEDAAKGQSSVNAGVPLFIVVVLSLLMVQLRSFSRMAMVFLTAPLGLIGVTLFLLLFRQPFGFVAMLGTIALAGMIMRNSVILVDQIEQDISHGLDRWHAIIEATVRRFRPIVLTALAAVLAMIPLSRSVFFGPMAVAIMGGLIVATVLTLLFLPALYAAWFRVKKDEARA	6.54	gnl|BL_ORD_ID|2016|hsp_num:0	2206			1497	1575	erythromycin; tetracycline; triclosan
BGC0001058.1|Zorbamycin_5 # 3090 # 3836 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.672	BGC0001058.1|Zorbamycin_5 	3090	3836	-	Loose	400	25.0238	vanR gene in vanM cluster	26.03	3002928	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGGTGCGCCCCCGGCCCCTGGCACGTGACCATTCATCACGCGGGATCCACGTTCGGTACGCGACCAGGCGTGTGTGGCACGATGCCGTGTTCGGGCAGGTCAGGGCGGCTGGAGGCAACGCTCTGGTCATGACGCGAGCGCGAGGTCGTGCAAAGCGCCACCAGAAACGGGCGTCACTGCTGTCACCGCTTCGGAGCAGCAGGCAGGCCAAGATCAAGGTCGCGACCACCTGGTGCGCCTCGTGGACACAGCTGTCGCCGCTGAGTCCGCACACGATGGCCCCGAAGCCGGCCGGCTGGTCCGACGTGCCCGCCACCTGCAAGGCCGAGGGCTTGCCCGCCGACCACCAGGGCGCACTCGGTCACCTAAGGCGGACGGCCTGGATTGCGAACGAACTGCTCAGCGCCTGGTCGCCATCGGTTGCCTCAAGGAGGCGGCGTGACCACTCTCCCCGTCGCTCCGACCATGGAGAGACAAGAACGTGCGTACCCCGACCGAGCCGTGTCCGGTGGGAGGGGCGGCTTCGCCGTGTGCGGTCGGTTGCGGCGGCGGAACAAGACACAGTCGGGCTAGCGTCCTCTTGGCCTCGGTCGTCCTTCGGGGCTGCATCGGGCAAGCGCGGTACGCAACATATGGCGCCGGGGCGGGTGGGTGAATATCTGTGCCCGCGGGTTGAGATTTCAGCGGAGCATACCGACAGGTTCTCTGTTGCAATAAGCGGGCTGGCGCTCTTCACCGCACACTGA	MVRPRPLARDHSSRGIHVRYATRRVWHDAVFGQVRAAGGNALVMTRARGRAKRHQKRASLLSPLRSSRQAKIKVATTWCASWTQLSPLSPHTMAPKPAGWSDVPATCKAEGLPADHQGALGHLRRTAWIANELLSAWSPSVASRRRRDHSPRRSDHGETRTCVPRPSRVRWEGRLRRVRSVAAAEQDTVGLASSWPRSSFGAASGKRGTQHMAPGRVGEYLCPRVEISAEHTDRFSVAISGLALFTAH	MRRISILIAEDEEEIADLLAIHLEKEGYDVIKVHDGQEALHVIQAQSIDLIILDIMMPKMDGYEVTRQVRAQYNMPIIFLSAKTSDFDKVHGLVIGGDDYITKPFTPIELVARVNAQLRRSMKLNHPQADDKKSILEFGEIVISPDQRTVFLYGENIGLTPKEFDILYLLASHPKKVYSVENIFQQVWNDAYFGGGNTVMVHIRTLRKKLGEDKRKNKLIKTVWGVGYTFNG	106.90	gnl|BL_ORD_ID|4735|hsp_num:0	752			516	687	vancomycin; teicoplanin
BGC0001058.1|Zorbamycin_6 # 3993 # 4436 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.653	BGC0001058.1|Zorbamycin_6 	3993	4436	-	Loose	400	23.8682	salE	45.83	3007029	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	sal-type ABC-F protein	ATGACCCCGTTCGCGGGCACCTTGCTGCAGATACTCCGGGGGTTTCTGCTGATCGCCTGGGTCGTCATGGCGGGTCTCACCGTCTTCACCCCCGACCAGGTGGATGGGAACCTCGCCTGGACGACGGCGGTGGTGGTCGCGGTGTACGCCGTGACGTTCGGGTGGCGTCTGCTGACCGCTCGGCTCGGCATGAACCGCTGTTACCTCCTGGCGGAGGGGGTGGCCCTGACCAACCGCTTCGGGCGGGTGATCGATTCCGTTCGGTGGAGCGACGTGACCGGTGTCCAGCAGACAACGGTCGTGGAGCTCTACATGGGAGCACACCGCATGGAGATTCACCGGAACCAGTCCGCCAAACCCCTTACATTCTTGGCACCCGGCGTGAAGTCACGGCTGGTGGAAGCGCTGCTCGCCGAAGGCCGCCGCGCAGGATCCTTGCAGTGA	MTPFAGTLLQILRGFLLIAWVVMAGLTVFTPDQVDGNLAWTTAVVVAVYAVTFGWRLLTARLGMNRCYLLAEGVALTNRFGRVIDSVRWSDVTGVQQTTVVELYMGAHRMEIHRNQSAKPLTFLAPGVKSRLVEALLAEGRRAGSLQ	MSFYFAQKPFEMFGKTLIQSVDLQFEKGEHIAVIGNNGVGKTTLLKALNNKYKEDTYLMDQNMTTFGNMTGIDYVISLNTELFHLKQALMDNYEKVSDYIALNGYEFEQTIITKAKQMALTEADLDKPIKVLSGGQQTRLALLRAFISNKPLILLDEPTNHLDQEMIDQLINHIQQSKRTIIYVSHHRGFIDQTASHVIEITPESTRKFNGNYKQYKEIKDLESQTEQRIYNKQQKEIQDLERTIKRVQTWHHSAQQKASVRNPIEQKKLSKLAQRAKVKEKQLNQKLQEKHIQEPSKETKSYYFSHQTSLPKRFLIRFEDVSVNIDGQAIYKHAHFEMKQNENILLTGPNGSGKSLFIALIRQHLSPDEGIIEITPSLKIGYFDHTNNNLNEAESPLSMLLVRTNITRSQAQTLLASFNFDKDQIKKPIRYLSMGEKSRLQFVLLYFSGANLLVLDEPTNYFDIVTQDLILSMIQSFTGQVLIVTHDSYLQSQFKAVHWEIKNQQLYNVSLTHTRESNLDETLKLLGEYKFIDENGHFETDN	27.07	gnl|BL_ORD_ID|4728|hsp_num:0	5740			1266	1338	tiamulin; retapamulin
BGC0001058.1|Zorbamycin_9 # 6427 # 7320 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.689	BGC0001058.1|Zorbamycin_9 	6427	7320	+	Loose	900	27.335	Corynebacterium striatum tetA	46.43	3004639	protein homolog model	n/a	n/a	penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCTCGAAGTGCCCATCCTGGGCCTGTCGCCGGCCAACCCCGTGATCGTCGGATCCGGGCTGCTGACGGACCAGGAACGCAACATCCGCCGGCTGCTGGGAAAGGGAGCCGGCGCCGTCGTCACCAAGACCATCCACCCGAGCCCCCCTCAGGGCCTCGACGAGCGGATCCTGCGCCTGCCGGTGGGGATGCTGAACAGCACCACGTACTCCAAGCGGTCGGTCAACCGCTGGCTGAAGACGCTGCGTTCGTTCGCCGACGACCGGTTGCCCGTCATCGCCTCCCTGCACGCCGACACGCCGGGCGAACTGGCCATGCTCGCCAAGGACGTCGAGACGACCGGCTGCCGGGCCCTGGAACTCGGCATCTCGTGTCTCAACGAGGAGGACGGTCTGGAGGACGACAACCCCGACCGGGTCTACGCCTACACTTCCGAGGTCCGCAGCAAGACGGCGCTGCCCATGTCCGTCAAACTCGCTGTCGGTGAGGGACTGCGGGACCGGGTGCGCGCCGCCATCGCCGGGGGCGCCGACGCCATCACCCTCAGCGACACCATCGCCGGCGCGGCCGTGTCCCCCACGACCGGCCGGCTGGAGTTGAACGGTGTCTTCGGCTACTCGGGACCGGGTCTCAAGCCGCTGGTCCTCGCTGCCATCTGGCAGTTACGGAAGAGCGGCATCGCCCTGCCGGTCATGGGCTGTGGCGGGGTGAGCAGTGGCCGCGACGTGGCCGACTACCTCAGCGTGGGCGCGAGTGTCGCACAGGTCTACACGGCCCTGCACACCGATATGTACCGGACGCTCGAGCGCATTCTGGCGGAGACCCGGGACCTGGTGGGTCCGCAAGCCGCCGTCCCGGGTTCCACCGAAGAGGCCCAGGAGGCGGCGATATGA	MLEVPILGLSPANPVIVGSGLLTDQERNIRRLLGKGAGAVVTKTIHPSPPQGLDERILRLPVGMLNSTTYSKRSVNRWLKTLRSFADDRLPVIASLHADTPGELAMLAKDVETTGCRALELGISCLNEEDGLEDDNPDRVYAYTSEVRSKTALPMSVKLAVGEGLRDRVRAAIAGGADAITLSDTIAGAAVSPTTGRLELNGVFGYSGPGLKPLVLAAIWQLRKSGIALPVMGCGGVSSGRDVADYLSVGASVAQVYTALHTDMYRTLERILAETRDLVGPQAAVPGSTEEAQEAAI	MKTYSWFVPPAPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSYLIGSGISAFVPVVVGMIVDGLVGEEKFNAWWLFAVLVGIFIIQFIGEATGDGLATASVRRVTHNAQQHLSSGVLRRGAGAMSPGTVLNTIDADANTVGRYRELLSFPLMAIGYAVCAMVAMWSVSPWISLAIPASALIIALFAAWTAGPVTRVSLKRRAAEADVAGLATDASQGIRTVKGLGAGATVATRFHAETAKANGLMLTHLRVEVWLGFARFCVAWLCNLGIVGLSAWMTLRGEITPGQLTSVALLVQPALTMAGLAFGDLASGWGRAVASGQRIEQLHHAGDDAAGPEPTDTPVPGAGLWILEPAERSYATAAAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDVVKQALAAAHCQDILRRLGGINEAGELPDAPLGEAGLNLSGGQRQRVALARALAADPEVLILDDPTTGLDSVTQADVVAAVAALRADKTTVVITGNAAWQHAGTELEVA	57.89	gnl|BL_ORD_ID|2120|hsp_num:0	3337			642	726	tetracycline; oxacillin; oxytetracycline
BGC0001058.1|Zorbamycin_10 # 7317 # 8147 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.697	BGC0001058.1|Zorbamycin_10 	7317	8147	+	Loose	400	25.7942	Erm(34)	35.14	3000600	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACCCACCGTGACGCGACACCGTCGCGTCTCACCGACCTGACCAGTGAACAGGTGGCCGACGCGGTGCGGGGACGGACCGTCGTATGGCCCATCGGGGCGATCGAGCAGCACGGCCCGCATCTGCCGCTTTCCGTCGACCTGATCCTGGCGGAGGCCTTCGCCACCGAGATCGCGCGGGAACTCGACGCGTTCACCCTGCCGGCACAGGCGATCGGTGCCCGGTCCCTGCCACAGAGCGGCGGCGGGCTGTTCTTCCCCGGTACGGTGTACGTGGGCGGCGACACGCTCGTGCGCTTCCTGCGTGACACGCTCTCCGCGCTGACTGTTCTCCCCATGGCCCGCCTCGTCGTGGTCAACGGCCACTACGAGAACGAGCCGTTCCTGTTCGAGGCACTGGACCAGGTGCGCGAGCGGGGACTGCTCGACGGCATGGAGGTCTTCGCGTTCAGTTGGTGGAGCCTGGTCCGGGACACCTGGACCGACGCGGAGACTCCCCGGTTCCCCGGCTGGCACGCCGAACACGCGGGAATCACCGAGACCAGCCTCATGCTCCACCTGCGTCCCGATCTCGTCACCGACGAGCGTCCCGACCACGACAGCCCGCCCCGGGCGGGTGTCTACCTGCACCCCGTCGACGTTGGACAGACCACCCACCGCGGTGTCCTGTCCTCGACGTCGGGATCGAGCTCCGGCCTCGGGGAGAAACTGCTGCGCCATGTCGTCGACGAGGCGACGGCCATGGTGCGCGACGGCACGGGGCTGCTTCTGGACCGGACCCGTCCGGCCCGCGGCGTCTCCGGCCGCCCGCGTGATCGCGAAGACCTGTAG	MTHRDATPSRLTDLTSEQVADAVRGRTVVWPIGAIEQHGPHLPLSVDLILAEAFATEIARELDAFTLPAQAIGARSLPQSGGGLFFPGTVYVGGDTLVRFLRDTLSALTVLPMARLVVVNGHYENEPFLFEALDQVRERGLLDGMEVFAFSWWSLVRDTWTDAETPRFPGWHAEHAGITETSLMLHLRPDLVTDERPDHDSPPRAGVYLHPVDVGQTTHRGVLSSTSGSSSGLGEKLLRHVVDEATAMVRDGTGLLLDRTRPARGVSGRPRDREDL	MTKKMNKYNGKKLSRGEPPNFSGQHFMHNKRLLKEIVDKADVSVRDTVLELGAGKGALTTILSERADRVLAVEYDQKCIEALQWKLVGSKNVSILHQDIMKVALPTEPFVVVSNIPYSITTAIMKMLLNNPKNKLQRGAIVMEKGAAKRFTSVSPKDAYVMAWHMWFDIHYERGISRSSFSPPPKVDSALVRIVRKQHPLFPYKEAKAMHDFLSYALNNPRAPLDQVLRGIFTAPQAKKVRQAIGVKPETPVAMLHARQWAMVCDAMVRHVPKVYWPRRKR	98.22	gnl|BL_ORD_ID|7|hsp_num:0	11			27	138	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0001058.1|Zorbamycin_11 # 8223 # 10724 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=14bp;gc_cont=0.696	BGC0001058.1|Zorbamycin_11 	8223	10724	+	Loose	1080	28.1054	vgaB	32.26	3000118	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	vga-type ABC-F protein	ATGTCCACACGACTGCGGCGGACCGTGCCGACCATGGTGATCGTCGTCTCGACTCTGCTCTCCACCGGAGCTGCGTCCGCCGGCTCCACAGCGGCGAACGCGCGGAGCGCAGGGACGGACGACGTGGCCACGGTCCAGCACGACGGATACCGCGCGGTCATACGCCGGACGCAGCACGGTGTGCCGCACGTGCTCGCGGCCGACGTCAAGAGCGCAGGCTTCGGCCAGGGCTGGGCCTATGCGGCGGACCGGGGCTGTGACCTGGCGGATCAGGTCGTCAAGCTCCGCAGTGAGCGTGCCCGCTGGTTCGGTCCCGGCCCCGACAACGCGCATCTGGCGTCCGACTTCGGTTACCACGCCCTGGGAATCAGAACCAAGGCCGAGCGTGAGCTGACGAAGCTCTCTCCCGACGTGCGCGCCATGGTCAGCGGTTATGCGGCGGGATTCAACGCCTATCTGGAACGCAGCGGCAAGCTGCCCGGATGGTGCGCCGACGCTCCCTGGGTGGGGAAGATCGACGAGGTCGACATACTGTCCCGGGAAAGGGACGTGGCGATCACCATGGGAAGCGCGACGCTGCTGGGCGCGATCACCCTGGCCCAGCCGCCCACCCGGCAGGAGAGGGCGAAGGGCACGGCCCCAGGCGTCGACGCGGAGCCCGGCCGCAAGCTGGTCGCCCAGCAGGCCCGGACGGTGCTGCGTGGTGACCGCCGTACCGCGGCGCTCGGCAGCAACGGTTGGGCGGTGGGGGAGGAGCGGACCACCGACCGCGGTGGATTGCTGGTCGCCAACCCGCACTTTCCCTGGGAGGGGGAGAACCGCTTCTGGGAGTCGCAACTGACCGTTCCCGGACGGCTCCAGGTCTACGGAGCGAACCTCGGCGGCCTGCCCGGTGTGCAGATCGGCTTCAACCGTGACGTGGCGTGGACCCACACCGTGTCGAGCGGCTGGCACACAACGGTGTACACGGTGAAGCTGACGGAGTCGGACCCCACGCGCTACCTCGTCGACGGCACGCCGGAAGGCATGACCTCGCGTACGTACTCCGTGCGGGTCAAGGGAACGGACGGCAGCCTGCAGACCGTACGGCGGACACTGTGGCAGACCCGCTACGGACCGGTGATCGACCTGTCCCCGGTGGATCCGTCCTACGGCTGGTCCCGCACGCAGGCCGTTACGTTCCAGGACGCCAACATCGGCAACGGGGGCATCCTGGAGCAGTACGCGGACATGGCGAAGGCCCGTTCGGTCGGCGAGCTCAAGGCGGCGCACCGCCGGCACCAGGCCGTTCCCTGGATGAACACCATCGCGGCGGACAAGAGTGGCGGGACGTGGTACGCGGACACCTCCGCCACGCCGAACTTGTCGGCCGACGGCATCGCCGCATGGCTGTCCCATCCCTTCGGTGTGCTGGACGGAAGCGACTCACGCCATGCCTGGCAGAAGGAACCCGGGGCGCGGCAGCCGGGGCTCGTACCGTTCGTCCGGCAACCGCAACTGAGCCGCCAGGACTACGTGTTCAACTCCAACGACAGTTACTGGCTGGCCAATCCGGAGCGGCCCCTGACCGGTTTCTCGCCCCTCTTCGGCTTCGAGAACGTGCCGCAGAGTGCACGCACCCGGCAGAACGCGCTCATGCTGCGCAAGAGCGGTCCGGCCTCCGTCTCCGGCTCGGACGGCCGGATCAGCCTGGCAGAAGCGGAGAAGGGGCTGACGTCGACCCGGGCGCTCACCTCGGACCACCTGCTCGCACCGGTCGTGCGGGCCTGCCGTGCCCAGGCCGGCACGCCCGTCGTCGTGGACGGCAGGTCCGTCGACGTCACGAAGTCCTGTGATGTGCTGGCCGATTGGGACGGCCGGTTCACCGTCGACAGCCGCGGGGCCGTGTTGTGGCGGGAGACCCTCGCCGCCGTCGAACGAGCCCACCCCGGGTCCGTGACGAACGCGGGCGCCCTGTTCAGCGAAGCGTTCGATCCGGCCAGGCCCGTGGACACGCCTGCCGGTCCCGCCGCGGACACCGCTCCGGTCCTGGAGGGTCTGGCCAAGGCTGCGCTGACCCTGGAAGCGGCCGGACTGCCCGCGGACGTACCGCTCGGCCGGGTCCAGTACGCGGTCAAGGACGGGAACAGGCTCCCCGTACCAGGCACGGCGGGATTCATCGGCGCCACCAATGTCGTCGAGCACCTGGCCCAGCCGGGAAGCTCCCTGGAGCCGGCCACCCCGGGCGGCACGCCGTTGGCGTACGGCGACCTGACCGACCAGGGATATCCCGTGAACACCGGGTCCAGCTTCATGCTGGTGGTGAACTTCACCAGGAACGGCCCGGTGGCCAAGGGGCTTCTGACCATGGGCCAGTCCCTGGACCCCGGCTCCCCGCACTTCACCGATCAGACCAGGGCCTTCGCCCGGTCGGAACTGGGCAGGCGGCCCTTCACGGAGAAGGAGATCCTTGCGGACCGGCATCTGGCCACGGAGATGGTGACCGGGCGCGTCGCACGCTGA	MSTRLRRTVPTMVIVVSTLLSTGAASAGSTAANARSAGTDDVATVQHDGYRAVIRRTQHGVPHVLAADVKSAGFGQGWAYAADRGCDLADQVVKLRSERARWFGPGPDNAHLASDFGYHALGIRTKAERELTKLSPDVRAMVSGYAAGFNAYLERSGKLPGWCADAPWVGKIDEVDILSRERDVAITMGSATLLGAITLAQPPTRQERAKGTAPGVDAEPGRKLVAQQARTVLRGDRRTAALGSNGWAVGEERTTDRGGLLVANPHFPWEGENRFWESQLTVPGRLQVYGANLGGLPGVQIGFNRDVAWTHTVSSGWHTTVYTVKLTESDPTRYLVDGTPEGMTSRTYSVRVKGTDGSLQTVRRTLWQTRYGPVIDLSPVDPSYGWSRTQAVTFQDANIGNGGILEQYADMAKARSVGELKAAHRRHQAVPWMNTIAADKSGGTWYADTSATPNLSADGIAAWLSHPFGVLDGSDSRHAWQKEPGARQPGLVPFVRQPQLSRQDYVFNSNDSYWLANPERPLTGFSPLFGFENVPQSARTRQNALMLRKSGPASVSGSDGRISLAEAEKGLTSTRALTSDHLLAPVVRACRAQAGTPVVVDGRSVDVTKSCDVLADWDGRFTVDSRGAVLWRETLAAVERAHPGSVTNAGALFSEAFDPARPVDTPAGPAADTAPVLEGLAKAALTLEAAGLPADVPLGRVQYAVKDGNRLPVPGTAGFIGATNVVEHLAQPGSSLEPATPGGTPLAYGDLTDQGYPVNTGSSFMLVVNFTRNGPVAKGLLTMGQSLDPGSPHFTDQTRAFARSELGRRPFTEKEILADRHLATEMVTGRVAR	MLKIDMKNVKKYYADKLILNIKELKIYSGDKIGIVGKNGVGKTTLLKIIKGLIEIDEGNIIISEKTTIKYISQLEEPHSKIIDGKYASIFQVENKWNDNMSGGEKTRFKLAEGFQDQCSLMLVDEPTSNLDIEGIELITNTFKEYRDTFLVVSHDRIFLDQVCTKIFEIENGYIREFIGNYTNYIEQKEMLLRKQQEEYEKYNSKRKQLEQAIKLKENKAQGMIKPPSKTMGTSESRIWKMQHATKQKKMHRNTKSLETRIDKLNHVEKIKELPSIKMDLPNREQFHGRNVISLKNLSIKFNNQFLWRDASFVIKGGEKVAIIGNNGVGKTTLLKLILEKVESVIISPSVKIGYVSQNLDVLQSHKSILENVMSTSIQDETIARIVLARLHFYRNDVHKEINVLSGGEQIKVAFAKLFVSDCNTLILDEPTNYLDIDAVEALEELLITYEGVVLFASHDKKFIQNLAEQLLIIENNKVKKFEGTYIEYLKIKDKPKLNTNEKELKEKKMILEMQISSLLSKISMEENEEKNKELDEKYKLKLKELKSLNKNI	150.91	gnl|BL_ORD_ID|1678|hsp_num:0	1817			828	921	virginiamycin M1; dalfopristin
BGC0001058.1|Zorbamycin_12 # 10945 # 11343 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.667	BGC0001058.1|Zorbamycin_12 	10945	11343	+	Loose	275	25.0238	AAC(6')-IIc	23.08	3002596	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGGCCGTATTGCTCTCGGGGGTTCCCGTTCTCGCCGCCCTCGACGTTTCCACCACGCAGAAGTTCTGGATCGAGGTCCTCGGCTTCACCGAGGAATTCCTCACCGAGGATTTCGGCGGCGTCAGCCGCGACGGGGTCGAGTTGTTCATCTGCTCCGTCGAGGACCAGGTCGTTCCCGACAACACGCAGGCGTGGCTGCGGGTCCGCGACATCGACGCCCTGCACGCCGAGTGGTCCGCGCGTGTCTCCTCGGACTACGCCGACGCCAGTCACCCTGCCATGACCGCGATCAGGGAGGTGCCCTGGGGGCGGGAGTTCGGGCTGCGCGACCCCGCCGGAAACCTGGTGCACTTCAGCGAGTTGAGCGAGGCGGCCGAAACGACCCGGACGGTTCGTTGA	MAVLLSGVPVLAALDVSTTQKFWIEVLGFTEEFLTEDFGGVSRDGVELFICSVEDQVVPDNTQAWLRVRDIDALHAEWSARVSSDYADASHPAMTAIREVPWGREFGLRDPAGNLVHFSELSEAAETTRTVR	MSANNAAIVLRVMAENDLPMLHAWLNRPHIVEWWGGEDERPTLDEVLEHYSPEVLAKQAVVPYIAMLDDEPIGYAQSYIALGSGDGWWEDETDPGVRGIDQSLANPSQLNKGLGTKLVRSLVELLFSDPAVTKIQTDPSPSNHRAIRCYEKAGFVQEKNILTPDGPAVYMVQTRQAFESLRTVQSFKIKGKWS	68.39	gnl|BL_ORD_ID|674|hsp_num:0	730			396	552	dibekacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin; gentamicin
BGC0001058.1|Zorbamycin_14 # 12106 # 13356 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.714	BGC0001058.1|Zorbamycin_14 	12106	13356	-	Loose	650	25.7942	EreA	46.43	3000361	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	ATGCGCATGACCGTCTCCGGCGCATCCGCGTCGGGCGGGTTCGACATGGTCGACCTGCACGACCCGATGCTGTACGGCCAGGGTGAACCGCATTCCGTATGGCGCCATCTGCGCAGGCACTCGCCCGTGCACCGCAATGTCACCGCGGACGGCAGGTCCTTCTGGTCGGTGACCCGCCACCAGGACGTCATGCGCGTGTTGCGCGATTACGAGGTCTTCACCTCCGCGCGAGGAAACCTCCTCACCACGCTGGGAACGGACGACGTGGCCGGCGGGCGCATGGTGACGGTCACTGATCCACCGCACCACGCCCGTTTGCGGGCGCCCCAGGTGGCCGCCCTCACGGCAGGCGTGCGCGGCACTGGAGGCACACGGATGCGCGAGGCGGTACGGGCGCTTCTGCGTCCTGCGCTCGACGGGTCCCCGTGGGACCTGGCGCGGGCGGCCACCCGTCTCCCCCTGATGGCCCTGGGGCCGGTGATGGGGCTGCCGGCGGCGGACTGGCCCGCACTGGGCCGGTTGGCGTTCGCCGCAGTGGCACCGGACGATCCGGTGTACGCCGCCGAAGGCACCCGTACGACGCTGGCGACGGCACACCACGAGCTCTTCTCGTACTTCCGCGCCGCCCTGCGGTCGCGGCATCGCTCCCCGGCGGACGACCTGCTGACCCGGCTGCTCCCGCCCGCCGGTGAGGACACCCGGGCAGCGGCCGAGTTGGCCGTGTACCACTGTTACAGCCTGCTGCTGGGGGCCGTCACCACCCTGCCGCACACGATGTCGGCGACGGCCTTGGCCATGGCAGAGAACAGCCGTGTCATCGAGGCGATGCGGCAGGGACCCCAGGCACTCGCCACCGGTGTCGAGGAGGCGCTGCGCTGGTCCTCACCCGCGGCACACGTCCTGCGGCACACGACACGGCCGGTGGAGCTGGCCGGAGTCCCGTTGTCCCGTGGTGAGGCCGTGGTGGCCTGGCTGGGCTCGGCCAACCGGGACGAGGCGGTCTTCCCCGACCCCTACCGCTTCGATCCCGGACGAACGCCCAACCGCCATCTGGCGTTCGGTTACGGCCCCCACTACTGCCTCGGCGCCGCCCTGGCCCGCGCGTCCCTGACGGCCGTTCTCGTCGAGCTGGTCGACGCGGTGGAGGCCGTGGAGGTGTGCGGTCCGGTCGAACACCTGAACTCGCACTTCATCGCGGGGATCAACCGGTTGCCGGTCCGTCTGACACCTCGTCGACGAGCGGCCCACTGA	MRMTVSGASASGGFDMVDLHDPMLYGQGEPHSVWRHLRRHSPVHRNVTADGRSFWSVTRHQDVMRVLRDYEVFTSARGNLLTTLGTDDVAGGRMVTVTDPPHHARLRAPQVAALTAGVRGTGGTRMREAVRALLRPALDGSPWDLARAATRLPLMALGPVMGLPAADWPALGRLAFAAVAPDDPVYAAEGTRTTLATAHHELFSYFRAALRSRHRSPADDLLTRLLPPAGEDTRAAAELAVYHCYSLLLGAVTTLPHTMSATALAMAENSRVIEAMRQGPQALATGVEEALRWSSPAAHVLRHTTRPVELAGVPLSRGEAVVAWLGSANRDEAVFPDPYRFDPGRTPNRHLAFGYGPHYCLGAALARASLTAVLVELVDAVEAVEVCGPVEHLNSHFIAGINRLPVRLTPRRRAAH	MTWRTTRTLLQPQKLDFNEFEILTSVIEGARIVGIGEGAHFVAEFSLARASLIRYLVERHEFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSVYGSVLIWLKSYLRESGRKLQLVGIDLPNTLNPRDDLAQLAEIIQLIDHLMKPHVDMLTHLLASIDGQSAVISSAKWGELETARQEKAISGVTRLKLRLASLAPVLKKHVNSDLFRKASDRIESIEYTLETLRIMKTFFDGTSLEGDTSVRDSYMAGVVDGMVRANPDVKIILLAHNNHLQKTPVSFSGELTAVPMGQHLAERVNYRAIAFTHLGPTVPEMHFPSPKSPLGFSVVTTPADAIREDSMEQYVIDACGTENSCLTLTDAPMEAKRMRSQSASVETKLSEAFDAIVCVTSAGKDSLVAL	102.46	gnl|BL_ORD_ID|917|hsp_num:0	991			90	174	erythromycin; roxithromycin; clarithromycin
BGC0001058.1|Zorbamycin_15 # 13611 # 19979 # 1 # ID=1_15;partial=00;start_type=TTG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.724	BGC0001058.1|Zorbamycin_15 	13611	19979	+	Loose	1000	132.494	almE	30.32	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	TTGCCGGAAGCGTTTCCCGCGTACTCAGCCTCCCCTGTTCAGTCCGCTCTGTGGACCCGTGTCACCCGCTCCCACCCCGACGGCACCACCGCGCGGCGTGAGTCGTCGTGGATCCTGCGTGGCGCCTGGGACGTGGAACGCCTGCGCCGGGCTCTGACCTCCGTCGTCGAACGACACGAGGCGCTCCGCACCACCGTCCGCGCCGCGGCCGCGCGCACCGAACCCGTCCAGAGTGTCGACGGCTTACCGGCGGATCTTCTCGACGTCGTGGATCTGTCCGATCGAGGTGACGGCGACACCGCCGCAGCGGCGGCGCGAACCGCCCGCGGCACCTGGTCCGCGGCTCTCGCCCGGCCGCAGGCCCCCGCCCTGCGCGCACTGCTGGTCGTGCGCCCGGGCCACGCCGAATTGGTCCTTAACGCGAGCGTCCTCGCGGCCGATCGGCGCACGCTGCGGATCGCCGCCCGGGAGGCCGCCGTCTGCCTCGCGGGGGAGAAGCCCGAGGGGGAGGTCACGCAGTATCCGGAAGTGGCGGCCTGGAACCTGGAGTTGCTGGCCGACGAGGAGTCGGCCGAGGACCGCGACCACTGGAACACGCTCCTGGCGACCGCCACCACCTGGGCCACGGCGCACCGGCCCGTCCGCACGCGGACCGTCCCGGCGGCAACGCCCGAGCACACCACGCTCCTCGACAGCGACCGCGTGCACCGCATCACCGCACTCGCGACAGCCGGTGGGACCTCCGCCCGAGCCGTGCTCGCCGCGGCCTGGACCGTGACCGTCGCACGACTCGCCGGGGCGGCGATACCCCTGGCCGTCACCGACGACGGGCGTGCCTTCGAGACGGTGCGGGAGGCTGCGGGTCCGTACGAGCGCGCCTTCCCCACCGTTGTCGACGCCCTGGAGGCATCCAGCTTCCACTCCGTGATCGACGAGGTCGCCGCGCAACTGGAGCGTGGCGGGGAGCTCGTTGACCACCTCGACTCGCGTCGATTCGACGCGCTGACGGACGAAGGGCTGTGGGCCGGCTTCGCCAGCGTTCCCGCCGCGCCGGTCCTCGACCACGGGGGAGTGCGCTGGCACGCCCTCGAAGAGCGCGCCCCACGCCCGGTCCGCACGCTGACCTGCACCGAGACCGCCGACACCGCGGGGTGGGAGCTGTCCTACTCCGGAGGGGACATGGCGGCAGTGCCCGCCGAAGCCGTCCTCCCCGTCTTCGTCGCAGCCCTGGACGCCCTGCTCGCCGCGCCCGGCGAGCCGCCCGCGGACTGCCCGCTCACCAGCGCCGGCGACCCCGGCAGCGATCTTGTCGGCGCCGTCTCCGAGACCCCTGCACCCGACCTCGCCGAGGCCGTGGCCCTGGTCGCTCTCCGTACACCCGACGCCGAGGCCGTGCGCTGCGGCGACGATCATCTCACCTACCGCGCCCTGGACGCCCTCGCCAACCGCTGGGCACGGCGCCTGACCGATGCCGGGGTCCGCCCGGGCGACCGCGTCGTCCTCGATCTCGACCGGGGTGTCGCCGTCCCCGCTGTCATGCTCGGTGTGCTGCGCGCCGGCGCGGTCTTCGTACCGCACGACACCTCGCACCCGGACGCGCGCCTCCGGTTCGTGCTGACCGACACGGCCGCCACGGCGGTGATCACCTGCCGGAGCCTTCACCCCGATGCCCACCCCGTCGTGCTGGCACCGGACGACGCGACCGTCGCCGGCCTCCCGGACACGGCCCCCGACACACGGCCGGCATCCACCGATCCGGCGTACGTGCTGTACACCTCCGGCACCACCGGTCGGCCCAAGGGAGTGGTCGTCCCACGACGCGCCCTGAACAACTACCTGACGTGGGCCGCCGAGACCTACCGTCTCGCCGAGGGCACGGGCAGCCTCGTCCATTCCCCGCTCGCCTTCGACTTCACCCTCACGGCGCTGCTGGCGCCCCTCACGGTCGGCGGGCGGGTGCTGCTCCTGCCTCCCGGCATCGGACCGTCCGGGCTGGCCGCCGCGCTGCGTACCCACACCGACCTCTCCCTGCTCAAACTGACGCCGACCCACCTGGACGCCCTCCAGCGGTTCGCCGGCGGCACGCAATGGGCGGGCCGGGTGCGCACCCTGGTCCTCGGCGGCGAGCAGCTGCACGCCGAGGACCTGGGCCCCCTGCGCGACCTGCCCGGCCTCAGGATCTTCAACGAGTACGGCCCCACCGAGACCGTGGTCGGTTCCACCGCGCACGAGGTGACCAGCTCCACGCCCACCCGCGGCCGGGTGCCCGTAGGCCGCCCCGTCGCGGGCACCGTCGTCACCGTCCGCGACCGCCGGGGCCGCCCGGTTCCCGCCGGTGTGCCCGGCGAGATACGCATCGGCGGCCCGGGCCTGGCCGACGGATACCTCGGCGACGCGACCACCACGCGTGAGCGGTTCGTCACCGACGCGCACGGCCCCCGCCCCTGGGAGATCCACTACCGTACGGGTGACCTGGGGCGCCTGCTGCCCGACGGCGACCTGGAGTTCCTGGGCCGCCTGGACGACCAGCTCAAGATCCGCGGCGTGCGGGTCGAACCGGACGAGGTGCGCACGGTCCTCCTGGAGCATCCCGGAACCCAGCGGGTCGCTGTCGTCGCCGCCGCCTTACGCGACTCCGCCGATGGATCGCGCCTGGTCGCCTACGTCGTGCCCGCCGACGCCGACCACACGGCTCCGGTGCGCCCCCGCGACCTGGTCGAGCACGCACGGCAGATCCTGCCCGCCGCGATGGTGCCTGTCGTCATGCTCGTGGACGAGTTGCCCACGACGCCCAACGGCAAGCTCGACCTGGACGCCCTGCCCCGTCCCGATCGCGATCTGCTCACCGAGCGCCCCTACACGGCACCGCGCGACCTCACCGAAGAGGTCCTCACCTCCGTCATCGCCGATGTGCTCGGCCTGGAGTGTGTCGGCATCGACGACGACTACCTGGCCCTGGGCGGCGACTCCATCCGCAGCGTCATGGTCGCGGCACGCGCCGCGCACCGGGGTGTGGCCGTCGGCGTCGCCCAGCTCCACGAGCACCCCACGGTCCGTGAGATCGCCGCCGCGCTCTCCCAGGAAGCCGGCACGACACCAGGCCACACCCGGCCGACCGGATCGTTCTCCCTGGTCAGCGCTGAGGACCGGGCCCTGATGCCGGAGGACGTTGAGGACGCCTTCCCGCTGAGCCTGCTCCAGGAAGGCATGATCTTCCACCGGGACTTCGCGGCGAAGTCGGCCGTCTACCACGCCATTGCCTCCGTGCGCCTCGAAGCCCCCTTCGACCTGGCACTGTTCGACACGGTTATCCGCGGTCTCGTGGAACGCCACCCCATGCTGCGGACCTCGTTCGACATGTCCACCTTCAGCCGCCCGCTGCAGCTGGTCCACCGGACGTTCGCCACTCCGCTGTTCCACGAGGACCTCCGCGGCCTCGACCCCGAGGAGCAGCGAGCCCGTGTCATGCGCTGGGTCGAGGGGGAGCAGGAGCGCGGCTTCGAACTCCATGACTACCCCCTGATCCGCTTCATGGTGCAGCGGCTCAGCGACGACGAGTTCCAGTTCACCTACGGCTTCCACCACGAGATCGTCGACGGGTGGAGCGAAGCCTTGATGATCACTGAGATCTTCGACCACTACTTCTCCCTGGTGTACGACGAACCCATCGAGCTGCGGACCCCCGCCGCATCGATGCGCGACGCCGTGGCGCTCGAACTCGAGGCGCTGGACGACCGCGCCAAGTACGACTTCTGGGACGCGTACCTGGCCGACGCCTCCCTCATGCGGCTGCCCCGCATCGAGGGGGGACAGACCGCGGACAAGGGCGCCCGGGACATCGTCCGGCGCACCGTGCCGGTCACCGCCGAGCTCTCCGATGCGCTCAAGCACTTCGCGCGAGACGAGGGCGTCCCGCTGAAGACCGTGCTGATGGCCGCCCACATGCGGGTCATGTCGCTGTTCGGCGGACACACCGACACCCTCAGCTATACCGTCACCAACGGCCGCCCCGAGGACACCGACGGCACTACCGCCATCGGCCTGTTCGTCAACAGCCTCGCCCACCGCGTCGCCATGCCCGGCGGAACCTGGCGCGACCTGGTCGCCGCGAGCCTCGCGTCGGAGCGCGCCACCATGCCGCACCGCCGGCTCCCCATGGCGGAACTCAAGCGCCACCAGGGCAACGAGCCGTTGGCCGAAACATTGTTCTTCTTCACCGACTACCACGTCTTCCGGGTGCTGGACCGCTGGCGCGCCCGGGGCGTCCGGCACGTCGCCGACGAGCTGTACGGCGAGTCGACGTTCCCGTTCTGCGGGATCTTCCGCCTCAACCGCGACAACGGGGACCTGGAGGTGAGGATCGAGTACGACAGCCTCCAGTTCTCCGGTGAACTGATGCGCGGCATCTCCGACGCCTATATCGAGGTCCTCAGCGCCATGGCCGGGGACCCGGACGGCCGCTACGACGCCCGGGACTTCCTGTCCGCCGGCGACCGGCGCACCCTGGAGTCCCTGCGAGGACCCGACCTGCCCGCGGCCGAGGACCGCTGCCTGCATCATCTCTTCGAGGAGAGAGCCCGCACGCAGCCCGACGCCACGGCCGTGCAGTGGTCGGGCGGCTCGATCTCCTACGCGGCCCTGGACCGGCGCGCCGGCGGACTGGCCCGAACCCTGCGGGCTCAGGGTGTCGGCGCCGAGGTGCCCGTCGGCATCCTCGCCGACCGCTCCGCCGAACAGATCATCGCCATCCTCGGCGTCCTCAAGGCCGGCGGCGCCTACGTACCGCTCGACCCCGCCCTGCCCGAGGCCCGGTTGGGGTCGATCGTGGCCGCGTCCGGCGTCCGCCTCGTCATCGCGCAGCGCGCCCGGAAGGACCGCGTGCCCGCCGGCACCACCGCACTGACCCTGGACCCGGTCGGCCGCACAGTCTCGGTACCCGATCAGGGCGGAGCACGCCCCGCTCCGCAGGCGGGCCCGGGTAACGCCGCCTACATCCTGTTCACCTCCGGATCGACCGGCGAGCCCAAGGGCGTCGTTGTAGAGCACCGCAACGTCGTCGCCTCGCTGCGCGCCCGCAGCGCGACCTATCCCGACCCCGTGGACCGCTTCCTCCTCCTGTCGTCGTTCGCCTTCGACAGCTCCGTGGTCGGCATCTTCTGGACCCTCACCGAGGGCGGCGCGCTCGTCCTGCTGCCCGAGGGAGCCCAGCTGGAACCGCTCGACGTGCTCGACCGGCTCGTGCGCGAACGCGTCACGCACACCCTCGCCATCCCCTCCCTGCTGGTGCCCGTGCTGGAAGAGGCCGGCGACGACGAGCTGGACGCCCTGCGCGTGGTCACGGCCGCCGGCGAACCCTGCCCCTCGGCACTCGGCGAACTGGCCCTCGACCGGGTCCCCCGCGCCTCGCTGCACAACGAGTACGGGCCCACCGAGGCGACCGTGTGGAGCACCGTGTGGACGGGCGGTCCGGGAACCGGCCGACCCCATCTGCCCATCGGCCGGCCCATCGCGGGCAGCCGCGCCCGCGTAGTCAACCCCCACGGCCACGACGTGCCGGTGGGCGTCTCGGGCGACCTCCTCGTCGCCGGTCCCGGCGTGGCCCGCGGCTACCTCGGACACCCCCGGGCCACCGCCGCCGCCTTCCGGCCCGACGCGCGCGCCGCCGCCCCCGGCGAGCGGCACTACGTCACCGGTGACGTAGTCCGCTGTCTGAGCGGCGGCGACCTGGAGTTCGTCGGACGCGACGACCAACAGGTCAAGATCCGCGGTTTTCGCGTGGAACTCAGCGAGATCGAGGCCGTTCTCGACGCCCATCCCGATGTCCACAAGGCCGTGGTGGTCGTCCACCCGGGTGGTCCGTCCGGCAGCAAGGAACTGACCGCCCACGTCGTCCTGCGGCCGGGGGCGACGCTCGACGCCGTGCGCGTGCAGCAGTTCGTACGCGACCGGCTGCCCCGCTACATGGTCCCCGCCCACGTCACGGTCCTCGACGCCGTGCCCCTGACCGCGACCGGCAAGGTCGACCGTTCCGCTCTGCCCGCGCCTGCCGTCACCCGGCGGTCCGACGTCCCGCACGTCGAACCCGCCACCGAGAGCGAACGGATGATCGCCGCCGTATGGTGCCGGGTGCTCGGCCTGGAACGGGTCAGCGCACGTTCCGGCTTCTTCGACCTCGGCGGTGAATCGCTCCGCGCGATGCAGGTCACCACGGCCGTCAACAAGGCCTTCGGCACCCGCATCACCGTGCGCGCCCTGTTCGACGCCGCCACCCTGGCGGAGTTCGCCGGCGTCATCGACGCGGCACGGCGCGGCGAGGGGCCGGTGGAACGGGGCATCGCCGCGGCGTCGGCCGAAGCGGCAGACCGATGA	MPEAFPAYSASPVQSALWTRVTRSHPDGTTARRESSWILRGAWDVERLRRALTSVVERHEALRTTVRAAAARTEPVQSVDGLPADLLDVVDLSDRGDGDTAAAAARTARGTWSAALARPQAPALRALLVVRPGHAELVLNASVLAADRRTLRIAAREAAVCLAGEKPEGEVTQYPEVAAWNLELLADEESAEDRDHWNTLLATATTWATAHRPVRTRTVPAATPEHTTLLDSDRVHRITALATAGGTSARAVLAAAWTVTVARLAGAAIPLAVTDDGRAFETVREAAGPYERAFPTVVDALEASSFHSVIDEVAAQLERGGELVDHLDSRRFDALTDEGLWAGFASVPAAPVLDHGGVRWHALEERAPRPVRTLTCTETADTAGWELSYSGGDMAAVPAEAVLPVFVAALDALLAAPGEPPADCPLTSAGDPGSDLVGAVSETPAPDLAEAVALVALRTPDAEAVRCGDDHLTYRALDALANRWARRLTDAGVRPGDRVVLDLDRGVAVPAVMLGVLRAGAVFVPHDTSHPDARLRFVLTDTAATAVITCRSLHPDAHPVVLAPDDATVAGLPDTAPDTRPASTDPAYVLYTSGTTGRPKGVVVPRRALNNYLTWAAETYRLAEGTGSLVHSPLAFDFTLTALLAPLTVGGRVLLLPPGIGPSGLAAALRTHTDLSLLKLTPTHLDALQRFAGGTQWAGRVRTLVLGGEQLHAEDLGPLRDLPGLRIFNEYGPTETVVGSTAHEVTSSTPTRGRVPVGRPVAGTVVTVRDRRGRPVPAGVPGEIRIGGPGLADGYLGDATTTRERFVTDAHGPRPWEIHYRTGDLGRLLPDGDLEFLGRLDDQLKIRGVRVEPDEVRTVLLEHPGTQRVAVVAAALRDSADGSRLVAYVVPADADHTAPVRPRDLVEHARQILPAAMVPVVMLVDELPTTPNGKLDLDALPRPDRDLLTERPYTAPRDLTEEVLTSVIADVLGLECVGIDDDYLALGGDSIRSVMVAARAAHRGVAVGVAQLHEHPTVREIAAALSQEAGTTPGHTRPTGSFSLVSAEDRALMPEDVEDAFPLSLLQEGMIFHRDFAAKSAVYHAIASVRLEAPFDLALFDTVIRGLVERHPMLRTSFDMSTFSRPLQLVHRTFATPLFHEDLRGLDPEEQRARVMRWVEGEQERGFELHDYPLIRFMVQRLSDDEFQFTYGFHHEIVDGWSEALMITEIFDHYFSLVYDEPIELRTPAASMRDAVALELEALDDRAKYDFWDAYLADASLMRLPRIEGGQTADKGARDIVRRTVPVTAELSDALKHFARDEGVPLKTVLMAAHMRVMSLFGGHTDTLSYTVTNGRPEDTDGTTAIGLFVNSLAHRVAMPGGTWRDLVAASLASERATMPHRRLPMAELKRHQGNEPLAETLFFFTDYHVFRVLDRWRARGVRHVADELYGESTFPFCGIFRLNRDNGDLEVRIEYDSLQFSGELMRGISDAYIEVLSAMAGDPDGRYDARDFLSAGDRRTLESLRGPDLPAAEDRCLHHLFEERARTQPDATAVQWSGGSISYAALDRRAGGLARTLRAQGVGAEVPVGILADRSAEQIIAILGVLKAGGAYVPLDPALPEARLGSIVAASGVRLVIAQRARKDRVPAGTTALTLDPVGRTVSVPDQGGARPAPQAGPGNAAYILFTSGSTGEPKGVVVEHRNVVASLRARSATYPDPVDRFLLLSSFAFDSSVVGIFWTLTEGGALVLLPEGAQLEPLDVLDRLVRERVTHTLAIPSLLVPVLEEAGDDELDALRVVTAAGEPCPSALGELALDRVPRASLHNEYGPTEATVWSTVWTGGPGTGRPHLPIGRPIAGSRARVVNPHGHDVPVGVSGDLLVAGPGVARGYLGHPRATAAAFRPDARAAAPGERHYVTGDVVRCLSGGDLEFVGRDDQQVKIRGFRVELSEIEAVLDAHPDVHKAVVVVHPGGPSGSKELTAHVVLRPGATLDAVRVQQFVRDRLPRYMVPAHVTVLDAVPLTATGKVDRSALPAPAVTRRSDVPHVEPATESERMIAAVWCRVLGLERVSARSGFFDLGGESLRAMQVTTAVNKAFGTRITVRALFDAATLAEFAGVIDAARRGEGPVERGIAAASAEAADR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	381.65	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1668	colistin A; colistin B
BGC0001058.1|Zorbamycin_16 # 19976 # 23293 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.734	BGC0001058.1|Zorbamycin_16 	19976	23293	+	Loose	1000	121.709	almE	26.65	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGATCTCCACGTACGGCGACGCCCGGCTCCACCCCCTGACCCCGGGGCAGCAGCGGCTGTGGTTCCTCCACCGGCTGTCCCCGGACAACCCCGCCTACAACGTCGTGATAGCGCTCCGGCTGCGCGGCCCGCTCCGTGCCGCCGCCCTGCGTGCCGCCGTGGCCGACGTGACCCGCCGTCACGCGGCTCTGCGCACCGTCTTCCCCGTGGAACCCGGGGGGCACGAGCCGATGGCCCGCGTCCTCCCCGACGGGCCGCCGCTGCGGCTGGTGGATTTCTCCGGCCTGCCCCCCGAGCAGTCCCACGCCGAGTCACGCCGCTTCCTGGACGCCGCCTCCGCCCGCTCCGTCGACCTCACGCACGGGCCCGTCACCCACTGGATCCTGCTGCGTGCCGCTCCCGCCGACCATCTGCTGGTCCTGCTCACCCACCACATCGTCTTCGACGGCGGTTCGCTGCCCGTCGTGTGCGCGGAACTGGAACACGCCTACCGCGAACCGGCCCACGGCCGGCCCGGACCGGCCGCACCGCACGACGGACTCCCGGTACCCGAGGCAGGGCAGGTCCCGGCGGACAGCCTGGCGTACTGGCGCGCCACCCTGGCCGGCGTACCGGCACAACCCCTGGTGCTCCCTGTCCTCGCCGGGCGCCGGAGAGCCGCCGGTCCCGCCACGGATGCGGCAGCCCTCGTCAGCGGCAGGTGCACACTGTCGGGCACGGGACTGAGCCGCCTGCGGACCCTGGCCGCCGAGGAGGGGTGCACCACTCAGCTCGTGCTGCTGACGGCCCTGATCTGCCTGCTGCACCGGTACAGCGGACAGGAGGACGTCGTCGTCGGCGTCCCGGTGGCCCTGCGCGACGCAGCCGAGGACGCCGGACGCGTCGGCCTGTACGTCAACCTGCTCCCCGTCCGGGTCCGTCTCGGCACGGGTGGCCTGCCCTTCCGGGCGGCGCTGCGCCGCACCCGCCGGGCGTGGCTGGACGCCCACGAACACCGAGGTGTGCCCTTCGAACGCCTCGTCGAGGAGTTCCACACCGACGCCACCCCCACCGTCCACCCCTTCTTCTCCGCGCTTTTCGCCTACCAGCAGGCACCGCCGCTGCCCCGGCTGGACGGCGTGGAGACCACGCTGGCGCCGGTCGCGCCCGCCGCGGCCAAGTACGAACTCACCGTCACCTCGACCGAGGACGAGCGGCAGATCTCCTTCGACCTGGACGTCGACAGCCGCTCGGCGGACCGCGCCGAGGCGGACGCCGCCGCCCGCCACTTGCGCGCGCTGCTGACCGCCGCGGTGAGCGCCCCCGAACGGACCGTCGCCGACCTGCCCCTGCTGGACGGCACGGAGCGGCGCGCCCTCGGTCCGTACTGGCCCGCCACCCAGCACGCCGCGCACACCGTCGCCAACGCCCCCGACCTGTGGGCGCCCGCCCACCGGCGTTTCGAGGAACAGGTCCGCCGCCGTCCCGACGCCGTGGCCGTCGTCCACGGCGCCCACAGCCTCACCTACGCCGCGCTCAACAACCGGGCCAATCGTCTCGCCCGGGAACTCGTGGCCCGTGGCGCCGGCCCGGAGACCGTCGTCGGCGTGTGCTTGCGCCGGACCACCCGCCTGCCCGTTACTCTGCTCGCCGTGCTCAAGGCGGGCGCCGCCTACCTGCCCCTCGATCCCGGGTACCCCGCCCAGCGGCTGAGCGGCATGATCGAAGACGCGTCCATGGGCCTGCTCGTCACCGAGCGGGACCTTCTGCACTCCACCGGTCTCGACGACCTGACCGATCCGGCCGACGTGATCGTCATGGACGACGACGCGGCCCCGGCCGTACGGCATCCCGGCCACGACCTTCTCGGCCCGGACACGGACGTCCACCCGAACGGCCTCGCCTACGTGCTGTTCACCTCGGGCTCCACCGGACGGCCCAAGGGCATCGCCCTCCAGTACGGAAACCTCGACACTTTCCTGCGCTGGGCGGGCCGCACCTTCTCCGCCGAGGAGCTGACGGCCGTCCTCGCCACCACCTCGGTCTCCTTCGACGTCTCCGTCTTCGAACTCTTCGCACCTCTCACCCACGGCGGCACCGTTCTGCTGGGTGACAACGCCCTGCACGTGCCCCACATGCCCGCGGCCGCCACGGCGACCCTGCTCAGTACGGTGCCCACGGCCGTGGACACCCTCGCCGAGGCCGACGCGATCCCCCGCTCGGTACGCACCGTCAACATCGGCGGCGAGACCCTGCAGCGCGGCGTCGTCGACCGACTGGCCGGCCGGGTGCCGGGCGTGCGCGTGCACAACCTGTACGGGCCCTCCGAGACCACCACACACTCCGCGAACGTCCGCGTGCCCCTCGACTCCGACGAGCCACCCACCATCGGGCGCCCCCTGCTCACCGTGCTGATGTGGGTGGCCGACCGCGGCAGCCGCCCGGTTCCCGTCGGGGTCACCGGCGAGATCGTCATCGGGGGCACGGGTCTTGCCCGGGGCTACGTCGGCCGCCCCCGGCTGACGGCCGAACGCTTCGCGCCCGACCCCGCGAGCGGCACCGACGGTGGTCGTCTCTACCTCACCGGCGACCAGGCGCGGGTGGACGGCCGAGGCGAACTGGTATTCCTCGGCCGCCGCGACTCGCAGATCAAACTACGCGGCGTCCGCATCGAACCCGAGGAGATCGAGACCGTCACCCGCGCCCACCCGGCGGTACTCGACGCGGCGGTCGTGGTGGAGCGTCAGGACGGCACACCCACCCGCCTCGTCGCCTTCGTCAAGGTGCGCCCCGAGGACGTGCCCGGCGAACAGGCCCTCACCTCCGACCTCCTCGCCCATCTGCGCACCCGGCTGCCCCGGGCGATGATCCCCGCCGAACTGAGGCTCCGGGCCGAGCTGCCGCTCAACTCCAACGGCAAGCTCGACCGCGGGGAACTGACCCGCCGGCTCGCGCTGGAACCCGTCCGGACGGAGGCGACCGCCCCGCTCGCGGCACCACCGCGCACCGAGCTGGAGAAGGCCGTGGCAACGATCTGGTGCGAGGTCCTCGACCTCCCGCACGTCGGACTGCACGACAACTTCCTCGAACTGGGCGGAAACTCCCTTCTCCTGCTCAAGTTGCACCGCAGACTGTGCGAAGCCGTCCATCCGGACCTCACGCTCGTCGACCTGTTCACCTGGCCGACCGTGGCGGCCATCGCCGAGCGCTTCGCCGGCGTCGTGGCCCGCGATGATGCGCCCGGCGCCGCCGAGAACACGGCCGGTGCGGCCGACCGCGGACGCCGGCGGCGCCGCTCCGCGGCCGTCGGCCGCCGTACGCCGGAGGCCGGACGGTGA	MISTYGDARLHPLTPGQQRLWFLHRLSPDNPAYNVVIALRLRGPLRAAALRAAVADVTRRHAALRTVFPVEPGGHEPMARVLPDGPPLRLVDFSGLPPEQSHAESRRFLDAASARSVDLTHGPVTHWILLRAAPADHLLVLLTHHIVFDGGSLPVVCAELEHAYREPAHGRPGPAAPHDGLPVPEAGQVPADSLAYWRATLAGVPAQPLVLPVLAGRRRAAGPATDAAALVSGRCTLSGTGLSRLRTLAAEEGCTTQLVLLTALICLLHRYSGQEDVVVGVPVALRDAAEDAGRVGLYVNLLPVRVRLGTGGLPFRAALRRTRRAWLDAHEHRGVPFERLVEEFHTDATPTVHPFFSALFAYQQAPPLPRLDGVETTLAPVAPAAAKYELTVTSTEDERQISFDLDVDSRSADRAEADAAARHLRALLTAAVSAPERTVADLPLLDGTERRALGPYWPATQHAAHTVANAPDLWAPAHRRFEEQVRRRPDAVAVVHGAHSLTYAALNNRANRLARELVARGAGPETVVGVCLRRTTRLPVTLLAVLKAGAAYLPLDPGYPAQRLSGMIEDASMGLLVTERDLLHSTGLDDLTDPADVIVMDDDAAPAVRHPGHDLLGPDTDVHPNGLAYVLFTSGSTGRPKGIALQYGNLDTFLRWAGRTFSAEELTAVLATTSVSFDVSVFELFAPLTHGGTVLLGDNALHVPHMPAAATATLLSTVPTAVDTLAEADAIPRSVRTVNIGGETLQRGVVDRLAGRVPGVRVHNLYGPSETTTHSANVRVPLDSDEPPTIGRPLLTVLMWVADRGSRPVPVGVTGEIVIGGTGLARGYVGRPRLTAERFAPDPASGTDGGRLYLTGDQARVDGRGELVFLGRRDSQIKLRGVRIEPEEIETVTRAHPAVLDAAVVVERQDGTPTRLVAFVKVRPEDVPGEQALTSDLLAHLRTRLPRAMIPAELRLRAELPLNSNGKLDRGELTRRLALEPVRTEATAPLAAPPRTELEKAVATIWCEVLDLPHVGLHDNFLELGGNSLLLLKLHRRLCEAVHPDLTLVDLFTWPTVAAIAERFAGVVARDDAPGAAENTAGAADRGRRRRRSAAVGRRTPEAGR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	198.74	gnl|BL_ORD_ID|4935|hsp_num:0	5928			300	1662	colistin A; colistin B
BGC0001058.1|Zorbamycin_17 # 23290 # 28725 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.751	BGC0001058.1|Zorbamycin_17 	23290	28725	+	Loose	400	30.4166	Erm(30)	25.89	3001265	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGAGCGTTCCCACCTTCCCACCCCCGGCCGGCGACGAGGACGAGGACATCGAGACCATCGCTGTGGTCGGCATGGCGTGCCGGCTGCCCGGTGCGGACACCCCGGAGCAGCTCTGGGCGAACCTCCGGGACGGGCGTTCGGCGGTGCGCCGCTTCCGCGCGGAGGAAGCGGCCGACATCCCGGGCCGTCCCCCCGTCATCGGCCACCCCGCCTTCGTCGGTGCCGAGGGCCTGCTCGACGGAGTGGACCTCTTCGACGCAGACCTCTTCGGGTACGCGCCCCGCGAGGCGCAGATCATGGACCCCCAGCACCGCATCGGCCTGGAGGTCGCCTGGGACGCCTTCGAGTCGGCCGGTTACGATCCCGCCGAGGCCGAAGGCCCCGTGGGCGTGTTCCTTTCCGCCGGCTTCAGCTCGTACCTGGTGCGCAACCTGCTGACCGATCCCGAGGCCGCACGGGTCCTGGGAGGACTGTCCCTGCTCGTCCACAACGACAAGGACTTCCTCGCCACCGGCGTCTCCCACCGGCTCGGACTGCGCGGGCCGAGCATCGCCGTCGGCTCGGCCTGCTCGTCCTCACTCGCCGCCGTCCATCTCGCCGCGCGCAGCCTCCAGTCCTACGAGTGCGACCTGGCGCTCGCCGGCGGGGTCTCCGTCCAGGTGCCCCAGCGACAGGGCTATCTCCACGCCCCCGACGGCATCTATTCACCGAGCGGTGCCTGCCGCCCCTTCGACCGCGCCGCCGACGGCACCGTGGGGGGCAGCGGTGCCGGCATGGTCCTTCTCAAACGCCTGTCCGACGCCGTCCGCGACGGCGACCACATCCACGCGGTGGTCCTGGGCTCGGCCCTCAACAACGACGGCCGCGACAAGATCGGCTTCACCGCGCCCAGCGTGCGCGGCCAGAGCGAGGTGATCGCCGAGGCCCACGCGGTCTCCGGTGTGTCGGCCGACACCGTCGGATATGTGGAAGCCCACGGCACGGGCACCGCACTGGGCGATCCGGTCGAGATCGAGGCCCTCACCAAAGCGTTCCGCCACACCACCGACCGGCGCGGGTACTGCGCCGTCGGCTCCCTGAAAGCGGCCATCGGCCACTTGGACGCCGCGGCCGGTATCGCCGGGTTCATCGCGGGCGTCCTCGTCGCCCGGGAGGGCACCGTACCCCCCAGTCCCTACTTCCGTGCCCCGAACCCGGCCATCGACTTCGCCGGCAGTCCGTTCTTCGTCACGACCGAGGCGCGGCCGCTGCCAGGCCCGCACGGCAGTCGCCGTGTCGGGGTCAGCTCCTTCGGCGTGGGCGGCACCAACGCCCATGTCGTCCTGCAGGAGTCCCCGGCCCCCGCCCGCCCCCGGCCGGAGCCCGGCGGCGAGGCCCCGCTGCTGCTGTCCGGCCGTGACCAGGACACCCTGCGTCGCACGGCCGACCGCCTCAGGCGCCACCTGATCGAGGCCCCCGGCACTTCCCTCGCCGACATCGCTCGCACCCTCTCGGGCAAGCGCGCCTTCCCCCACCGCAGGGTGGTGCTCGCCCCGGACACCGCCACCGCCGTACGAGCCTTGGAGGCGGCACCGGAGGAACCCGCCGTCGCCCGCCGTGTGGTGTTCACCCTGCCCGATCCGACGGCCCTGAGCCGGGCGGACCTCGCCGCGCTCGCCGCGGAGCCCGCCGTGACCCGGGCCCTGGACGCCCTGATCGACCGGGCCGCCCGCTCGGACGTGATCGTGCCACGCCCCGACGACGCCCGCGCATCCCGTCCCGTGACCGGGGCGCCCGCCACCGCCTTCGCCGTCCAGTACGCCCTGGTGGAGGCGCTGGCCGGGTGGGGTGTGCGCCCCGCCGCCGTGAGTGGCGCGGGCACCGGTGAACTCACCGCGGCCGTGGTCGCCGGGATGCTCACCCCGGTCCAGGCGCTGCGTCTGCTGACAGCCGCCACACCCGGCGAGCGCGCCGCCGCCCTCGCCGACCCGGCGCCGTCGGCGCCGTCCCTCCCATGCGTCGGCGCCCGTAGCGAGGGTCCCGTGACCGGACGGCACCTCCTGCGCCCCGACTTCGGGGCCCCGGCGCCCGGGGACACGGCCGAGCCGGTTCCCCACCCGGACCCCGGTCCGGGCGCGCCCCTGCTCGACGTCCGTCTCGGTCTTCCTGGCGGTCCCGCCTCGACACCGGCGCTCCGCCGCACCGCCTGGTCGCCTCCCGGCCCCACCGGCAAGGGCCCGGTGCCGGTGCTCGCCGCCCTGTGGGAAGCCGGCGTCGCCTTGAAACTCGACACCTTTCACCGCGACCGGGGAGCCCGGCGTGCCACGGTGCCCGGGCACGTCTTCCGGCGCACCCGCCACTGGGTCGGACCTCCCGCAGTCCCGGCCGGCGCGCTCGCCCCGGTCCTGGAGGAACTCCACCACGCGGTCGGCCGGGAACGCCCTTCCACCCTCGCGGACCGGCCCGCGGCACTCGCGGCCCTGGACGGACTGTGCGCCGAGCTCGCCCTGGCCCACCTCACCGACGACCCGCACGGTGACTTCCTCCGCGCCGGCCGGACCGTCGACGAACTCGCCACCCGCCTCGGCACGCTGCCCGCCTACCGGCCGTTCCTCGAGTACCAGCTGTCCCTGCTGGTCGAGGACGGGCTCGCGGTACGCGACGGGGCGCGCCACACCGTGACCACCACGAGGCAGGCCGACCCGGAAGGGCACGCCGCCCGGATCCGTGCACGCCACCCGGACGTCGCGGGGATCGCGGAACTGCTGCTGCACTGCGGGCGCGGCTACCGCGACGGCCTGCGCCGGCCGGGAGCGGGACTTGCCGTGCTCCATCCGCGCGGCGAAGGCGACCCGGCGGCCCGGCTCCTCACCGAGCGGACCACACCGTACTCCTGGGCCGACCCGCTCGCCTCGACGGTGGCGCGGTTCGCCCGGCGGCTGGCCGACGGACGGGACCAGCCGTTACGCGTGCTGGAGGTGGGCGCGGGAGGCGGACGGCTGACACAGCACCTCGTCGCCGCACTGGACGGAACCTCCGCCCGCTGCACGGTCACCGACGTCAGCGCCCACTTCGTGGCGGCGCTGCGTGCCCGGCGCGTGCCGCGCGGTCACGGCACGGTCGACACCGCGGTCCTCGACATCACGGCCGACCCCGCCGCCCAGGGATTCTCCCCGGCCTCGTACGACCTGGTCGTCGGCCTCGACGTGGTCCACGCGACACCGGACGTCCACGACACCCTGCGCCGGCTGCGCACCCTGCTCGCACCCGCCGGCACGCTCGCGCTGATCGAGACGACCGCCCGGGACCGCTGGATACCGATGGTGTGGGGCCTCACCGAAGGATGGTGGAACGCCCGCGACGGCCGGTGCGGAGGACCGCTGCTGTCCGCCGAGGAATGGTGCGCCGCGCTGCGGGCCGCCGGCCTCGCCGTCGACGGGGCCGTGCCGGGCCCGGCGGAACCGACCGCGGACGCCGCCCTCCTGCTCGCCCGCCGGGCCGGGGACCCGGCCTCGCCGGATGCCGGTACGGCCGGCGGCACCCCGGCCGGCCGGGAGACGCCCGCCCGCGTCCCGGACCCCGCACGGTGGACGTACCGCACCGGCTGGCACAGCGCGGTCAGCCCGGCTCCCGGCCCCGACCCGGCCGGCCGTACCTGCCTGGTCTTCGGGGAAGGCGACCTCGGGGACCGCGTCTGCCGACTGCTGGGGGAGCGGGACGTGCGGGTGGTGCGCGTACGGCCCGCCGGGCACCCGGCCGACGGCGCCGCGGACGTCCACGGCGTGGACCCGGCCGACCCGGACGCCCATCAGAGGCTCGTGGACACCCTGACCGAGCGGGGCGTGACCGTCGACCTCGTCGCACACCTGTGGAACGCGGAGTGCCCGGTGACCGGTCTCGAAGCGGTCGAGGAGGCCAGGACGCGCGGTCTGCACAGCGTGCTGGACACCGTCCGGGCGCTGTCCCGCACCGACCGGGGAACCCCCCGACGACTGCTGATCGCGACGGCCGGTGGCCAGGACGTGCTCGGCGGCGACCTGCGCCATCCCGAACAGTCCCTGCTCACCGCCGCCGCCAAGGTGCTGCCGCGGGAGTATCCCGGTCTCGCCTGCACCGTCGTCGATCTGGCGCCCGACGCGCCCGACGACCCGAAGCGACAGGCCGAGCAGATGGTCGCCGAACTCCTCGCGGCCGAGACCCCGCCCCTCGTCGCCCACCGGGGCCGGCGCCGCTGGCTGCCGCACGTGCGGCCGCACCCGCTTCCCGCCCCCGACCGTCCCCTGGTCCGGCCCGGGGGCGGTTACCTGGTGTGCGGGGGACTCGGCGGCGTCGGACTCGTCCTCTCCGAGCACCTGCTGCGGGAGGGCGGACAGGTGCTGCTCACGCGCCGCACTCCGTTCCCGCCCCGGAGCCGATGGGCCGAACTGCCGGCCGACAGCCCCGACGGGCGCATCGCCCGACGCCTCCTGGCCGCCGAAGGCTCCGGCGGACGCGCCCTCGTGCTCCACGCCGACCTCACCGACCTCACCGCCATGCAGCACGTCGTGGCCACGGCACACCGCGAGTTCGGCGGCCTGCACGGCGTGGTGCACGCCGCCGGCGTCACGGACCCCGCCGGTGTCGTCCAACGCCGCGACCGCAGCGGCACCGACCGGGCCGTCGCCTCCAAGACGACCGGCACGCTTGTCCTCGAACGCGCTCTGGCCGGCACCACGCCCGACTTCGTCCTGCTGTGTTCCTCCATCGGCACCGAGCTGTACAAGCTCAAGTACGGCGAGGTGGGCTACGTGGCGGCCAACGAGTTCCTCAACGCCTTCGCCCACAGCCGCCGGGCCCTCGGCATGCCGGTGGTCGCCGTCGGCTGGACCGACTGGCTGGAGGGCGGCATGTGGACCACGGCCCGCCGCGAACTGGACAGCCGGTACCAGGTGGACGCCCCCGACGGGATCCACCCCGCTGACGACCTGCTCCTCGGTCTCACCGACGCCGAGGGCGTCGAGGTGTTCCGCCGCGTGGCGCATGCCGACGAGCCGCACCTCCTGGTCTCCACCCAGGACCTGCAGGCGCTGCTGGCCCGGCACGAGGACTACACCGTCGACGACCACCGCAGGGCCGTCCGTGGGCTGCAACGCGCTCGCGACGTACCGGCACGCCCGGTGGCGGACGTACCCGCGGCGACCGGCCGGCCCGCCGAGATCACGGAGCGGACCGTCGCCGGCTGGTGGTCCCACCTGCTCGGTGTCGACGACCCGCAGCCCGACGACGACTTCTTCGCACTCGGCGGCGACTCCCTGATCGCCCTGCGGATGCTCGCGGTCGCCGAGGAGGAGGCGGGCGCCGAAGTGTCCCTGCCGTGGTTCTTCAACCACCCCACCGTCGCCGAGCTGGTGGCGGAGATCAACCGGTTGCGGCGGCACACCGATGCCGTCGGAGGCGAGGAACGGGTGCTGCTGTGA	MSVPTFPPPAGDEDEDIETIAVVGMACRLPGADTPEQLWANLRDGRSAVRRFRAEEAADIPGRPPVIGHPAFVGAEGLLDGVDLFDADLFGYAPREAQIMDPQHRIGLEVAWDAFESAGYDPAEAEGPVGVFLSAGFSSYLVRNLLTDPEAARVLGGLSLLVHNDKDFLATGVSHRLGLRGPSIAVGSACSSSLAAVHLAARSLQSYECDLALAGGVSVQVPQRQGYLHAPDGIYSPSGACRPFDRAADGTVGGSGAGMVLLKRLSDAVRDGDHIHAVVLGSALNNDGRDKIGFTAPSVRGQSEVIAEAHAVSGVSADTVGYVEAHGTGTALGDPVEIEALTKAFRHTTDRRGYCAVGSLKAAIGHLDAAAGIAGFIAGVLVAREGTVPPSPYFRAPNPAIDFAGSPFFVTTEARPLPGPHGSRRVGVSSFGVGGTNAHVVLQESPAPARPRPEPGGEAPLLLSGRDQDTLRRTADRLRRHLIEAPGTSLADIARTLSGKRAFPHRRVVLAPDTATAVRALEAAPEEPAVARRVVFTLPDPTALSRADLAALAAEPAVTRALDALIDRAARSDVIVPRPDDARASRPVTGAPATAFAVQYALVEALAGWGVRPAAVSGAGTGELTAAVVAGMLTPVQALRLLTAATPGERAAALADPAPSAPSLPCVGARSEGPVTGRHLLRPDFGAPAPGDTAEPVPHPDPGPGAPLLDVRLGLPGGPASTPALRRTAWSPPGPTGKGPVPVLAALWEAGVALKLDTFHRDRGARRATVPGHVFRRTRHWVGPPAVPAGALAPVLEELHHAVGRERPSTLADRPAALAALDGLCAELALAHLTDDPHGDFLRAGRTVDELATRLGTLPAYRPFLEYQLSLLVEDGLAVRDGARHTVTTTRQADPEGHAARIRARHPDVAGIAELLLHCGRGYRDGLRRPGAGLAVLHPRGEGDPAARLLTERTTPYSWADPLASTVARFARRLADGRDQPLRVLEVGAGGGRLTQHLVAALDGTSARCTVTDVSAHFVAALRARRVPRGHGTVDTAVLDITADPAAQGFSPASYDLVVGLDVVHATPDVHDTLRRLRTLLAPAGTLALIETTARDRWIPMVWGLTEGWWNARDGRCGGPLLSAEEWCAALRAAGLAVDGAVPGPAEPTADAALLLARRAGDPASPDAGTAGGTPAGRETPARVPDPARWTYRTGWHSAVSPAPGPDPAGRTCLVFGEGDLGDRVCRLLGERDVRVVRVRPAGHPADGAADVHGVDPADPDAHQRLVDTLTERGVTVDLVAHLWNAECPVTGLEAVEEARTRGLHSVLDTVRALSRTDRGTPRRLLIATAGGQDVLGGDLRHPEQSLLTAAAKVLPREYPGLACTVVDLAPDAPDDPKRQAEQMVAELLAAETPPLVAHRGRRRWLPHVRPHPLPAPDRPLVRPGGGYLVCGGLGGVGLVLSEHLLREGGQVLLTRRTPFPPRSRWAELPADSPDGRIARRLLAAEGSGGRALVLHADLTDLTAMQHVVATAHREFGGLHGVVHAAGVTDPAGVVQRRDRSGTDRAVASKTTGTLVLERALAGTTPDFVLLCSSIGTELYKLKYGEVGYVAANEFLNAFAHSRRALGMPVVAVGWTDWLEGGMWTTARRELDSRYQVDAPDGIHPADDLLLGLTDAEGVEVFRRVAHADEPHLLVSTQDLQALLARHEDYTVDDHRRAVRGLQRARDVPARPVADVPAATGRPAEITERTVAGWWSHLLGVDDPQPDDDFFALGGDSLIALRMLAVAEEEAGAEVSLPWFFNHPTVAELVAEINRLRRHTDAVGGEERVLL	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	538.99	gnl|BL_ORD_ID|1123|hsp_num:0	1224			120	600	narbomycin; methymycin; pikromycin
BGC0001058.1|Zorbamycin_18 # 28722 # 30653 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=12bp;gc_cont=0.747	BGC0001058.1|Zorbamycin_18 	28722	30653	+	Loose	1000	26.9498	MCR-8.4	25.0	3007228	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	GTGACCATCGAGGACCACTACGCGGACTTGGTGGCGCGTGGCGTGCGGCTGGCCGCCGAGGACGGCCGGCTTCGCTGCACGGCCCCGGCCGGCGTGCTCACCGACGCGCTGCTGCGCGAAGTGTCCGCGCGCAAGGACGAGTTGCTCGCCCACCTCGCCGTACGCCGGGTGCCGCTGTCCTTCGCGCAGGAACAGCTCTGGGTGGCACACCGTCTCGACCCGGCCGGCTCGGCCTACCACGAGCCCGTGCTCGTCGAGCTCGACGGCCCGCTGCGTCCGACGGCACTGCGCCGCGCGCTCGATGCCGTGTACCACCGGCACGAGACGCTGCGCACGGTGTACCCCACCCACCGGGGGCGGCCCCATCAGGTGGTACTCGGACCCGGTCCCTGCCCGTTCACCGTCGTCGACCTCTCGGGTCTCCCCGCGCACACCCGTGAGGATGCCGCCCGGCAGCAGGCGGAGCGAGAAGTGCGTCGCCCGTTCGACCTGACGTACGGACCCCTGCTGCGCGCCGTCCTGTTCGTGCTCGACACCGAGCGGCACCGGCTGCTGCTGACACGCCACCACATCGCCGGGGACGGCTGGTCCCTGGGGCTGCTGCTGGGCGACCTCGGCGACGCCTACCGCGCCGCGGCTGGTACGGACGGGCACCCGGTGCTGCCCGAGAACGACGTCCGTTACACGGACTTCGCCGAGTGGCAGCGCGCCACCCGACGCGACGACCCCCTCGGCGCCCGGGGCGCGGAGCGGGTCCGCGCGCTGCGCGGCGCCCCCACCAGCCTGCGGCTGCCACCCCCGAAGGCCGCCCGGCCGGCCCCCGGAGCCGCACCGGGCGACGCACGCATCGCCCGGACGGTCGCCCTGCGCCTCGATCCGGAACTCGCCGCCGGCATCCGCACCCTGGCCGAGCGCGGCCGGATCACCCCGTTCACCGTCCTGCTCACCGCCTACGCCACCGCCCTCGGCCACTGCTGCGGCCAGCACGACCTGCTGATCGGCACCCCGGTGGCCGGGCGCCCCCGGACCGAGTACGAACAGGTCGTCGGCACCTTCGCCAACCTCGTGCCGATCCGGATCCGCTTGGAGGGGAACCCCGCCGTCGACACCCTGCTGCGCCGGGTCCACGCGGAGGCGCTGGCCGCGCTGGAGGCGCGCGACGTGCCCTTCGCGGCGCTCGTCGCCGAGACAGCGCCCGGCCGGGGCTTCGACGCCGACCCGCTGTGCCAGGCCACTTTCTCCCTGCAGAACCTCCCCCCGGCCAAGGCGGCGCTGCCAGGACTGCGCACCGGGCTGCTTCCCCCGCCGGAGGTGGCGCCCAAGGGCGCCCTGACCACCATCGCGACCCCGGTCGACGGCGGCTACGAGGTGACGCTCGCCCACGACCCCGCACGCATCGACGACGAGACCGTGCGCGCTCTCGCCGACGGCTTCGAGAGGGTGCTGCGGCAGGCCGTGGCCGATCCGGCGGCGACCCTGGCCCAAGCCGTCGGTCCCGATGTCCTGCGCCCGGTCACGGACCCCGCCCCGACTGTCGGCGAACCCCGGCCGGAGCCCAAGGCCGAGCCGTCCGCCGTCGCGGCACCAGATGCCGCCCGAGCGCCCGCGACGCCCACGCAGCACCGGCTGGCTGAGCTGTGGCGGGAACTGCTGTCGCTGCCGCCGGACGCCGCCCCCGACATCCACGCCAACTTCTTCGATCTCGGCGGGGACTCCATCAAACTCACCCAACTGCTGGCCTGGGTGATGGACGTCTTCGGGATCGACCTGCCGGTGCGCCGGATCCACGAACTGCTCGACATCGCGTCGCTCGCGTCCGCCGTCGACGACGCCGTGCGCCGGCGGGACGAGGAGGCCGACGCCGCCCTCGCCGCCCTCGTGCGCGAGGTGGAGGAACTGCCCGAGGAGGAGCTACGCAAGCGACTGCGCTGA	MTIEDHYADLVARGVRLAAEDGRLRCTAPAGVLTDALLREVSARKDELLAHLAVRRVPLSFAQEQLWVAHRLDPAGSAYHEPVLVELDGPLRPTALRRALDAVYHRHETLRTVYPTHRGRPHQVVLGPGPCPFTVVDLSGLPAHTREDAARQQAEREVRRPFDLTYGPLLRAVLFVLDTERHRLLLTRHHIAGDGWSLGLLLGDLGDAYRAAAGTDGHPVLPENDVRYTDFAEWQRATRRDDPLGARGAERVRALRGAPTSLRLPPPKAARPAPGAAPGDARIARTVALRLDPELAAGIRTLAERGRITPFTVLLTAYATALGHCCGQHDLLIGTPVAGRPRTEYEQVVGTFANLVPIRIRLEGNPAVDTLLRRVHAEALAALEARDVPFAALVAETAPGRGFDADPLCQATFSLQNLPPAKAALPGLRTGLLPPPEVAPKGALTTIATPVDGGYEVTLAHDPARIDDETVRALADGFERVLRQAVADPAATLAQAVGPDVLRPVTDPAPTVGEPRPEPKAEPSAVAAPDAARAPATPTQHRLAELWRELLSLPPDAAPDIHANFFDLGGDSIKLTQLLAWVMDVFGIDLPVRRIHELLDIASLASAVDDAVRRRDEEADAALAALVREVEELPEEELRKRLR	MFKYLLSFKLNPVQRTWAAAFFFTTIGNIALWQTLWINVDVHNIHNLLFFASLPIFLFCFLSILLTPVMVIPYLCRPLLVVLILISACCSYFMMKYNILIDRSMVQNFFETNQAELTSYLSVPFLSTLFLLGIVPAIILALPSTDNKRGAFRIELWWLAHICIAVVLLAMVTMVFYKDYASLIRNNMQIKDQALPFNFVRNTNGYLKRKYQASSTILQSVGEDAVRPIYSNAPPKLVVVVVGETARAQNFQLNGYSRVTNPYLSRRHDVISFKNVSSCGTATAISLPCMFSRMSRNEYNEVRAASEENLLDILKRTGVEVLWRNNNNGGCKGICKRVPTDDMPAMKVIGECVNKDGTCFDEVLLNQLSSRINAMQGDALIVLHQMGSHGPTYFERYPSTSKVFRPTCDSNLIEKCSNKELVNTYDNTLVYTDRMLSKTIELLQRYSGMRDVAMIYLSDHGESLGESGIYLHGTPYIIAPNEQTHIPMFMWFSSSFAQHSKLNLECLTGNADKQYSHDNFYHSILGLFNVKTSVYKPELDMFTLCRQSDHTPLSSAVVREKTDGNG	113.81	gnl|BL_ORD_ID|4848|hsp_num:0	5833			366	699	colistin A; colistin B
BGC0001058.1|Zorbamycin_19 # 30818 # 38794 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.744	BGC0001058.1|Zorbamycin_19 	30818	38794	+	Loose	1000	122.479	almE	28.97	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGTGTCGGAGCGCTGCCCTCCCGGCTCACGCGCGCTGATCGCCTACCCCTCCGGGCCGGAGTACGTCCTGGGCTTCCTGGGGTGCCTGTACGCGGGCGTCGTCGCCGTCCCCTGCGACGTGCCGAGCCGGGGTCCGGGGCGGGAGCGATTCGCGTCGCTCGTCGCCGACGCCGAACCGGCCGCCGTGCTGACCGACACTCCCGCGGACGGCCCGCCTCACCTCGACATCCGCGCGGCGGGCGGCGGAGCCACCGTGCCCGCGCACCGGCCCGGCGCCGACGCCCCGGCATTCCTCCAGTACACCTCCGGCTCCACGCGTGAGCCGCGCGGCGTCGTCATCACACACGCCAACCTCATGGCGAACGAACGGATGATCGCCGAGGCGTGCGGGCACGACGCCGAGTCGACTTTCGTGGGATGGCTGCCGCTCTTCCACGACATGGGCATGGTCGCCAACGTCCTGCAGCCGCTGTACCTGGGCGCCTGCGGGGTGCTCATGCCTCCCGAGGCGTTCCTGCGCAAGCCCGCCCGCTGGCTGCGTGCCATCTCCCGGTACCGCGCCCACACCAGCGGCGGCCCCAACTTCGCGTACGAACTGTGCGCCGAGCGCATCCGCCCCGAGGAAACCGAGGGCCTGGAGCTGAGCAGCTGGCGGGTCGCCTACAACGGCGCCGAGCCGGTGCGGGCGGACACCCTGGCCCGTTTCGAGCGGCGCTTCGCGCGGAACGGACTGCGCGCCGAGGCGGCCTTCCCGTGCTTCGGCCTCGCCGAGGCGACCCTGATCGTGAGCGGCACGCCCAAGGACTCCCCGGCCCGCGTCCTGCGCGCCGACGCCGTCGCGCTGGACGCCGGCACGGTCCGCCCCGCCGCGCCGGGTGCGGACTCCGTGCCGCTGGTCAGCAGCGGCCGGGCGGTGCCCGACACCGACATCCGTATCGTCGCCACCTCCACCGGCCGCGCGTGCGCCGACGGGCAGGTCGGCGAGATCTGGGTGGACAGTCCCAGCGTGGCACGCGCGTACTGGCGCCGGCCCGACGAGTCGCAGACGCTCAACGCGCGGCTGGAGGCCGACGGACCTCGTCATCTGCGCACCGGCGACCTGGGGGCGCTGGTCGACGGGGAGCTGTACGTCACCGGCCGGCACAAGGACCTGATCGTCGTGCGTGGGCGCAACCACCATCCCCAGGACGTGGAGTGGACGGCCGAACGCGCGCACCCGCTGCTGCGGCCCTCCTGCAGCGCTGCCTTCTCCTTGGACCGGGGCGGCCGCGAATTCGCGGTGCTGCTCTGCGAGTTCCGCGAGGGCGCGGACCCCGACGCCGCCGCCGAGGCGGCTGCCGCGGTGCGTGCCGCCGTCCTCGCCGAGCACGGCGTGGAGATCGACGAGATCGCCTTCGTGCCCAGGGGAACAGTCCGCAAGACGACCAGTGGAAAGGTCCGCCGCCAGTGGTGTCGGCAGCGCCACGGCGAGGGCGCGCTGCCCGTGGTGGCCACGTTCATCCGCTCCCTGCGTCCGGACGCGTCGGCCGCCCCCGACTGGCCGACGCCGGCGACCCTGCGCTCGGTGACGCGCGAGCGGGCGCGGCACCTGCTGTCCCGTGCGCTCCTGGGAGCGGCCGGGGTCGCTCCGGGGGCAGGCGACCCGGCGGCCACCCTGGTCGCGGCGGGCATGGACTCGCTGACGGCCCTGCAACTGCACCAGGACCTGGAGAACCGCTACGACGTGGTGCTGCCGCCGGCCGCGCTCCTCGGCGACGCGTCGGTCACGGACGTCGCCGAGGGTGTCCTGCGGACCCTGCCCCCCGACGCCGGGACGCGCACTCCGCCCTCCGCCGACGGCGTTCTCGCCTCCGGAACGCGGGAGTTCCCGCTCTCCCCGGGACAGCGCGCCCTGTGGTTCGAACATCATGCGGTACCCGGCAACACCGCGTACCACCTGGCCCGGGCGCTGCGCGTCGAAGGACCGTTCGACGAGACCCGGCTGGCCGCCGCCGTGGACCGGGTCGTCGCCCGTCACGCCCTGCTCCGCACCTGCTTCCCCGACCGGGGTGGCGAACCCGTCAACCGGGTGCTGCCCACGGGGCCGCGCCTGGTGTGCACGGACGCGACCGAGATGTCCGAAGCCGCTTTCGCCCAGACCCTCCGGAGAGCGGCCGTCGCGCCGTTCGCCCTCGACGACACCCCGCCGGTGCGGTTCACCTGGTTCCGGCGGGGCCCCGGAGAAGGCGTCCTGCTGCTCAACGCCCACCATCTCGTCGCCGACTACTGGTCATTGGTCACGATCCTGCGGGAGCTGTTCGCCCCTCGACACGGCACCGACACCCCCACGGTGCCTCGCAGCCACCGCTCCGAGACGGACTTCGCCGCGTACACCGAGGCCCGGCGGCACATCCTGGAGACGGACCGCGACCGGCTGTGGGCGCACTGGCGTGGCGTCCTCGGCACCACCGACCGTGCCGCCGTGCTGCCCCCCGACCGGCCGCGTGGCGCGTACCGCTCCTTCAGGGGTGCCCGGACCGTCTTCCGGCTGCCCGGCGACACGCTCACCGCCCTGCGCGCACTGGCCCGTGCCCAGGGCGCCACCCTCTTCCAGGCACTGTTCGCCGCCCACCTCGCCCTGCTGCACGACTGCACCGGGCAGGACGACGTCGTCGCCGGCATGCTCGCCGCCGACCGCCGGCACGGCGCCACGGCCGACCTTGTCGGACACCTGGTCGACACCTTGCCCATCCGCTCCCGGCGCGCCCCCGGCGACGACTTCACCGCCTTCCTCGCACGCACCCGCGCAGGGGTCCTGGAGGCCTTGGACCACGCCGTGCCGTTCCCCGACCTGGTCGCGGCGCTGCGGCCCGCCCGTTCCACGGCGCATGCGCCGCTGGTGCGCACGCTGTTCGTGATGCACCGCGAACAGGGCGACGCCGACGACGGCTTCCGCACGCTGGCCCTGAACGTGCCGGGCACACTCCGCCTGAACGGGCACACGCTGCACACCGTGCCGGTGGAGACCGGTGGCGCACAGTTCGACCTCGTCCTGTCCATGGCGGAGGTCGGGAACGAGCTCGTCGGTGTCTGGGAGTACGACACCGACCTGTTCGACGCCGCCACCGTGGACCTTCTCGGTGCACGCTTCACCACACTCCTGCGCGAGTGCGCCGCCCGTCCCGAACACCCCCTGACGCGCCATCCGGTCCTCGGTCCGGCGCAGGCCGCCCACCGGCTGCACAGCGCGCAGTACGGGCCGCTGCGCGACCGGTCCCCGGCCGACGCGCTGCACCTGCGGGTGGCCCGGCAGTCCGCGCGGGTGCCCGACGCCGCCGCCGTCACCACCGAGGACGCGGCCGGCGTCGCGCACACCCTCAGCTATGCCGCCCTGGAGCGTGCCACGGCCGCGCTCGCCGCCCGGCTGCGGGACCGGGGCATCGGTGCCGAGGACCGGGTCCTGATCGCGCTGCCCCGTGACGTGTGGCTGCCCGTCGCCTACCTGGCGACTTGGCGCGCCGGCGCGGTCCCCGTCCCGGTCGGCCCGGACGACCCGCCCGCCCGGTGGGCCCTGATCGCCGAAGACAGCGATGCCCGCGCCGTGCTCGCCCACCACGGGTCCGCCGCCCGCTCGCTGGCTCCCGTCGCGCTCGACCCGGCGGACGGCGGGCCCGCTCCGGCCGGACCGCGCCGCGAGCCGCTCGGCGCGGCCCACCCTCTGGCCGCCGCCTGCGTGCTCTACACCTCCGGCTCCACCGGGCGGCCCAAGGGCGTGGTCCTCACCCACGGTGGGCTCGCCAACCGCGTCGCCTGGATGGACGAGGCCTTCACCCCGCGCGCGGACGAGCGCGTCCTGCACAAGACGCCGGTCACCTTCGACGTCTCCCTGTGGGAGCTGATGTGGCCGCTCACCACCGGCGCCACCTTGGTCGTCGCGCCGCCAGGGGCCCACCGGGACGCCGTGCGGCTGCGTGACCTGATGGACCGCCACCAGGTCACCACGACGCACTTCGTCCCCTCGGTCCTGGCCGGCTTCCTCGAAGCCCACGCGCCTGAGCGCCGCCCCTGCAACGCCCGGTCGCTCCGCCAGGTGCTCTGCAGCGGCGAGGTCCTGTCCGAGAGCCTCGCCCGCCGCCTGCACGACCGCCTCACCGCGCGGCTCCACAACCTGTACGGACCCACCGAGGCGTCGATCGACGTCACCGCCTGGCGCCGGGAGCCGGGGGAGCGGGGCCCCGTTCCCATCGGCAGGCCCCTCGCGAACACCGTGATCAGGGTGCTGGACGCCTCAGGCCGGCCCGCCGTGCCGCCGGCCGTCGGACTGTTGTGGATCGGCGGAACCGCTCCCGCCCGGGGCTACCTCGGCGCCCCGGCCGCCACCGCCCGCGCCTTCCGCCCGGACCCGTACGCCGACGAACCGGGCGCCAGACTGTACGCCTCCGGAGACCTCGCCCGGTGGCGCCCCGACGGTGCCCTGGAGTTCCACGGCCGTGCCGACGACCAGGTGAAGATCTCCGGCAACCGGGTGACCCTCGGCGAGGTCACCGAGGCCCTGCGCGCCCTGCCGTTCGTCCGGGACGCCGCCGTCATCGCGCACGGCGGTGAGCTCCTCGGCTATGTCGTCCCCACCGCCGGCGCGGAGCACGACGATCCGGCACGCACCGCCGAGGCCGCGCGCCGCGCACTGCGCGAGACCCTGCCGTCCTACCTGGTCCCCAGCGCGGTGCAGGCCCTTGCGGCGCTGCCGCTGAACAGCACCGGCAAACTCGACCGAGAAAGGCTGCCCCTGACTCCGAGCCGCCCGGCGCCCACCGGTGACGCAGGTCGCCCGCCGCGCACGGAACCGGAGCGCCGTATCGCGTCGCTGTGGGAGCGTGTGCTGTCCGTGGAGGCGGTTGGCGCTGACGACGACTTCTTCGTCCTCGGCGGTGACTCCCTCACCGCGCTGCGGGTTGTGGGCACCGCGCAACGCGAGGGCATCGCCTTCTCGGTCGGCGACCTCTACGACCACCCCACCGTTGCCGCCCTCGCCCGGCACGCCGCCACGACGGACGGGCGCCCTCCGGCCGCGACCGAGCCCTTCGCCCTGTGCCCGGGGCCGCGCCCCGCCCACGTCGAGGACGCCTACCCGCTGTCGATGGCGCAGCGCGCCCTGCTGTTCCAGCAGGCACACCACCCGGGGTACGAGGTCTACACGACCACGGTGACCGTGAACCGTCCCCTGGACGCCGAAGCCCTGCGCACCGCGGTCCGACGGCTGATGCGCCGGCACGGCTATCTCCGCTCCTCCTTCGACCCGGCCGCCCGCCCCGAACCCCTCCAGCTCGTCCATCCGCACATGGATTGCCCCCTCACCGTGCGCGACCTGACCGGTCTCTCGCCGGCGGCGGCCGAAGCGGACCTGGCTGCCTGGCTGGAGGAGGAGCGTGGACGGCCCTTCGACACCTCGCGCGGGCCGCTGATCCGGTTCACCGCACACGACCTCGGCGATCACCACCACTTCACCGTCAGCAGCTTCGGCCTCGACGGCTGGTGCACGGCCACCGTGGTGACCGAGGTCCTCGGCGAGGCGGCCCGACCCGGTTCCCCCGGGGCAGCAGCGCCACGGCTCGGCTACGCGGACTTCGTCGCCCTTGAGCGTCGTGCCTTGGATGAGCCGGAGCACCGTGACTTCTGGGCCCGTACGCTCGCCGGTGCCGCCCCCTGCCGCCTGCCCCGCTGGGAACCGGTGCCCCGCTCCGGCCCCGCTCGGGTGCGGCGCTCGGTGCTGCCCGTGGACGACCGGGTGGCCGAACGACTGCACGCGGTGGCCCGGGAGCTCGGAGTCCCGCTCAAGTCGGTGCTGCTCGCCGCACACCTGAGGGTGGTCCGGGTGACCGCCGGCACCGAGGACGTGACCACCGGCCTGGAGACCAACGGTCGCCCCGAAGGCCCTGACGGAGACCGTGTGGTGGGACTCTTCAACAACATCGTGCCCCTGCGCCTGCCCGTCAGGTCCGCCACCTGGGCGGAACTGGTGCGCGCCGCCCACTCGGCTGAACGCGAGATACTGCCCCACCGCCGCTATCCGCTGGCCCGGCTCGAACGCGAGCACGGCGCCGCCCGGCTCTTCGACACGATGTTCGTCTACACCCACTTCCACCTCTACGAACAGGTGCCCGCCGAGGCGGCCCTCGATCCGGCCAGCGTCCGGGCTCCGGACCAGACGTACGTCCCGCTCACCGCCCATGCCAACGTCGAGGCGGGCACGGGCCGGCTCAGGATCCTGCTCGAACACGATCCCCGCGAGTTCTCCGAGGAGCAGACCGCCGCCCTCGCCGCGTCCTACGCCGACGCCCTCACCGCCCTGGCCGCGGACCCCCGGGCCCGCTGGGACGCCGGTCTCCTCCCCACCCCGCAGGGACCCCCCGACGAGCCCGCGTTCGTGCCCGTGCACCGGCTCGTCGAAGCCGCCGCCCGTCGTCATCCGGACCGCACCGCCGTGAGCGCCGACCGGGACCAGCTCAGCTACGCGGGACTGTGGGCCGCCTCCAGCCAGCTCGCCTCCGCGCTGCGCGTCCGGGGCGTGGGCCCGGAGGACGTGGTCGCCCTGCACGGTGTCCGGCGCCCGGAGACCGTCGTCGCCCTGCTCGCCGTGCTGCGGGCGGGTGCGGCTTGTCTGCCCGTCGATCCCCGATGGCCGGCCGCGCGGGTCGCGGACCTCCTGGCCGACGCCGGCGCGCAGCTCTACCTCGCCGCACCCGGCGAACGTGTCGGAGGGCTGCCCGCCGACGTGGCCGTACTGCGTACCGACGCCCCCGCGCCGGCCGGGTGCGGCGCCGAGCCCTCAGTGCACCCGGAAGCCCTGGCCACCGTGATGTTCACGTCCGGCTCCTCGGGCCGCCCCAAGGGCATCGGCGTACCGCACCGGGGTCTGGCGGGTTACATACGCTGGGCCGTCGGGGAGTACGGCATCGACGCCGACACCCGGTCACTGGTGCACTCCCCGCTCTCCTTCGACCTCACCGTCACCACCCTGCTGGCCCCACTCACCACCGGTGGCGCCGTCGACCTGCTCCGCTCCGACGACCCGGCCGCCACCGGCCGTGCCCTGCGCGCCGGTCCGCACACCCTGCTGAAGGTCACCCCCGCGCACGCCGACGCCCTCGCCGAGCAGATCGGCCCGCGTGGAGCGCCGGCGCTGCGCGCCGTCGTGATGGGCGGCGAGCAACTGTCACTCGGCACCGTGCACGCCTGGCGCCGCGTGGCTCCGTCGGCCACCGTCTTCAATGAGTACGGCCCCACTGAGACGGTCGTCGGCTGTGCCGTGCACCGTTGTGCCGACGCGCCGGCGGACTCGCGCGTGCCCATCGGCGTCGCCGCGGCGGGCGCGTCGCTGACCGTGATGCGCGCCGGGCTGCCTGCCTCCGCACACGCCGAGGGTGAACTCCACGTCGGTGGTCGCGGGGTGACCCGCGGCTATCTGGGCCGGCCCGCCGCCACCGCCGAGGCGTTCGTGCCCGACCCCGTCTCATTGCGTTCCGGGGCCCGCGTCTACCGCACCGGCGACCTGGTCTCCCGCCGCCATGACGGGCTGTACGTCTTCCACGGACGCCTCGACGATCAGATCAAGGTGGCCGGCCACCGGGTGGAGCCCGGTGAGATCGAGGCCGCCCTGCGTGCCCATCCCGGCATCCGTGCTGCGGCCGTCACCCTCGTGGGACGGCAACTCGTCGCCTACACAGTGCCGGTGACAGAACATCAGGTAACGAACGGGTATTCGATCATGGAATGGTTGTCGGTTAGGCTGCCCGCGTACCTGCTTCCGCACCGGTATGTCCCGCTGCCGGAACTGCCGTACACGCCGAACGGAAAGGTGGACCGCGCCATGCTGCCGTCGCCCGAGCAGCGCCGCGACGAACTGGCGGAGCGCTTACGGCAGATGAGTCCGGACGAGGTGCGCAGCCGGCTCGCTGCCGCGCGGGCCGCCCGGCGCGGCGGACGGAACCGGACATGA	MVSERCPPGSRALIAYPSGPEYVLGFLGCLYAGVVAVPCDVPSRGPGRERFASLVADAEPAAVLTDTPADGPPHLDIRAAGGGATVPAHRPGADAPAFLQYTSGSTREPRGVVITHANLMANERMIAEACGHDAESTFVGWLPLFHDMGMVANVLQPLYLGACGVLMPPEAFLRKPARWLRAISRYRAHTSGGPNFAYELCAERIRPEETEGLELSSWRVAYNGAEPVRADTLARFERRFARNGLRAEAAFPCFGLAEATLIVSGTPKDSPARVLRADAVALDAGTVRPAAPGADSVPLVSSGRAVPDTDIRIVATSTGRACADGQVGEIWVDSPSVARAYWRRPDESQTLNARLEADGPRHLRTGDLGALVDGELYVTGRHKDLIVVRGRNHHPQDVEWTAERAHPLLRPSCSAAFSLDRGGREFAVLLCEFREGADPDAAAEAAAAVRAAVLAEHGVEIDEIAFVPRGTVRKTTSGKVRRQWCRQRHGEGALPVVATFIRSLRPDASAAPDWPTPATLRSVTRERARHLLSRALLGAAGVAPGAGDPAATLVAAGMDSLTALQLHQDLENRYDVVLPPAALLGDASVTDVAEGVLRTLPPDAGTRTPPSADGVLASGTREFPLSPGQRALWFEHHAVPGNTAYHLARALRVEGPFDETRLAAAVDRVVARHALLRTCFPDRGGEPVNRVLPTGPRLVCTDATEMSEAAFAQTLRRAAVAPFALDDTPPVRFTWFRRGPGEGVLLLNAHHLVADYWSLVTILRELFAPRHGTDTPTVPRSHRSETDFAAYTEARRHILETDRDRLWAHWRGVLGTTDRAAVLPPDRPRGAYRSFRGARTVFRLPGDTLTALRALARAQGATLFQALFAAHLALLHDCTGQDDVVAGMLAADRRHGATADLVGHLVDTLPIRSRRAPGDDFTAFLARTRAGVLEALDHAVPFPDLVAALRPARSTAHAPLVRTLFVMHREQGDADDGFRTLALNVPGTLRLNGHTLHTVPVETGGAQFDLVLSMAEVGNELVGVWEYDTDLFDAATVDLLGARFTTLLRECAARPEHPLTRHPVLGPAQAAHRLHSAQYGPLRDRSPADALHLRVARQSARVPDAAAVTTEDAAGVAHTLSYAALERATAALAARLRDRGIGAEDRVLIALPRDVWLPVAYLATWRAGAVPVPVGPDDPPARWALIAEDSDARAVLAHHGSAARSLAPVALDPADGGPAPAGPRREPLGAAHPLAAACVLYTSGSTGRPKGVVLTHGGLANRVAWMDEAFTPRADERVLHKTPVTFDVSLWELMWPLTTGATLVVAPPGAHRDAVRLRDLMDRHQVTTTHFVPSVLAGFLEAHAPERRPCNARSLRQVLCSGEVLSESLARRLHDRLTARLHNLYGPTEASIDVTAWRREPGERGPVPIGRPLANTVIRVLDASGRPAVPPAVGLLWIGGTAPARGYLGAPAATARAFRPDPYADEPGARLYASGDLARWRPDGALEFHGRADDQVKISGNRVTLGEVTEALRALPFVRDAAVIAHGGELLGYVVPTAGAEHDDPARTAEAARRALRETLPSYLVPSAVQALAALPLNSTGKLDRERLPLTPSRPAPTGDAGRPPRTEPERRIASLWERVLSVEAVGADDDFFVLGGDSLTALRVVGTAQREGIAFSVGDLYDHPTVAALARHAATTDGRPPAATEPFALCPGPRPAHVEDAYPLSMAQRALLFQQAHHPGYEVYTTTVTVNRPLDAEALRTAVRRLMRRHGYLRSSFDPAARPEPLQLVHPHMDCPLTVRDLTGLSPAAAEADLAAWLEEERGRPFDTSRGPLIRFTAHDLGDHHHFTVSSFGLDGWCTATVVTEVLGEAARPGSPGAAAPRLGYADFVALERRALDEPEHRDFWARTLAGAAPCRLPRWEPVPRSGPARVRRSVLPVDDRVAERLHAVARELGVPLKSVLLAAHLRVVRVTAGTEDVTTGLETNGRPEGPDGDRVVGLFNNIVPLRLPVRSATWAELVRAAHSAEREILPHRRYPLARLEREHGAARLFDTMFVYTHFHLYEQVPAEAALDPASVRAPDQTYVPLTAHANVEAGTGRLRILLEHDPREFSEEQTAALAASYADALTALAADPRARWDAGLLPTPQGPPDEPAFVPVHRLVEAAARRHPDRTAVSADRDQLSYAGLWAASSQLASALRVRGVGPEDVVALHGVRRPETVVALLAVLRAGAACLPVDPRWPAARVADLLADAGAQLYLAAPGERVGGLPADVAVLRTDAPAPAGCGAEPSVHPEALATVMFTSGSSGRPKGIGVPHRGLAGYIRWAVGEYGIDADTRSLVHSPLSFDLTVTTLLAPLTTGGAVDLLRSDDPAATGRALRAGPHTLLKVTPAHADALAEQIGPRGAPALRAVVMGGEQLSLGTVHAWRRVAPSATVFNEYGPTETVVGCAVHRCADAPADSRVPIGVAAAGASLTVMRAGLPASAHAEGELHVGGRGVTRGYLGRPAATAEAFVPDPVSLRSGARVYRTGDLVSRRHDGLYVFHGRLDDQIKVAGHRVEPGEIEAALRAHPGIRAAAVTLVGRQLVAYTVPVTEHQVTNGYSIMEWLSVRLPAYLLPHRYVPLPELPYTPNGKVDRAMLPSPEQRRDELAERLRQMSPDEVRSRLAAARAARRGGRNRT	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	478.06	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1629	colistin A; colistin B
BGC0001058.1|Zorbamycin_20 # 38791 # 40584 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.744	BGC0001058.1|Zorbamycin_20 	38791	40584	+	Loose	730	27.335	farA	27.18	3003961	protein homolog model	n/a	n/a	antibacterial free fatty acids	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGCCACGACGACGCGGCGCTGACCCCGGAGCAGGAGGAACTGCTCGGCCTGTGGCTCGCCGACGAGGTGCCCGGCACGCAGCCCGACGCCGGCCACCACATTCCGCCGCGCCACGCCGCCGAGTCCGTGCTGGCCGGCATCTGGGCCGAGGCGCTGGGCGTACCGCACGTCGGGATGACGGACGACTACTTCGCCCTGGGCGGCGACTCGGTGCTGGCCATCGTCATCGTCGCACGCGCGGCCGAAGCCGGTCTCGACATCTCTGCGCGGGACCTGTTCGAGGCCCGTACCATCGCGGGACTCGCCCTGGACGAGGACCGGCTCCGCGACGTCCCGTCCCCGGCCCGGCCGGCATCCATCGCCGCCGAACCCGTCGGCGACCTGCCTCTCACCCCTCTCCAGGAGGGCATCCTCTACCACTCGCTGGCATCGGGCCGGCAACGGGACGGCTACCTGGTCCAGGCCCACTGCCTGGTCACCGGGGCGGTCGACCTGCCGCTGCTGCGCGGCGCCTGGGAGACGGTGCTCGCCCGGCAGCCCGCCCTGCGCACCGCGTTCAGGCTGAGCGGACCGGACGGGCCACGCCGATGGATCGCCCCCACGGCGGTCCTGCCCTGGACCGAGGAGGACTGGCGCGGCAGCGACGCACAGGCCGCCCTCGCCGAACACCTGTGCCGCGACCGCGCGGCCGGCTTCGATCTGGAACGCCCGCCCCTGTCCCGCGTCGCCGTGTTCCGGGAGGCCGGGGACCGGCACCGCATGGTGTGGACTCACCACCACCTGATCCTGGACGGCTGGTCCCAGCAGATCGTCCTGCGCGACGTCCTGGAGCACTACGCGGGCCTCGTCGCGGGCACCCTCCGGGACCCGGCCACACCGCTCGTCCAGTCCGCCCCCGCCCCCGGGACGACCCTCACCGCGGCACCGGCGGCCGAGGAGGAGGACCACTGGCGCGGTCTGCTCGCCGGGGCGCGGCCAACCCTGCTGGTACCGGAGCGGGACGACACGGAGGAGCCGCAGGGCCGTGGCCGTGCCGTGGTCACCGATGTCTGGCCGGCCGACCTGGTCACCGCCCTGGAGACGTTCGCGGCCGGCACCGGTGTGACCGTCGCCACCGTCGTCACCGCCTGCTGGGGCATGGTGGCCGCCGCCCGGACCGGTGCCGACGAGGCTCTGTTCGGACTGACGGTGTCCGGTCGGGACCCGGCCCTGCCCGGCGCCGGGGAACGCGTCGGAATGTTCGTCAACACCCTGCTCACCCGGGTGACCGATGAGGGAGCGACGGCGGAGGAGTGGCTGCGGGAACTGCAGAGCCGGATGGCCCGGTCCCGGCGCTTCTCGGGCACCGCGCTGAGCCGGGTGCTGCGTCGGTCGGGGTACGACCGGCTGTTCGACTCCCTGCTCGTGGTCGAGAACTTCCCCACCTGGCTGGGGCCGGGCACCAGGGTCGCCGGACTGGTCGTCGACCACGTCGACGTCGTCGTCGACGAGGGTTACCCCCTGGTCGTCGAGGTGGCGACGCACAAGGGCCTGGTCGTACGGCTGCGGCACGATGCTGCGAAGGTCTCCGTCGCACAGGCGGAGGACATCGTCGGGGACCTGCGCGCCTGTGCGCAGTTGCTGGTCACGGGGGCCGCCCCTGCTCCCGCCGGGGTGCGTGCCGCGCTGACGGACCGCCTCGCCGCCGCCCGCGACCGGGCCGTCCTCGCCCGCCGCGCCAAAGCACGGGACCTGCTCGGCGCGGCGCGCCGGCGTCCTGCGGACCACGACGCACGAGAGGGCGGGACATGA	MSHDDAALTPEQEELLGLWLADEVPGTQPDAGHHIPPRHAAESVLAGIWAEALGVPHVGMTDDYFALGGDSVLAIVIVARAAEAGLDISARDLFEARTIAGLALDEDRLRDVPSPARPASIAAEPVGDLPLTPLQEGILYHSLASGRQRDGYLVQAHCLVTGAVDLPLLRGAWETVLARQPALRTAFRLSGPDGPRRWIAPTAVLPWTEEDWRGSDAQAALAEHLCRDRAAGFDLERPPLSRVAVFREAGDRHRMVWTHHHLILDGWSQQIVLRDVLEHYAGLVAGTLRDPATPLVQSAPAPGTTLTAAPAAEEEDHWRGLLAGARPTLLVPERDDTEEPQGRGRAVVTDVWPADLVTALETFAAGTGVTVATVVTACWGMVAAARTGADEALFGLTVSGRDPALPGAGERVGMFVNTLLTRVTDEGATAEEWLRELQSRMARSRRFSGTALSRVLRRSGYDRLFDSLLVVENFPTWLGPGTRVAGLVVDHVDVVVDEGYPLVVEVATHKGLVVRLRHDAAKVSVAQAEDIVGDLRACAQLLVTGAAPAPAGVRAALTDRLAAARDRAVLARRAKARDLLGAARRRPADHDAREGGT	MDTHTDETKLQNTQAKRKRRLTALTLLFALAAAAAGSAFFLWWQHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDTSAAGAPVSKTPGAALPEMESTDWSEVDRTVDEILGQSAP	155.47	gnl|BL_ORD_ID|2189|hsp_num:0	2428			735	987	palmitic acid; oleic acid; linoleic acid
BGC0001058.1|Zorbamycin_21 # 40581 # 41543 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.719	BGC0001058.1|Zorbamycin_21 	40581	41543	+	Loose	1200	44.2838	arnA	24.24	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACCCGGGTTCTGGTCACCGGAGCCTCCGGCTTCATCGCCGGCCGACTCGTCGAACGGCTGCGCCGCGACGGTCACCGGGTGCGGGCCGCGGGCCGCCGTCCCGCGGCCGCCGACGAGTTCGTCCAGGCCGACCTGCGCGACGCGGAGCAGTGCCGGCGGGCCGTCGAGGGAACCGACGTGGTGTTCGCCCTCGCCGCCAACATGGGCGGCATAGGCTGGACCCACCACGCTCCCGCGGAGATCCTCCGGGACAACCTCCTCATCACCACCCAGACCGTCGAGGCGGCCCGGGCCGCGGGCGTCACCACGCTGGTCTACGCGTCTTCGGCCTGCATCTACCCTCGCTACCTGCAGACTCGTCCGGACAGCCCCGCCCTGCGGGAGGACCAGGTCTTCCCCGCGGACCCCGACATGTCGTACGGCTGGGAGAAGCTCACCGGCGAGACGCTGTGCGCGACCTACCGCGACGCCTTCGGGATGGACATCAAGGTCGCACGGCTGCACACCGTGTACGGGCCTGGTGCCGCCTGGTCGGGCCCGCGTGCGAAGGCACTGATGGCGCTGTGCGCGAAGGTCGCCGCCATCGACGGGAACGCCGGGACGATCGAGGTCTGGGGCGACGGCACGCAGACCCGCTCCTTCTGTCACGTCGACGACTGCGTGGAGGGCCTGACGCGACTCGCCGCCTCCGGTGTCACGGTGCCGGTGAACATCGGCTCGGACGAACGCGTCACCATCGCGGACGCCGTACGGCTGATCGCGGACGCCGCCGGCAAGGAGGTCACGATGAGCTTCGCGCCGCACCAGCCGGTGGGACCGCTGGGCCGCAGCTCCGACAACACCCTGTGCGGCGAGCTGCTCGGCTGGACTCCCGGTGTTCCGCTGGCGGAGGGCATCCGCGAGACCTACCACTGGGTCGCCGCGCGGGTGGCGGGAGAGAGGAGCCGAGCCGGTGTCTGA	MTRVLVTGASGFIAGRLVERLRRDGHRVRAAGRRPAAADEFVQADLRDAEQCRRAVEGTDVVFALAANMGGIGWTHHAPAEILRDNLLITTQTVEAARAAGVTTLVYASSACIYPRYLQTRPDSPALREDQVFPADPDMSYGWEKLTGETLCATYRDAFGMDIKVARLHTVYGPGAAWSGPRAKALMALCAKVAAIDGNAGTIEVWGDGTQTRSFCHVDDCVEGLTRLAASGVTVPVNIGSDERVTIADAVRLIADAAGKEVTMSFAPHQPVGPLGRSSDNTLCGELLGWTPGVPLAEGIRETYHWVAARVAGERSRAGV	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	48.34	gnl|BL_ORD_ID|1513|hsp_num:0	1643			951	1977	polymyxin B
BGC0001058.1|Zorbamycin_22 # 41536 # 43092 # 1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.732	BGC0001058.1|Zorbamycin_22 	41536	43092	+	Loose	300	27.335	AAC(3)-VIIa	33.33	3002541	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGTCTGACCACGACCGCACACGCCCGGAGCGGACGCTCGCCCGGCTCCTGCTCGGCCACCTTCCGGGCCGGCGTGACAGGAGTCTCCAGGACCTGGCGACCGCCTTGCTGCGCGACCGGGAAGGGCACAGCCCGGTCCTCGACGCCGTCAACACCACACTCGCCGTGCGCCGAGACCTCACTTACTGGCTGCGGCTCGAACCACGGCGCCACTGGTCCCGGCTGACACACCGCCCGGTGCCGCACGCCGGACCCGACCGCCCACTGTCCCTGCTGTGCCCGAGCCGGGGCCGCGTCGGTAACCTGGGCTCCTTCCTGCGCAGTGTCCACCGCACCGCCGTCAAGCCCGGCCGGGTCGAGGTAATGGTCTACGTCGACGAGGACGACCCCGCGCTGCCCGCGTACCGCCGGATGTTCGCCCGCACCGCGAAAATCTGGCCGAGTCTGGGCGCGTGCCGCCTGCTCGTGGGTCCACCCGAGGGCGTACCCCAGGCATGGAACGCGCTCGCGGCGCGGGCCAGGGGCGATCTGCTGATGATGGCCAACGACGACCAGCTCTACGTCGACCACGGCTGGGACACCACCCTGGACAACCGGGTGACGCAGCTGACCGCCCTGCACGGCGACGACGTGCTGTGCCTGTACTTCGACGACGGCCAGTACACCGACGGGGGGCGCGACTTCCCGATCGTCACCCGCAGTTGGTACGACACCCTCGGCTACTTCACCCCGACCGTCTTCCAGCAGTGGGAGGTGGAACGGTGGGTCTTCGACATCGCCCTGCGCCTGGAGCGCTGCCACCCGGTGCCCGGGGTGTTCGTGGAGCATCGCCACTACCAGGACTACAAGGCGCCCTTCGACGAGACCTACCAGCGTCACCGGGTGACCCGGGAGAAGTCCCTCGCCGATCACGCCCTGTTCCTCGCCACCGAGTCGCAGCGCGCCGCCGAGGCCGAACGGCTGCGCCGGGTGATGGCTCCCGCATCGGGCCAGGGTTCCGCCCCGACCACGGGCCCCGCCGTGCCCGGCACGGCCGATCCGATCCCCGCCCGTACCGCGGCGCCCGCGACCGTACTGCCCGATCCCTGGTTCGCCGGCCGGCTGGCGGCGTCCCGAGCCCGGATGGCGGCCGAGGCGACCGCCTGGCGCGACCGCGTCGCACCCGGTACGGCCCCCCATACGCTGCCGTTGTGGACGGACGGGCGGCCCGCGACCGGCAGCGAGGCGAACTTTCCGGCCACCCTGGACGTGCTCGCCGCGATTCCCGAGATCGGCGCGGCCCGGGACGGGACCGCGGTCCTCGAGTGGTGGCCCGCCGGCAGCGACGCCGCCACCTCCGGGGGTGCCCCGCAGCGGTCGACCACCCTGCTCGCCCTTTCCGGCACGCCGGGCGTCCGCCTCCGGCTCGACGGGTGCGCACACCCCTTGCCCGCGGACGGCTGTCTGACGTACGAGGCCGCCTCGAGCCGGGAGACACGGAACGACGGCCCGGACGGTGCGCTCCTGCTCGCCCTGGGCACCGCCCGACCGGACGTCGACCACCGGAGCGAAGGATGA	MSDHDRTRPERTLARLLLGHLPGRRDRSLQDLATALLRDREGHSPVLDAVNTTLAVRRDLTYWLRLEPRRHWSRLTHRPVPHAGPDRPLSLLCPSRGRVGNLGSFLRSVHRTAVKPGRVEVMVYVDEDDPALPAYRRMFARTAKIWPSLGACRLLVGPPEGVPQAWNALAARARGDLLMMANDDQLYVDHGWDTTLDNRVTQLTALHGDDVLCLYFDDGQYTDGGRDFPIVTRSWYDTLGYFTPTVFQQWEVERWVFDIALRLERCHPVPGVFVEHRHYQDYKAPFDETYQRHRVTREKSLADHALFLATESQRAAEAERLRRVMAPASGQGSAPTTGPAVPGTADPIPARTAAPATVLPDPWFAGRLAASRARMAAEATAWRDRVAPGTAPHTLPLWTDGRPATGSEANFPATLDVLAAIPEIGAARDGTAVLEWWPAGSDAATSGGAPQRSTTLLALSGTPGVRLRLDGCAHPLPADGCLTYEAASSRETRNDGPDGALLLALGTARPDVDHRSEG	MDELALLKRSDGPVTRTRLARDLTALGLGDGDTVMFHTRMSAVGYVAGGPETVIGALRDVVGERGTLMVTCGWNDAPPYDFTDWPQTWQDARRAEHPAYDPVLSEADHNNGRLPEALRRRPGAVRSRHPDASFAALGAAATALTADHPWDDPHGPDSPLARLVAMGGRVLLLGAPLEALTLLHHAEALADAPGKRFVDYEQPILVDGERVWRRFHDIDSEDGAFDYSALVPEGTEAFEIIGRDMRAAGIGRRGTVGAADSHLFEARDVVDFGVAWMEEKLGRERGPGG	179.86	gnl|BL_ORD_ID|597|hsp_num:0	653			453	699	paromomycin
BGC0001058.1|Zorbamycin_23 # 43097 # 45010 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.740	BGC0001058.1|Zorbamycin_23 	43097	45010	+	Loose	690	28.4906	MexJ	42.86	3003692	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTGCGGAATAGTCGCCGCAGTGGACTTCGACGGCTCGCTCGGCGCGGACGCCGTGGCACCCGCCCTGCGGGTGCTGCGGCCGAGGGGCCCTGACGGCGAGGGGACGTGGGTCTCACCGACGGGCCGGGCCGTGCTGGGCCACACCCGCCTGGCCGTCAACGACCCCGCGGGCGGGGCCCAGCCCATGAGCGTCGCCGACGGCGCCCTCTGGATCGTCGCCAACGGCGAGTTCTACGGGCACCGTGCGCTGCGCGAGCGGCTGCGACGCCGTGGCGTGGCGGTGCGCAGCGGCAGCGACAGCGAGGTCGCCCTGCACCTGTTCCACGCGCACCGCGAACGGGCCCTGGACGAACTGCACGGCGAGTTCGCGTTCGTCGTCTGGGACGAGCGGCGGGCGGAACTGACCGCCGTGCGCGACCGCTTCGGCGTGAAGCCGCTCTACTACGCGCGCCTGGGCCGCCGGCTCCTGATCGCCTCCGAGATCAAGGCGCTCCTCGCCCTCGGCGTGTCACCCGAATGGGACACGGCGGCGTTCGCCGATCACCTGAACCTGGCAATGGGGCCGGACGCCACGCCCGTACGGGCGGTGCGCCAGGTGCCCCCGGGCTGTCTGCTCCACGCCGACGCCGGCGGACTGCGCCTGCGCGAGTACTGGGACATCGACTATCCCCGCGCGGAGGAGCACGCCGACGTCCGCGAGCAGGACCGGTCCGCCCACCTGGACGCGGTGGAGGCCGCCCTCACCCAGGCCGTGCTCCGGCGCACGGACGTCGACGGGCCCCTGGCCTGCCACCTCAGCGGAGGGCTGGACTCCTCCTCCGTCCTCGCGCTGGCAGCCCGTACCCGTGACATCACCGCCTTCACGGTGGCGTTCGAGGGCTCCGGCCTCGACGAGAGCGCCCTCGCCCGCCGTACCGCCGACCACCTCGGTGTCCGTCACCAGGTCGTCCACCACACCCCCGACGGCCATCTCGACCGGCTGGTGCGGACCCTGCACGCCGGCGAGATGGTCCAGGAGAACCCGCACGGCGTGGCGCGGTCCGTGCACGCGGGCGCCATCGCCGCGGCGGGCCACAAGGTCGCCCTGGCGGGGGAGGGCGGCGACGAAGTCCTCGCCGGCTACCCGCAGTTCGGCAAGGACCTGGCCTTGACGCTGGATCCGGCACAGCGGGCTCGCACACGCGCCGCGTACGCGCAGCTGGCGGACACCGCCGACCTGCCCCGCCATCTGCGCACCCTCGTGGCGGATCTCGGCTTCGTCCCTTCCTGGATCGTCGAACGCCATGCGACCGTCGCCCGGCCGATCGCCGCCCTGCTCACCCCCGACTTCGCCCGGCTGACCCGCGAACGCGACAGCGCCGCCGCGCTCCTGGCCCGGGCCGGGGATCGGCTCGTCGACCGCACACCACTGCACCGGTCCCTCTACCTGTTCGCCCGCAGCCGGTTCGCGAACTACATCCTGATGGCCGAACGGCTCGACGCCGCGCACGGCGTCGAGGTCCGGCTTCCCTTCCTTGACGACGGGCTCTTCGACGTGCTCCGGCGCACTCCGCCCCAGTGGTACGCCCACGACGGCCACACCAAACACCTCCTGCGCGCCACGGTCGGCACCCAGATGCTCACCGCCGAGGTCCGAAGCGGCCGCAAGCGCGGCTTCATGGCACCGCCCGCGATCGGCGACGAGGCGGCCTTCGCCGCCCTCCGCGGCGCCATCACCCCGGCCGCGCTCGACGACAGTCCGTTCTTCGACCGCCGGGCCGTCCTGGCCTGGCTCGACCGGTTACGTGCCCTGCCTGCGGCGCGGCGCGCGGTCCACGACCCGATCGTGCAACTGGTCGCCGGGGCGCTCCTCCTGACGGACGTCTTCCGGCAGGCCGGGCGCGCCGCCCACGAAAGGAGCGTCCGTGTCTGA	MCGIVAAVDFDGSLGADAVAPALRVLRPRGPDGEGTWVSPTGRAVLGHTRLAVNDPAGGAQPMSVADGALWIVANGEFYGHRALRERLRRRGVAVRSGSDSEVALHLFHAHRERALDELHGEFAFVVWDERRAELTAVRDRFGVKPLYYARLGRRLLIASEIKALLALGVSPEWDTAAFADHLNLAMGPDATPVRAVRQVPPGCLLHADAGGLRLREYWDIDYPRAEEHADVREQDRSAHLDAVEAALTQAVLRRTDVDGPLACHLSGGLDSSSVLALAARTRDITAFTVAFEGSGLDESALARRTADHLGVRHQVVHHTPDGHLDRLVRTLHAGEMVQENPHGVARSVHAGAIAAAGHKVALAGEGGDEVLAGYPQFGKDLALTLDPAQRARTRAAYAQLADTADLPRHLRTLVADLGFVPSWIVERHATVARPIAALLTPDFARLTRERDSAAALLARAGDRLVDRTPLHRSLYLFARSRFANYILMAERLDAAHGVEVRLPFLDDGLFDVLRRTPPQWYAHDGHTKHLLRATVGTQMLTAEVRSGRKRGFMAPPAIGDEAAFAALRGAITPAALDDSPFFDRRAVLAWLDRLRALPAARRAVHDPIVQLVAGALLLTDVFRQAGRAAHERSVRV	MYRHIPLVALSLFSSLFLAACGNGTPPPAAARPAIVVQPQPAGEVSQAFPGEIRARHEPELAFRIGGKVIRRLVEVGERVKKDQPLAELDPQDVRLQLEAARAQVSAAEANLQTVRAEYRRYRTLLDRNLVSHSQFENIQNSYRAGEARLKQIRAEFNVADNQAGYAVLRSPQDGVIASRRVEVGQVVAAGQTVFSLAADGEREVLIGLPEHSFERFRIGQPVSVELWSQRDRRFAGHIRELSPAADPQSRTFAARVAFDDRATPAELGQSARVYVAAAEAVPLSVPLSALTAEAGQAFVWVVEPGSSTLRRQAVRTGPYAEDRVPVLEGLKAGDWVVATGVQVLREGQQVRPIDRANRTVKLAAKE	173.57	gnl|BL_ORD_ID|2015|hsp_num:0	2205			486	633	erythromycin; tetracycline; triclosan
BGC0001058.1|Zorbamycin_24 # 45003 # 52922 # 1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.740	BGC0001058.1|Zorbamycin_24 	45003	52922	+	Loose	1000	136.732	almE	31.49	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGTCTGACGGCACCACCGCCGACGACCTCCGCACCCGCATCGCGGCGCTGCCCCCCGGACGGCGCGAACTGCTGGAGGCATTGCTCCGGCAGCGGCAGGAGGAGAACAGCGCCGGCATCCCGCGCCGTCCCGACCCGGCCCGTCCCGCCCCGCCCTCCTTCGGCCAGGAGCGGATGTGGGTGTTGTCCGAGCTCGGCCAGCACGCCTACCGGTACGGCGCCGCCGTGCGGTTGCGCGGCACGCTCAACCCCGCCGCCCTGCGTACCGCTGTCGACCACCTCGTGCGCCGGCACGAGGTACTGAGGACCGTCTTCGACGCCGAGGGCCGCCAGGTCGTGCGGCCCGTGGCCCCGCAGGACCTGCCCCTGGTCGACATGACCGCCGCCGCGGGCGGACCGTCGCCCGAGGCGTTCCTCACCCAGGTGCTGCGCGCCGCCTCCCTGCGCCCCTACGACCTCGCCGCGGGACCACTGCTGCGCCCCGTGCTGTTCCGGCTCGCCCCACGCGAGCACGTCCTGCTGCTCGCCGCGCACCACGCGGTCACGGACGGCTGGTCGCTGGGCGTGCTCGTCGCTGAGTTCGCCGCGCACTACCGCGAGGCTCTGGCCGGACACCCCTGCGCACTGCCCGAACCGCCCGTCCAGTACGCCGACTACGCGATCTGGCAGCGCCGGCGGGCCGGCGGAGCCGAACGGGAACGACTGCTGGACTTCTGGCGTCCCCGGATCGCCGAGCACGCCGTACCCCGACTGCCCTGGGACCGCGCCAAGCCGGACACCCCGCGGGCCGGCGGCGGCACCGAGGTACGGACGGTCACCGGCCCCCGCCTCGACGCGCTGCGGGCCGTCGCCGCCGCCGAGGGCGCCACCGCCTTCATGGTCGCCACCACGGCACTGCTGACCGTGCTGGCCTCCGTGACCGGCCGGCGCGACCTGGCCGTCGGCACCCTCGTCGCCGGTCGCACACGACCGGAACTGCGAGGGCTCGTTGGCTACTTCGCCAACGTGCTGCCCGTGCGGCTGGATACCGGCTCGCACCCCACCCCCCGCCGGCTGCTGCGCGCCGTGCGCGACGAGACGCTGAACGTCCTCGCCCACCAGGAACTGCCGTACGAGGTGTTGCTGGAGGAACTGCGGCGCACCGGCGACCGCGCCGCATTCGCACGTCCCCTGAACGTCCTCTGCGTGGGGCAGCAGGCTGTGGCAGCCGTCGACCTGCCCGGGCTGCGCGCGGAACCGGTCGACATTCCCCTCGGCGCGGCGGAGTTCGATCTCACGCTGGAGCTCCGTGACCACGACGACGCCTGGCAGCTCGCCCTTCAGTACGACCGAGACCTGTTCGACCCCGCCACCGCGCGCGCCCTCGGCGCCCGCCTGATGACCGCCCTGGACGCCCTCGTCGACGCGCCGGACGAGCCGACGACCGGGGCGGTCCGCACGGCGCGCGCCGCGGGCGTCCCCGACGGGACGGACCACACCGCCGTCGTCCACCGGATCTTCGAACGGCGGGCCGCGGAGGTCCCCGACGCCGTGGCCGTCGTGGACGGCACCCGCCACCTGACGTACCGCGGCCTGAACGGTGCGGCCAACCGCCTCGCCCGTCTGCTGCGCCGGCACGGCGTCGGCCCGGAGGACCGGGTGGCGCTGCGACTGGAACGCTCCGCCGAAAGCGTCCTCGCCATGCTGGCCGTGCTCAAGACGGGTGCCGCCTTCGTCCCCCTGGACCCCGGCTTCCCGGCGCGGCGCGTCACAGCCCTGCTCCGTGACGCCCGCCCCTCCTGCCTGATCACCACCGAGGCGCTCGCCGCCGGCTGGGACGGTCCTGAAGCGGCACTGCCCAGCGTGCTGCTCGACACCCACCGGGCCGAGCTCGACCGGCTCCGGCGGGACGACCTTCGACTGCCCGTCCACCCGGCCCAGGCCGCCTACGTGATCCACACCTCGGGTTCCACCGGCGAGCCCAGGGGTGTCGTGGGCCTGCACTCCGGCCTCGTCAACCGCTGCCGCTGGGCGGCGCGGACGATGCCGTACGCTCCCGACGACACATGCGCGGTCCGAGCCCCCCTGGGTTTCGTGGACTCCGTGGCGGAGGTCTTCGCGCCCCTGCTGGACGGCGCCCGCCTGGACATCGTCGGGCCGGACAGCGGCGCCGACCCCACCGCCCTCGCCGACCACCTGGCCACCCGGCGGGCCACCCGGTTGCTGACCGTGCCCTCCCTGCTGGAACCGCTCCTGGCCACGGTGCCCGACCTGGCGACGCGGCTCGCCCCGCTGCGCCTGTGCGTCACCAGCGGCGAGGCACCCGGACCCACCCTGGCGCGCCGCTTCGCGCACGCCGTTCCCGGAACGCGGCTGTTCAACCTCTACGGCAGCGCCGAGGTCGCGGCGGACGCCACCGCCGTCGAACTCGCTCCCGACACCCCGTACGCGGTCGTGCCGATCGGAACACCGGTCGACGGCGTCCGGGTACACGTCACGCACCCCGCGACAGGTCACCCCGCCGACGATCTCGTCCCGGGCGAACTGCTCGTCGGCGGTGCGGGACTGGCGCGCGGCTACCACGGACGGCCCGCTGCCACGGCCGAGCGCTTCGTGCCCGACCCGGCCGGAACGCCCGGCGCCCGCGCCTTCCGCAGCGGTGACCTGGCCCGCCGCCGCCCCGACGGAACCCTGGAACACCTCGGCCGCACCGACGACCGGCTGAAGATCCGTGGCATGCGTGTGGAACCCGCCGCCGTCGAAAGGGCGCTGTGCGCCCTGCCCGGCATCCGCGAGGCCGCTGTTCATCCCGCCCTGGACGCCGATGGCGTGCTGATCCTCGCGGCCCTGCTGATCACCGACGGACCGCTCGACCGCACAGCGGTGCGCCGCGCCCTGGCACGCCGACTGCCCGCACACGAGGTCCCCTCCCGGCTGCGGGCCGTCGACGCCCTGCCGCGCACCCCCAGCGGGAAGCTGGACCGTGCGGCCCTGGCCGCCGCGAGCCCCGCGGGCCGCCCCAGCCGGTCCGGCCCCGCCGGCCGGACGACGGGAACACCGCACACCCACGACACGGCCCCCGCCGCGTCGCGCACCTTCCGGCTGGTGTGCGAGGTCTTCGGCGCCCTGCTGCCCGACGCCGACGGCCACGTGGGCCCCGACGAGGACTTCTTCGAGCTGGGCGGCCACTCGGTCCTGGCCGTGCGTGCCGTCCACCGGCTGCGCGCCCGTACCGGGGCCCGTATCGCACTGCGCGACCTCATCGAGGCACCCACCCCTCGCGCTCTGGCCGCACGCATCAGCGCCATGACCCGCCACGCTTCCCCTGCGGGCGCGCAAGCGGAGCCCGTGCCCACGGGACCCCACGACCACCACGCGCCCTTCCCGCTCACCGAGGTGCAACAGGCCTACTACATAGGCCGCTCCGCCGACATGGAGCTCGGCAACGTCTCGACCTACGGCTATGTGGAGATGGCGACCCAGGGCCTCGACGTGCCGCGCTTCAACCGCGCGCTGCACCGGATCATCGAACGCCACCCCATGCTGCGGGCCGTCATCGACGCCGACGGCACCCAGCGCGTCCTGCCGACGGTTCCCGCCTACGAGGTCGACACATACGACCTGCGCGGCCTTCCGCAGGCCGAGGCCGAAGAGGCCCTGCGCACCACCCGCGCGGTCATGTCGCACCAAGTCCTGCCCGCCGACCGCTGGCCCCTGTTCGACGTCCGGGCCTCCGTGCTGCCCGGCACCACCACCCTCCTGCACATCGGCCTCGACTCCCTGGTCTGTGACGCCCACAGCTTCGGCCTGCTCCTGGCCGAACTGGCCGACGTCTACCGGGCTCCCGACACCCCGCTCCCGCCGCTCGCCCTGACCTTCCGCGACTGCGTCCTCGCCCGGGCCGCCGAACGGCACGGTACGGAACACCGGCAGGCCGCCGCCTACTGGCGCGACCGCCTCCCCGACCTGCCACCCGGGCCGGAACTCCCGTTCGCCCGTGCCCCCGAGGACGTCGACCGACCCGAGTTCCACCGCCGCGCCGCGCGCCTGGAACCGGCGCGCTGGGCACGGCTGAAGCAGCGCGCCCTGCGGCACGGCCTCACCCCGTCCGGCGTGCTGCTCGCCGCCTTCGCCGAGATCGTGACCCTCTGGAGCCGTCGGCCTCACTACACCCTGATGCTCACCTTCTTCGACCGGCTGGTCGAGCACCCCGACGTGGACGCCGTCATCGGTGACTTCACCTCCCTCATCCCCCTGGAGGTCGACCACCGCGAGCCGGGCGCCTTCGCCGGACGCGCCCGGCGCATCCAGCACCGTCTCTGGGACGACCTCGACCACGCCCAGGTCAGCGGTGTCACCGTGATGCGCGAATGGCTCAGGGAACACGGTGAGGAACCCAGGGCCGTCAACCCGGTCGTCTTCACGTCGAACCTGGTGACCTCCCGCCCCCGCCCTGGACGGGCCGAGCCGGGTGCCGGTCAGCCCTTCGGCCCGGTGGTGTACGCGGTCAGCCAGACACCCCAGGTGGGCCTGGACCACCAGGTCGCCGAGGTGGACGGTGCGCTGGAGTACAACTGGGACGCCGTCGACGCCCTCTTCCCGAGCGGCCTCCTCGACGAGGCCTTCTCCGCCTACGCGGCCTTCCTGGACCGGCTGTCCGATCCCGAGCACCCCGACTGGGACGCGCTGCCGCCACCGGAGCCGCCGGCCGGGCAGACCGCCCGCAGGGCCGCCGTCAACCGCACCGAGGCGCCCGTCCCCGACGTCTGTCTGCACGACCTGGTGAACGAAACGGCCCGCACCCGTCCCGACGACCCGGCGGTGATCACCGACACCGTGCGGCTGACCTACCGGGAACTCGTCGACGCCTCCCTCGCCGTGGCCCGGGCTCTGCACCACCGGGGCGTGCGCCCGGGTGACCTCGTCGCCGTGGCCGCACGCAAGGGATGGCAACAGGCCGTCGCCGCCCTCGGAGTGCTCCAGGGCAAGGCTGCCTTCCTGCCCCTCGACCCGGACCAGCCGGCTCAGCGCACCAGACGTCTGATCGAGGACAGCGGTGTCCGGCACGTCCTCGTCGAACGTGCCGGACGGGCCGGGTTCCCCGGCACCGGCGGCGTCGGCGTCATCGCCGTGGAGGACTGTCTGACCACCGCCGGCTCCGGCGGCGCGCCCGGCGAGCCCTGCACGCCCGGCGACCTCGCCTACGTGATCCACACCTCCGGCTCCACCGGCACTCCCAAGGGCGTCGTCATCGATCACGCGGGCGCCGTCAACACGATCGTCGCCGTCAACCGCCGTTTCGGCGTAGGCCCCGCCGACCGCGTGCTGGCGGTGTCCTCCCTCCACTTCGACCTCGGCGTGTACGACCTGTTCGGCACCTGGGCCGCGGGCGCGGCGGTCGTCCTGCCCGAACACGGCCGCCGCACCAGTCCGGCCCACTGGACCGACCTGATGCGGCGCCACGGAGTGACCGTGTGGAACTCCGTGCCGGCCCTTGCCGGCCTCCTCGTGGAGTACGCCGAGCACGCCGACGGCTCGGCGGCCACCGCCCCGGCCGGCCTGCGCGTGGCGCTGCTCAGCGGCGACTGGATTCCGCTGGACCTCCCCGGCCGGCTGCGATCGGTCGCACCCGACTGCCGAGTCATCGGCATGGGGGGCGCGACAGAGGCGTCCATCTGGTCCGTGTGGTACCCCGTGGAGCACGTCGACCCGGCCTGGCGCAGCATTCCCTACGGCCTGCCCCTGGACAACCAGACCGTGCACGTCGTCGACGACCACGGCAGACCCCGTCCCGACTGGGTGCCCGGCGAGCTGCAGATCGGCGGCCGGGGCGTCGCGCTGGGCTACTGGCGTGACCCGCGGCGCACGGCGGAGAAGTTCCCGCAATGCCCCACCGGATCCGGCGCTGTGGAACGCCGGTACCGCACCGGCGACATCGTGCGGTTCCTCCCCGACGGCCTGCTGGAGTTCCTCGGCCGCGAGGACACCCAGGTCAAGATCTCCGGCCACCGGGTGGAACTCGGTGAGATCGAGACCGCCCTCTCCCGGGTCCCGGGCGTCCGCGCCGCCGTCGTGGTCGCCCCCAGCACGGCCGACCGGCAACGCAGGCTGGTCGGTTACTACCTGTCCGACCCCGGAGCCGCCCCGGACCCCGCCACGGTGCGCGAACGGCTCCTCGAGGTGCTTCCCGGCCACGCCGTCCCACCACGCCTGATCCCGCTGGAGCAGTTCCCGCTGACGACCAACGGCAAGGTGGACCGGGGGCGGCTGCGCGACCTGCCCGTCGGCCACGCGCCCGGCGCCCCCCGGCGCCGGGCGGACGCGTGGGAGCGACGCGTCGCCGCCGTCTGGGCGGAGGTGCTGCGCGTGGACGACGTCGCCCCGGACGACGACTTCTTCGCCCTCGGCGGAACCTCCCTCGCGGCGATGCGTCTGACGACCAGGATCCAGTCGGAGTTCGGCGCCCGGCTGAGCCTCCTCGACCTCTACCGGGCCCCGACCGTCGCCGCCACCGCGCAGCGACTGGCCGCCGCCAAGGACGCCCCCGCGTCCGCGGCACCCGGCCAGACGCCCGACCCGGCCCTCGAACTGCGCCCCGACCCGTTCGGCCGGCACGACCCCTTCCCCCTCACCGATGTCCAGCAGGCCTACTGGCTCGGTCGGCTGGCCTCGGCCGAACTCGGGCGCGTCGCCACCCACACCTACGCCGAACTCGATCTGGAAGAGCTGGAGGTCGACCGGCTGGAGGAGGCCGTGCGCCGGCTCGTGGCCCGCCACGACTCGCTGCGGACGGTGATCCTGCCCTCCGGCCGGCAACGCGTCCTGGAGCACGTGCCCGACTACGCCGTGGACCACCTCGACCTGCGCGGCCGAAGCCCCGAGGACATCGCGGAGCTGCACGCCCGCACCCGCGAGGAACTGTCGCACCGCGTCGCCCCCGCCGACCGGTGGCCGTTGTTCGCCCTGCGCGCCCACCGCCTCGACGAGGGCCGGACCCGGCTCTTCGTCAGTCTCGACCTGCTGATCGCGGACGCCCACAGCGTCCACGTACTCACCGCCGAACTCCTCACCCTCTACCGGGACCCTCAGCGAGAACTGCCCCCGCTCGGCCTGACCTACCGGGACTACGTCCTGGCCGCCGAACGGGCCCGCACCTCACCGCAGCGCGCTCGGGCCCTGGAGTACTGGCGAGCGGAAGCCCACCGGCTGCCCCCGGCCCCCGAACTCCCGCAGCGCGTCCACCCGCGCTCCGTGGACCGGCCCCGCTTCGAGCGGCTCACCACGTCCTTCGGACCGGAGGTGTGGGGCACGCTCGTCCGGCGCGCCGCGGCGGCCGGTCTCACGCCCTCGGTGGTGGTGTGCACCGCCTTCTGCGACGTGTTGCGCACCTTCAGCGGCAGGGAGGGTGGCTTCACCCTCAACCTGACCACCTTCAACAGGGAGCGGGTGCACCCCGACATCGATCAGGTGATCGGTGACTTCACCACGCTCACCCTGCTCGCCGTAGGCCCCTCGCTGCCCCGTTTCCGCGCCCGTGCCCAGGACCTGCAACAGCGGCTCTGGGAACGGCTGGAGCACCGCGCGGTCAGTGGCGTGGAGGTACTGCGCATGCTGCGCGAGGACGCCCGTCGCCGGCACGACAGCATGATGCCCGTCGTCTTCACCAGCATGCTGATGCCGGAGCTGATGGCGGACGGTGAGGAACCCGTCCCGTGGCGCGGCGAGACCGCGTACGCGGTCAGCCAGACGCCGCAGGTGCTCCTGGACCACCAGATCAGTGAGCGCGCCGGGATCCTCACCTGCACCTGGGACTACGTGGTCCAGGTCTTTCCGGACGGCCTCGTCGAGGCCGTGTTCAACGCCTTCGACGAGCAGATGCGACGGCTGGCGACCGACGACGACGAATGGGGAACGGACACGCATGTCCAGTACGACGCGTAA	MSDGTTADDLRTRIAALPPGRRELLEALLRQRQEENSAGIPRRPDPARPAPPSFGQERMWVLSELGQHAYRYGAAVRLRGTLNPAALRTAVDHLVRRHEVLRTVFDAEGRQVVRPVAPQDLPLVDMTAAAGGPSPEAFLTQVLRAASLRPYDLAAGPLLRPVLFRLAPREHVLLLAAHHAVTDGWSLGVLVAEFAAHYREALAGHPCALPEPPVQYADYAIWQRRRAGGAERERLLDFWRPRIAEHAVPRLPWDRAKPDTPRAGGGTEVRTVTGPRLDALRAVAAAEGATAFMVATTALLTVLASVTGRRDLAVGTLVAGRTRPELRGLVGYFANVLPVRLDTGSHPTPRRLLRAVRDETLNVLAHQELPYEVLLEELRRTGDRAAFARPLNVLCVGQQAVAAVDLPGLRAEPVDIPLGAAEFDLTLELRDHDDAWQLALQYDRDLFDPATARALGARLMTALDALVDAPDEPTTGAVRTARAAGVPDGTDHTAVVHRIFERRAAEVPDAVAVVDGTRHLTYRGLNGAANRLARLLRRHGVGPEDRVALRLERSAESVLAMLAVLKTGAAFVPLDPGFPARRVTALLRDARPSCLITTEALAAGWDGPEAALPSVLLDTHRAELDRLRRDDLRLPVHPAQAAYVIHTSGSTGEPRGVVGLHSGLVNRCRWAARTMPYAPDDTCAVRAPLGFVDSVAEVFAPLLDGARLDIVGPDSGADPTALADHLATRRATRLLTVPSLLEPLLATVPDLATRLAPLRLCVTSGEAPGPTLARRFAHAVPGTRLFNLYGSAEVAADATAVELAPDTPYAVVPIGTPVDGVRVHVTHPATGHPADDLVPGELLVGGAGLARGYHGRPAATAERFVPDPAGTPGARAFRSGDLARRRPDGTLEHLGRTDDRLKIRGMRVEPAAVERALCALPGIREAAVHPALDADGVLILAALLITDGPLDRTAVRRALARRLPAHEVPSRLRAVDALPRTPSGKLDRAALAAASPAGRPSRSGPAGRTTGTPHTHDTAPAASRTFRLVCEVFGALLPDADGHVGPDEDFFELGGHSVLAVRAVHRLRARTGARIALRDLIEAPTPRALAARISAMTRHASPAGAQAEPVPTGPHDHHAPFPLTEVQQAYYIGRSADMELGNVSTYGYVEMATQGLDVPRFNRALHRIIERHPMLRAVIDADGTQRVLPTVPAYEVDTYDLRGLPQAEAEEALRTTRAVMSHQVLPADRWPLFDVRASVLPGTTTLLHIGLDSLVCDAHSFGLLLAELADVYRAPDTPLPPLALTFRDCVLARAAERHGTEHRQAAAYWRDRLPDLPPGPELPFARAPEDVDRPEFHRRAARLEPARWARLKQRALRHGLTPSGVLLAAFAEIVTLWSRRPHYTLMLTFFDRLVEHPDVDAVIGDFTSLIPLEVDHREPGAFAGRARRIQHRLWDDLDHAQVSGVTVMREWLREHGEEPRAVNPVVFTSNLVTSRPRPGRAEPGAGQPFGPVVYAVSQTPQVGLDHQVAEVDGALEYNWDAVDALFPSGLLDEAFSAYAAFLDRLSDPEHPDWDALPPPEPPAGQTARRAAVNRTEAPVPDVCLHDLVNETARTRPDDPAVITDTVRLTYRELVDASLAVARALHHRGVRPGDLVAVAARKGWQQAVAALGVLQGKAAFLPLDPDQPAQRTRRLIEDSGVRHVLVERAGRAGFPGTGGVGVIAVEDCLTTAGSGGAPGEPCTPGDLAYVIHTSGSTGTPKGVVIDHAGAVNTIVAVNRRFGVGPADRVLAVSSLHFDLGVYDLFGTWAAGAAVVLPEHGRRTSPAHWTDLMRRHGVTVWNSVPALAGLLVEYAEHADGSAATAPAGLRVALLSGDWIPLDLPGRLRSVAPDCRVIGMGGATEASIWSVWYPVEHVDPAWRSIPYGLPLDNQTVHVVDDHGRPRPDWVPGELQIGGRGVALGYWRDPRRTAEKFPQCPTGSGAVERRYRTGDIVRFLPDGLLEFLGREDTQVKISGHRVELGEIETALSRVPGVRAAVVVAPSTADRQRRLVGYYLSDPGAAPDPATVRERLLEVLPGHAVPPRLIPLEQFPLTTNGKVDRGRLRDLPVGHAPGAPRRRADAWERRVAAVWAEVLRVDDVAPDDDFFALGGTSLAAMRLTTRIQSEFGARLSLLDLYRAPTVAATAQRLAAAKDAPASAAPGQTPDPALELRPDPFGRHDPFPLTDVQQAYWLGRLASAELGRVATHTYAELDLEELEVDRLEEAVRRLVARHDSLRTVILPSGRQRVLEHVPDYAVDHLDLRGRSPEDIAELHARTREELSHRVAPADRWPLFALRAHRLDEGRTRLFVSLDLLIADAHSVHVLTAELLTLYRDPQRELPPLGLTYRDYVLAAERARTSPQRARALEYWRAEAHRLPPAPELPQRVHPRSVDRPRFERLTTSFGPEVWGTLVRRAAAAGLTPSVVVCTAFCDVLRTFSGREGGFTLNLTTFNRERVHPDIDQVIGDFTTLTLLAVGPSLPRFRARAQDLQQRLWERLEHRAVSGVEVLRMLREDARRRHDSMMPVVFTSMLMPELMADGEEPVPWRGETAYAVSQTPQVLLDHQISERAGILTCTWDYVVQVFPDGLVEAVFNAFDEQMRRLATDDDEWGTDTHVQYDA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	474.64	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1617	colistin A; colistin B
BGC0001058.1|Zorbamycin_25 # 52903 # 55446 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.735	BGC0001058.1|Zorbamycin_25 	52903	55446	+	Loose	1000	33.113	almE	19.52	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGTCCAGTACGACGCGTAACCAGCACGACCTGCTGCCGGCCGGACCGGTCGGCCATGAGGTCGCGGGACCGGCGCAACCGCCGTCGGTGACCGCCCTCCTCCACGCGGCGTCCGTCCGGTTCGCCGACCGGACCGCCCTGATCAGCTCCCGTGCCACCCTCACACACCGCGAGCTGGGTGCACGCGTCACGGGGCTCGCCCGGCGCATCGCGGACGCGGGTGCCGGGCCGGGCAGCCGGGTCGCCGTGTGCGCCGAACCGGGCTGGGAGCACGTCGTCGGAGCGCTCGCCGTGCTGTGGACCGGGGCGACGTACGTACCGGTGCCGCCGGATCTGAACCGTGCGGCCCGCTGGCAGCGACTCGCCGCGGTGGGCGCGGACGTCGCCGTCACCCAGCCCTGGCTGCGCGAACGGATGGACTGGCACGCCGACGTCACCGTGCTGACCGTGGACGGCGCGGACTCTCCCGAAGCGGCCGGGCCCGTCGAGCCCCCCTCTGTCCACGGCGGCACCCTCGCGCTGATCGGCGCGCCGGAGAGCGGCACGGTCCCGTTGAGCCTGTCCGCGGCAGCCGTCGCCCGTACCGTGGAGGACGTCAACCGACGCCTCGGCGTCACCTGTGAGGACCGTCTCCTCGGCGTGACCCCGTTGGCCAGCGAACGCGCTCTCTACGACATGCTGGGACCGCTCACGGTTGGCGGCGCCCTCGTCCTGCCCGACGACATCGATCTGCGCAACCCGGCCGCCTGGGTCGCTCTGGCGGCCGGCCACACGGTGACGGTCTGGTCCGCCACGCCCACCCTGACCCGCATGTTCCTCGACTTCGCGGAGGGAGCCGATGGCACACTGCCCGTCCCGCCACGCCGTTACGCGATCAGCGGCGAGCCGCTGCCCCGTACCACGGCCGAACGGTTGCGGGCCCTCGCCGGTCCCGGCGGCCGGGTGCTCTACCTGGGGGAGGGGGCCGATCCCGGAATCTGGGCCACCTGCATGCCGGTCGGGGACCTGGACGACGACTGGGGCTGGGTCCCGCTGGGCGGAGCGCTGGCCCACCGCGAGGTGCGCGTCCTGTCGGACTCCCTCGCCCGCTGCCCGGTCTGGGTGACCGGCCGCGTGCACCACGACGACCCGGACGCGTCCGCCCCGGACGGGCGGCTACTGCCCAGTGGCTATTTGGGGCGCGAACTGCCTACCGGAATTGTCGAGTTCGCCGGTGACCGGGCGGCCCGCATGTGGCTCAACGAACGCCCGCTGAATCTGCTCGACGTCGAACTGGCCCTGTGGCGACATGCCTCGGTGGCCGCGGCCGTCGTCGTCAGCCCCACCGGCACCGGGACCGTGGCCCACGTCAAACCGGCACCGGGCGCCGCGATCAGCGGCGAGGAACTGCGCGCGTACCTGCGGCGCATGGTCTCTCCCTACCTGCTGCCCGAGCGTGTCGAACTCGTCCTCGACTTCCCGACGACGCCGGACGGACGCGTCGACCGGGCCGCCCTCGCCTCCTCCGCCCCCCTCCCCGGCACCGGTACCGACACCGCCATGACCGCTCCGGCACCCGACGCCGAACTCCTGGAACGGGCGGCGTCGGTGGCGACCCGGCTGCTCGGTGTGAGCCCCATCGAACCGCACATGAACCTCCTCGACCTGGGGGCGACCTCTGTCGACCTGGTGCGGCTGGCCACCGTCGTGGAGGAGGAGCTGGGCATTGTCGTAGACATGCCGGAACTGCTCCAGTTCCCCTCCCTCGCCGTCCTGGTGAGCGGACACAGCACACGCGACGCCAACGACACTGACACCCCGGACACCCCGGACACCGCCTCGGCCTCCGTCGCGGACCCGTCCGCGGACCCGGCCACGGACGACGTACTGCACCGTCTGCAGGACCGCCAGGCCTTCAAGGACCGGCGCCCGGGCCTGCGGCACGACCTCGACGACGCCGAGGGCATCGACCTGGCCCCCGAACACACGGAGCGCATAGCACTGCGCCGCACGGTCCGCCGCTTCGGCAGCGGGCCGGTGCCCGCCGCCGACCTCGGGGCGCTCCTCGCCGCGCTGCGCGAAACCGACACCGGCGAGGGACCCCACCGCGCCTATCCCTCCGCGGGCGGCGCCTATCCCGTCCAGGTGTACGCCGTGGTCAAAGCCGGCGCCGTCGACGGACTGCCCGGCGGCTGCTATTACCACCATCCTGTGCGCAACCGTCTCGTTCCCCTCACCCCCGCCCACGCCCTGCACCCCGAAGACCACCACGAGGTCAACCGCGCGGTCGCGGAACGGGCCGGCTTCGCCCTCCACCTGGTCGGCCGCACCCGGGCCGTCACGCCTCTCTACGGCGAACTCGCCGACCACTTCACCGCGTACGAGGCGGGTGCCATCGGCCAACTCCTCATGACGCTCGCGGCGGAACACGGCATCGGCCTGTGCCCGGTGGCCGGCGTACGCCCCGGCGCTCTCATCGGGGCGCTCGACCTCGCCGACGGCGACGTAGTGCTGCACACCCTCCTGGGCGGCCCCGCCCCCGACACGGGCGGTGACGCCCAGTGA	MSSTTRNQHDLLPAGPVGHEVAGPAQPPSVTALLHAASVRFADRTALISSRATLTHRELGARVTGLARRIADAGAGPGSRVAVCAEPGWEHVVGALAVLWTGATYVPVPPDLNRAARWQRLAAVGADVAVTQPWLRERMDWHADVTVLTVDGADSPEAAGPVEPPSVHGGTLALIGAPESGTVPLSLSAAAVARTVEDVNRRLGVTCEDRLLGVTPLASERALYDMLGPLTVGGALVLPDDIDLRNPAAWVALAAGHTVTVWSATPTLTRMFLDFAEGADGTLPVPPRRYAISGEPLPRTTAERLRALAGPGGRVLYLGEGADPGIWATCMPVGDLDDDWGWVPLGGALAHREVRVLSDSLARCPVWVTGRVHHDDPDASAPDGRLLPSGYLGRELPTGIVEFAGDRAARMWLNERPLNLLDVELALWRHASVAAAVVVSPTGTGTVAHVKPAPGAAISGEELRAYLRRMVSPYLLPERVELVLDFPTTPDGRVDRAALASSAPLPGTGTDTAMTAPAPDAELLERAASVATRLLGVSPIEPHMNLLDLGATSVDLVRLATVVEEELGIVVDMPELLQFPSLAVLVSGHSTRDANDTDTPDTPDTASASVADPSADPATDDVLHRLQDRQAFKDRRPGLRHDLDDAEGIDLAPEHTERIALRRTVRRFGSGPVPAADLGALLAALRETDTGEGPHRAYPSAGGAYPVQVYAVVKAGAVDGLPGGCYYHHPVRNRLVPLTPAHALHPEDHHEVNRAVAERAGFALHLVGRTRAVTPLYGELADHFTAYEAGAIGQLLMTLAAEHGIGLCPVAGVRPGALIGALDLADGDVVLHTLLGGPAPDTGGDAQ	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	152.34	gnl|BL_ORD_ID|4935|hsp_num:0	5928			633	1638	colistin A; colistin B
BGC0001058.1|Zorbamycin_26 # 55443 # 56588 # 1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.764	BGC0001058.1|Zorbamycin_26 	55443	56588	+	Loose	850	26.1794	OpmB	32.14	3004072	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAACCTGCGCCACGGCCCGGGACGGGTGCCCCGCCGCCCGGTCGAGGAGCGGCCTGCCGCCCTGGTGCAGACCGGCTCCACCCCTGCCGGCCGCACCCTGCCGGTCGTCGTGGAGGCTGTCGACGACGCCGTCGACCCGGCCGCGTGGGCCGCCCGCGACACCGGCCGGCTGCGCGATCTGCTGGACCGTCATGGAGCGGTGCTGCTGCGCGGCTTCCAGACGACGCCGGGCGACCTGCCCCGCCTGCTGCGACCGCTGGGCGGGGACCCTCTGCAGTACCGGGAGCGCTCCACGCCGCGCACCGCGCTGGGCGGCGGTGTCTACACCTCCACCGACCATCCGGCCGACCAGGTCATCGCCCTGCACAACGAGAACGCCTACCAGTCGGCCTTCCCGGGGCTGCTGGCCTTCCAGTGCACCGTGCCGGCGCGGGCCGGGGGCGGTACCCCCCTCGCCGACTGCCGGCGCGTGCTCGCCCGGCTCGCCCCGGCCGTCGTCGAACGCTTCGTCCGCACAGGGGTGTGCTACCTCCGCACCTACCACCCCGGCGTCGGCCTGTCCTGGCAGGACGCGTTCGGCACCGACGACCGCGACGAGGTGAGCAGCTACTCCTCCCGCGGAGGCATCGAGGCCCACTGGCGCCCCGACGGCACGCTCCACACCCGCCAGACCCAGCCGGCCCTCGCCCGCCACCCCCGCACCGGGGAGGACGTCTGGTTCAACCACGCGGCGTTCTTCCACCCGGACGGTCTGGACCCCGCCCTGCGCGCGGCGCTGCGCGCCCGCTACCCGCGCGAGGAGGACCTGCCCCACCACGTCACCTTCGGCGACGGCGGCCCGATCCCCGCCGCAGACCTCGCCCACATCCGCGCCGCCTACGCCGCCGAAGCCGGCGTCGTCCCGTGGCGCGCCGGGGACGTCCTGCTGGTGGACAACCTTCTCGCGGCACACGGCCGCGAGCCCTACCGGGGCGAACGACGGGTCGCCGTCGCCATGGCCGGCCTGCTGGACCGCCAGGCCGTCCGCGCGGACCGCCAGACCGTTCGCGAGGACCGCCCGGCCATTCGGGAGGACCGCCCGGCCATTCGGGAGGACCGCCCGGCCATTCGGGAGGACCGCCCGGCGGGAGAGGCCGCACCATGA	MNLRHGPGRVPRRPVEERPAALVQTGSTPAGRTLPVVVEAVDDAVDPAAWAARDTGRLRDLLDRHGAVLLRGFQTTPGDLPRLLRPLGGDPLQYRERSTPRTALGGGVYTSTDHPADQVIALHNENAYQSAFPGLLAFQCTVPARAGGGTPLADCRRVLARLAPAVVERFVRTGVCYLRTYHPGVGLSWQDAFGTDDRDEVSSYSSRGGIEAHWRPDGTLHTRQTQPALARHPRTGEDVWFNHAAFFHPDGLDPALRAALRARYPREEDLPHHVTFGDGGPIPAADLAHIRAAYAAEAGVVPWRAGDVLLVDNLLAAHGREPYRGERRVAVAMAGLLDRQAVRADRQTVREDRPAIREDRPAIREDRPAIREDRPAGEAAP	MKHTPSLLALALVAALGGCAIGPDYQRPDLAVPAEFKEAEGWRRAEPRDVFQRGAWWELYGDQTLNDLQMHLERSNQTLAQSVAQFRQAEALVRGARAAFFPSITGNVGKTRSGQGGGDSTVLLPGGSTVSSGGSGAISTSYSTNLSVSWEVDLWGKLRRQLEANQASLHASAADLAAVRLSQQSQLAQNYLQLRVMDEQIRLLNDTVTAYERSLKVAENKYRAGIVTRADVAQARTQLKSTQAQAIDLKYQRAQLEHAIAVLVGLPPAQFNLPPVASVPKLPDLPAVVPSQLLERRPDIASAERKVISANAQIGVAKAAYFPDLTLSAAGGYRSGSLSNWISTPNRFWSIGPQFAMTLFDGGLIGSQVDQAEATYDQTVATYRQTVLDGFREVEDYLVQLSVLDEESGVQREALESAREALRLAENQYKAGTVDYTDVVTNQATALSNERTVLTLLGSRLTASVQLIAAMGGGWDSADIERTDERLGRVEEGLPPSP	76.51	gnl|BL_ORD_ID|2312|hsp_num:0	2716			1293	1461	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0001058.1|Zorbamycin_27 # 56585 # 57997 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.732	BGC0001058.1|Zorbamycin_27 	56585	57997	+	Loose	1200	25.7942	tet(T)	29.41	3000193	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAGCCACCACTCGCCGGCGCAGGCCCTCTGGCCGCTGCAGAGCCGCTACTGGCCCCTGCTGGAGGAGACCTCCTCCGGCACCCCCGTGCGCTGCCGCGCGCTGCTCCTCACCGGTCACGTCGACGTTCCCCGGCTGGTGGAGGCCGTGCACCGCGTCGTCGACCACCACCCCGTCCTGCGGGCACGACTGTCCGACGACGACGGCACCCTGCGGCTGCGCACCGCCGGCACGCCGTCACCCGTCGCCGTGTGGAGCGCGGACCGCGCCGACTGCGCCCGCGCCCTGCGGGAGGCCGCCGCGACTCCCCGTGACCCACGGCGGGATTCCCTGGCCACGTTCGACGTCGTACGCATCGCGCCCGACCAGTTCGTCCTCGCCATGACCGCGCACTTCCTCGTGGCGGACCTCGGTTCGCTCTACGCCACCCTCGGCTCCGTCCTGCGCGCCTACTTCGGGCGCCACCGGCCCGGGGGCCGTCCCCCGCAACCGCCCGCCCTCGGACCGGTGCCACCCGCCCGGAAGGCCTGGTGGGCTCGGCGACTGGCGCGATGGCAGGGTCAGGGCACCTTCGCTGCCGCCCTGGGCGCCCGAGCCCCGGACCGCCGGATCACCGCCACCCAGGTCCAGCCCGTGTCCGGTGCCGCGTGGCACCGCCTGGCCGCGCGGGCCGCGGACGCCGGCTGCAGCCCCGATCTGGCGGTCGTCGCCCTGCTCGCCTCCTGGCGCGCCATGATGGCACCGGACACCACGACCGCCGTGTTCGCCGCCTGGACCGACCTGCGCCACACCCACGGAGGAGACGGGCTCATAGGCCCGCTCTCCGACCAGATCGCCTTCGGCGTCGAACTGGACGGCCACGCCCGGATGACGTTCCCGGACCTGCTGCGCCGCACCCATGCCGGGCTGCTCGACACCATGGTTCGCCACGTCCCCTACGACGAACTGCGCCATTTGCACCGCGCGGAGCACCCCGGCGCCCTCCCGGTATGGGACACCCGCGTGCACTTCTGCCGCATCCCGCCGCGCAGTTCGCTCACCCGTGACGAGCCGTCCCTCGCGGAGCTCGGCCTGTCCGTCGAGTTGTTCGACGAAAGCCGGTTGCTCCCCGTCGCACCCCCGGCCGACGGCGCCGCCTGGGACGGGGTCAACGCCGACCTCCACCTCACCGAACACGGCGTCGACGACGTGGCGTTGACCCTGCACTACAACGCAACGACCTTGGAAGAACACGCCGTTCGCTTGATGCTGCGCTCCATCTCGGACATGATCACCGAGGTCGGCGAGGCTCCCGGGCAACTCCTGCCCGACCTCTGGCGGTCCCTAGGAGTGCCCGGTCACGGCGGACGGGATCGACAGGAGGCGCCGACGTGCGCCGTGCCCCCACACCCAGCGAAGGGACACAACCGATGA	MSHHSPAQALWPLQSRYWPLLEETSSGTPVRCRALLLTGHVDVPRLVEAVHRVVDHHPVLRARLSDDDGTLRLRTAGTPSPVAVWSADRADCARALREAAATPRDPRRDSLATFDVVRIAPDQFVLAMTAHFLVADLGSLYATLGSVLRAYFGRHRPGGRPPQPPALGPVPPARKAWWARRLARWQGQGTFAAALGARAPDRRITATQVQPVSGAAWHRLAARAADAGCSPDLAVVALLASWRAMMAPDTTTAVFAAWTDLRHTHGGDGLIGPLSDQIAFGVELDGHARMTFPDLLRRTHAGLLDTMVRHVPYDELRHLHRAEHPGALPVWDTRVHFCRIPPRSSLTRDEPSLAELGLSVELFDESRLLPVAPPADGAAWDGVNADLHLTEHGVDDVALTLHYNATTLEEHAVRLMLRSISDMITEVGEAPGQLLPDLWRSLGVPGHGGRDRQEAPTCAVPPHPAKGHNR	MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRASTVSFNYNDTKVNIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLNIPTLIFVNKIDRKGVCLDEIYTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQIIEKLLDINDYLAEKYINGDVIAEKEYNDVFLDEINNCNLYPVFHGSALKNIGIDELLFAITKYLPTKSYNTEDLLSAYVYKIDRDEKSRKMTFLRVFSGNIRTRQDVYINGTEETFKIKSLESIMNGEIVKVGQVNSGDIAIISNANSLKIGDYIGKKYDGILDIKIAQPALRASIKPCDLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILRLFGNIQMEVIESLLKSRYKIDARFGELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSFQNAVKDAVEKACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGTEILEPYLKYTVQVPNDFCGRVMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSELLSYSNGKGIFITEPYGYDIYNDKPIINDIGNDNNDSNKEGLRYLFQKQDEN	72.20	gnl|BL_ORD_ID|1954|hsp_num:0	2037			1098	1200	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0001058.1|Zorbamycin_28 # 57994 # 58605 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.694	BGC0001058.1|Zorbamycin_28 	57994	58605	+	Loose	500	26.9498	CTX-M-151	31.37	3002008	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGACAGCCGTCTCCGAGGACGACGACAACCGCGCGTACGCCGTGGTGGTCAACCACGAGGAGCAGTACTCGATCTGGCCCGTCGACCAGGACCTTCCCACCGGATGGCGGACCGAGGGCACCACAGGCAGCAAGGATGCGTGTCTCGACCACATTGAGCGAGTGTGGACCGACATGCGCCCGCTCAGCCTGCGGCTGTTCATGGAAGAGCAGGCCCGCCGCCCGGAGGCGGACGAACCGCACGACCAGGATCCGGAGGAGGACGAGGTGCCCTCCCTGCTGGACCGACTGGCCACGGGAGACCACCCGGTGGAGCCCGGACTGCGTCCGGAGCGCACCGCCGTCGCCCTGCGCGAGAGCCTTGAACGCGGCTACGTCCTCGTACGGTTCACCGAGACCCGCGGCGGCAGCGAGCTCGGAGTCACCGTCGACCCCGAGGCCACGGACACCTCCGCGGCCGACTTCGACGCGGGCACCGGGACGTTGCGTCTCGTCGGTGACCTCACCCTCGACTTCGAGTCCGCCCGCTGCCACGCCGACATCGATCTGGCCACTCTCCAGGGCCACGGCCGGCTAGAACGGACGGCTCCCGTGGGACAGCCCCTGACATGA	MTAVSEDDDNRAYAVVVNHEEQYSIWPVDQDLPTGWRTEGTTGSKDACLDHIERVWTDMRPLSLRLFMEEQARRPEADEPHDQDPEEDEVPSLLDRLATGDHPVEPGLRPERTAVALRESLERGYVLVRFTETRGGSELGVTVDPEATDTSAADFDAGTGTLRLVGDLTLDFESARCHADIDLATLQGHGRLERTAPVGQPLT	MINKRLSIALALAAMIGTPVAMALESQKPGSDSANHIQHQMVQQLSALEKSANGRLGVAVIDTGSGAIAGWRMDEPFPMCSTSKVMAVAALLKQSEQTPELMSQPQPVASGDLVNYNPITERFVGKSMTFDELSAATLQYSDNAAMNLILAKLGGPQKVTAFARSIGDDKFRLDRNEPSLNTAIPGDLRDTSTPRAMALSLQKLALGDALGQVQREKLSHWLRGNTTGAASIRAGLPSGWSVGDKTGSGDYGTTNDIAVVWPTGRPPLVIVTYFTQPQQQAESQRPVLAKAAAIVASHYVLPKG	66.78	gnl|BL_ORD_ID|331|hsp_num:0	362			705	858	
BGC0001058.1|Zorbamycin_29 # 58602 # 59762 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.733	BGC0001058.1|Zorbamycin_29 	58602	59762	+	Loose	125	26.9498	vanXY gene in vanE cluster	26.83	3002967	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanXY	ATGAGCCGTATGAGGCCCGAACGCGCCGGGAGCGTCCGACGGCTGTGCGTCTTCGCGCGGCTGGACGCTCCGGGCATGGGCGACCTCGTCCAGCGCAACATCTTCCTGAAACTGCTGCGCGAGGCCCATCCGCACGCCACGCTCACCCTGGTGGTGGGTGAGACCGTCGCCCGTGTCCACCGCACCCTGCTGGATCGCCACGGCTACGCGGACGACCTCCTTACCTGCCCCGACCCGGTCCACGCCCCCGGTGATCCGGCGCCGCCGCCCGCCTTCCTGCGGACGCTGCGCGACCGGGCGTTCGACCTGTGCCTGGTCGACCCCGACAGCACCGGCCTGGACGCCTCCCACGCCCACGCCGCCGGCATACCGCGCCGCATCGCACTGCCCACGGGCGGACCGGGAGACGCCTCCATCACTCATCCGGTCCGCCTGCCGCCCCCGCTGCTGGGCCGACCTGACCTCTACGAGTACGCCACCGGCCTGGCAGCCGCCCTCGGTCTGCCCACCCCCCTGCGCGCCGCGAGGGTCGTCCCGCCGTTCCCGTACACCCCGGTCGCCGACCCGTTCCCGACCGGGGACGGGAGACGGGTCGTCGTCCATCCTGGCGGCGCCCCCCACTGGAACCGACGCTGGCCCGCCGGACGGTACGCGGAACTGTGCGATCGGCTGCTGGCGGAAGGCGCCCGGGTGGCACTCATCGGCTCGCCGGACGAGCGCAGTGAACTGGAAGCACTGCGGGACACCTGCGCGTCCGGGGGTGAGCGTCCCCTGGTCCTGGTGCCGCACAGCCTCGACGCCCTGGCCACGGCCCTGGCCTCGGCACGACTCGTGGTCGGCAACGACTCAGCCCCGGCGCACATCGCCGCCGCGCTGCGCGTACCCACGGTCGTCATCTACGGGCCGACCGCCACCGAGTACCTCTGGTCCCGCATCTACCCCCTGCACCACGGGGTGTCCTTGCGCTACCCCTGCCGCACCTTGCGGCGCTCCGCCCACGACCCAGCGGCCACCCGCTGCGACCGCGGCTGTGCCACCGCCTACCGTCCGGACGGCGGATACCCCCACTGCCTGACGGACCTGGACGTCTCCACCGTGTGGCCCGTCGTCACCGCCCGGCTCGGCACCTCAGACGAGCACGAGAGGGAAGCAACGCCATGA	MSRMRPERAGSVRRLCVFARLDAPGMGDLVQRNIFLKLLREAHPHATLTLVVGETVARVHRTLLDRHGYADDLLTCPDPVHAPGDPAPPPAFLRTLRDRAFDLCLVDPDSTGLDASHAHAAGIPRRIALPTGGPGDASITHPVRLPPPLLGRPDLYEYATGLAAALGLPTPLRAARVVPPFPYTPVADPFPTGDGRRVVVHPGGAPHWNRRWPAGRYAELCDRLLAEGARVALIGSPDERSELEALRDTCASGGERPLVLVPHSLDALATALASARLVVGNDSAPAHIAAALRVPTVVIYGPTATEYLWSRIYPLHHGVSLRYPCRTLRRSAHDPAATRCDRGCATAYRPDGGYPHCLTDLDVSTVWPVVTARLGTSDEHEREATP	MKKNYLRLINENNEIKDSERPSHLVQAPFAQTNILVDPMVAIQLEKLIKTTGLDSQIITIDGYRSKETQQALWDETIQEKGLEFAHKYVAKPGCSEHEIGLAVDLGLATKENDFIRPSFTDSPIVDKFLKHMTDFGFILRYQKGKESITNINYEPWHFRYVGTPHSSIMVQQNWVLEEYIEFIESIRGTAYEA	200.00	gnl|BL_ORD_ID|603|hsp_num:0	559			147	384	vancomycin
BGC0001058.1|Zorbamycin_30 # 59759 # 61387 # 1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.703	BGC0001058.1|Zorbamycin_30 	59759	61387	+	Loose	700	27.335	Klebsiella pneumoniae KpnG	24.69	3004588	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCGAGGGACTTCCGCCCGGTTCCGTGCGGACGCTGCTGTCCGTCAACTTCAACCACGACGGCGCCGCCGTTCTGCTGACCGACGGCCGAATACGGGCCTTCGTCACCACCGAGCGCCTCTCCCGCCTCAAGAAGCACCCGGGGCTGCGCGAGGAGGATCTCGACGAACTGCTCGACCAGGCCGGTGCCGACATCGGCGACATCGACCATGTGCTGCTGTGCAATCTCCATCTCATGGACTCGCCCGACATCGCCACCCTGCACGGCAGCGACCTCAAGGACACCTGGCTGGAGTTCTGGGTCAACCAGCGCAACGACACCGTGCTGTTACGGGGCCGGCGCATCCCCTGCACGGTCAATCCGGACCACCACCTGCTGCACGCCGCCGCCGCGTTCTACACTTCACCGTTCCCCTCGGGGGTCAGCGTCGCCATCGACCCCACCGGCTGCCGTGCCTTCCTCGGCCGCGACAACCGGCTGTACCCGCTGCGACGTGACTTCGACAGCTGGTTCGACGCCAACTACGGCTACGCACACGTCGCCCACCACCTCTTCGGCTCGGCGATCGTCGGCGCGGGCAAGGTCATGGGCCTCGCCCCCTACGGCGCGCCACGGGACGGCGCCCACGCCCCGCTGCCCGAGGTCTCCTCCTTCGCCGAGCTGGTCGCGCTTGCGGACGCCGACCCCGTCGTCGTGGAATCCGACGGCCGGCCGCTCAACGCACGCCTGGCCTACTACATCCAGCGGGGCCTCGAAGAGCAGGTCGACCGGCTCTTCACCGAGCTCGAGCCGCTGTGCCGGCGCAACGGATACGAGCCCACCATCTGCCTGAGCGGCGGCACCGCCCTCAATGCCCCCGCCACCGAGAAGGCGTTCACCCGGTCCGGTTTCACCGGGCTGCACCTGCACCCGGCCTGCGGCGACGACGGCACCGCCCTGGGTGCGGCCCTGTGGTACTGGCACGACGTGCTCGGCCGGCCCCGACGTGAGCACGCCAATGCCGAGTTGATGTACGGGCGACGCGACCACGGGCGCCCCGCGGTCGAACGCGCCCTGCGCGCCCTCGCCGGTGCCCTGCACGTCGAGGTCACCGAGGACCACGCCGGACGCGCCGCGGAACTGGTCGAACAGGGCGCAGTGGTCGGCTGGTTCGAAGGCGCCGCGGAGATAGGTCCCCGGGCCCTCGGGCATCGCAGCATCGTCGCCGACCCCCGCGACCCGCACATGCGCGACCGGCTCAACACCCGGGTGAAGCACCGCGAGCGGTTCCGTCCCTTCGCGCCGTCGGTGCTGAACGAACACGCCGCCGAGTGGTTCGGCATCAGAGACAGCCCTTTCATGCTCCGGGCCGCCGCTGCCCGCCGTGACGGCATCCCCGCCGCCGTCCACGTCGACAACACCGCGCGCATCCAGACCGTGGAGCGCGCCGACAACCCCGCCTTCCACCGGCTCGTCGAACGCTTCGCCCACCGCACGGGCGTTCCGATGGTCGTCAACACCAGCCTCAACACCCGGGGTCACCCGATCGTCGAAACCCCCGAGGAAGCGCTCGGGACCCTGCGGGAGTCCGGCCTGACCCATCTGGTCTTCCCCGGCTACGTCATCGCCAAGGAGGCGCCGAAGTGA	MTEGLPPGSVRTLLSVNFNHDGAAVLLTDGRIRAFVTTERLSRLKKHPGLREEDLDELLDQAGADIGDIDHVLLCNLHLMDSPDIATLHGSDLKDTWLEFWVNQRNDTVLLRGRRIPCTVNPDHHLLHAAAAFYTSPFPSGVSVAIDPTGCRAFLGRDNRLYPLRRDFDSWFDANYGYAHVAHHLFGSAIVGAGKVMGLAPYGAPRDGAHAPLPEVSSFAELVALADADPVVVESDGRPLNARLAYYIQRGLEEQVDRLFTELEPLCRRNGYEPTICLSGGTALNAPATEKAFTRSGFTGLHLHPACGDDGTALGAALWYWHDVLGRPRREHANAELMYGRRDHGRPAVERALRALAGALHVEVTEDHAGRAAELVEQGAVVGWFEGAAEIGPRALGHRSIVADPRDPHMRDRLNTRVKHRERFRPFAPSVLNEHAAEWFGIRDSPFMLRAAAARRDGIPAAVHVDNTARIQTVERADNPAFHRLVERFAHRTGVPMVVNTSLNTRGHPIVETPEEALGTLRESGLTHLVFPGYVIAKEAPK	MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIIAVAYGIYWFLVLRHYEETDDAYVAGNQVQIMAQVAGSVTKVWADNTDYVQKGDPLVTLDRTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALSQAQADLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTRLEQQPAVLQAATEVRNAWLALQRTQIVSPISGYVSRRSVQPGAQIGTTTPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRDGEMLASQVRSSPVYESNAREIALDPVNKLIDEIIQANAG	138.97	gnl|BL_ORD_ID|2731|hsp_num:0	3298			756	990	erythromycin; gentamicin C; ciprofloxacin; spectinomycin; streptomycin; tobramycin; ceftazidime; ertapenem; piperacillin; azithromycin; imipenem; polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4; norfloxacin; ticarcillin; gentamicin
BGC0001058.1|Zorbamycin_31 # 61384 # 61650 # 1 # ID=1_31;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.715	BGC0001058.1|Zorbamycin_31 	61384	61650	+	Loose	600	23.8682	ALG11-1	27.27	3006892	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ALG11 beta-lactamase	GTGACGGGACGCCCGACCACACCCAACGAGGAGCGGCTGGTCGAACCGCTGCGTGCCATCTGGTCGGAGGTGCTGCAACGCGACGTGGCGCCCGGGGACGACTTCCTCGACCTCGGCGGCGGCTCCCTGCACGCCATCCGCATCGTCCACCGCGTCGAGGAGCGGTACGCGACGGAACTGTCGGTCCGCAGCGTTCTGGAGACCCGCACCGTCGCCGCCATGGCCCGCCATCTCGCCCACGTCCTCGACCGGGACCCGCGCTCATGA	MTGRPTTPNEERLVEPLRAIWSEVLQRDVAPGDDFLDLGGGSLHAIRIVHRVEERYATELSVRSVLETRTVAAMARHLAHVLDRDPRS	MAASAAVSLVVFLFVFVFTFAHAQDQPASWAQPQKPVRIFGNTWYVGTRGLSAILITSPTGAVLIDGAVREAASDIASNITSLGVRLEDIKLIVNSHAHNDHAGAIAELQRRTGATVAALPWSAEALRSGRKHQGDPQFESPTSPPDRVANVKTIQDGEVLRAGGVEVTAHKTAGHTPGGTTWTWRSCEENRCVDIVYADSLTAVSADGFRFTDNKTYPQAIDDFNKGYAFLRSASCDILVTPHPEASDFWGRIAKRDAGERDALIDRSQCARYADRADAQLQKRLATERAERPK	29.83	gnl|BL_ORD_ID|3289|hsp_num:0	4358			747	879	
BGC0001058.1|Zorbamycin_33 # 63140 # 64411 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.669	BGC0001058.1|Zorbamycin_33 	63140	64411	+	Loose	600	28.8758	BRO-1	52.0	3004761	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BRO Beta-lactamase	ATGACCGCGATGGGGCCGGGTGAGTTGCTCTCCGCGGCGGCCGACGTTGTCAGGGAAGACCCCGACAAGCGTCTCGCGATCTACGTCCACGTGCCGTTCTGCCTGTCCAAGTGCCACTTCTGCGACTGGGTCGTGGACATCCCCGTACGCCGGCTGCGTTATGACGAGGAGGAACGCCGCGACTATCTCGATGCGCTCCGTACCCAGATCCGGCTGTACGGACCGCTGCTCACCGGTCTGGGATACCGTCCCGAAGTCATGTACTGGGGAGGTGGTACCCCCACACGGCTCACCCCGCGGGAGCTGACGCACCTGGCGGAAACGGTCCGGGAGTCCTTCGACCTGTCCACACTGCGCCAGTGGTCGGTGGAGACCACCCCGAACGACCTGACCGAGGACCGGGTGGCGGCGCTGCGCGAGGCCGGGGTCGATCGCATGAGCATCGGCGTGCAGTCGCTGAGCGAGTACCAGCTACGGGTCTCGGGCCGAGCCCACGGCCCGGACGACGTGACGCGGGCCGTGGAACTGCTGCGTGCGGGCGGCATCGACAACTTCAACGTGGATCTGATCTCCGGCTTCCCCGGTGAGACCCTCGACGCGCTGGGTGAGACCTTCGACCGGCTGCTGGCCCTCGATCCGCCGCACGTGTCGGTCTACCCCTACAGGGCAACCCCCAAGACGGTGATGGCCATGCAGCTGACGCGCCGGCAGATCGAGGCGCACGACAGAACCGCCATGACCCGGGCCTACGAGTTGTCCATGGAGCGGCTGCGCGCGGCGGGGTACCACGAGTACTGCCACGGGTACTGGGTCCGTGACCCCGCCCACGAGGACCAGGACGGCAACTACAAGTACGACCTGACCGGGGACAAAATCGGCTTTGGCAGCGGCGCCGAGTCGATCATCGGCCACCATCTGCTGTGGAACGAGAACCGCAAGTACGACGAGTATCTCGGCCACCCCGATCGATTCACCTTCGCCCACCGCTTCTCCCTCGACGAACCCTCCCGGCTGACAGCCACCGTCGGCGGGGCCCTGATGACCCGCGAGGGGGTGGTCTTCGAACGGTTCCGCCGGCTGACGGGACTGTCCTTCCACGACGTCCGCGACACCCCGTACTTCCGACGCTGGCTCACCGTGCTCACCGACTGCGGTGCCCGGTTCGCTGAGACACCGACCGCCCTGCGCATGGAGTCGGACACCATTCACCGCGCCTACATCACCCATCTCGCCTACACCATGTACTCGGGACTCACCCCCGAGCGCGCCTGA	MTAMGPGELLSAAADVVREDPDKRLAIYVHVPFCLSKCHFCDWVVDIPVRRLRYDEEERRDYLDALRTQIRLYGPLLTGLGYRPEVMYWGGGTPTRLTPRELTHLAETVRESFDLSTLRQWSVETTPNDLTEDRVAALREAGVDRMSIGVQSLSEYQLRVSGRAHGPDDVTRAVELLRAGGIDNFNVDLISGFPGETLDALGETFDRLLALDPPHVSVYPYRATPKTVMAMQLTRRQIEAHDRTAMTRAYELSMERLRAAGYHEYCHGYWVRDPAHEDQDGNYKYDLTGDKIGFGSGAESIIGHHLLWNENRKYDEYLGHPDRFTFAHRFSLDEPSRLTATVGGALMTREGVVFERFRRLTGLSFHDVRDTPYFRRWLTVLTDCGARFAETPTALRMESDTIHRAYITHLAYTMYSGLTPERA	MQRRHFLQKTLLALPIIFSGNLLTGCKTNLSDDYLPDDKITNNPNLLQNKLKEILPIWENKFNAKIGMTIIADNGELSSHRGNEYFPVNSTIKAFIASHILLLVDKEKLDLNEKIIIKESDLIEYSPVCKKYFDENKPISISELCEATITLSDNGSANILLDKIGGLTAFNQFLKEIGADMVLANNEPLLNRSHYGETSDTAKPIPYTKSLKALIVGNILSNQSKEQLITWLINDKVADNLLRKYLPKNWRIGDKTGTGSESKNIIAVIWNENNKPYFISLFITQPHDGKSLDFKNQKDEIMAQIGKEIYPFL	135.14	gnl|BL_ORD_ID|2375|hsp_num:0	3565			756	825	
BGC0001058.1|Zorbamycin_34 # 64483 # 65028 # 1 # ID=1_34;partial=00;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=9bp;gc_cont=0.747	BGC0001058.1|Zorbamycin_34 	64483	65028	+	Loose	475	28.8758	KPC-94	35.0	3007402	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam	antibiotic inactivation	KPC beta-lactamase	TTGGAACACCAGCCAGAACCCGCCGCGCGTCTGTTCGCGGCCGTACAGGCGGCGGACGCCGCCGGTGCCCGCACCGCCCTGGTCGAGGACGCCTCGCCCGCCGCGCGTGACGCCCACGGATGGACCCCGCTGCACTGGGCGGCCGGCCGGGGGAGCACGGAACTGGTGGCCCTGCTTCTCGAACACGGCGCCGATCCCCGTGCCGCGGCCGACGGGCGCACGCCCTACGACGTCGCCCTTGCCGCGGGGCACGTCACCGTGGCCCGCGCGCTGGCCCGTTTCCGGGACGGCGGCACATGGCAGCCGTACTGCCGGGCGTACCCGCTGGGGGAGCTTCGGCGGTTCCCGGGCTGGCAGGACTCCACCGGCGAGGACGACTCCGCCGTCGTGTACCTGCACGACGACCTGACCGTCACCGCCTCTGTGATCCCCGGCGACCGGAGCGTCTTCGCCGGGGACACCCCCGGCTGGAGCGACTTCTGCCGGGACGCCCTCGACTTCGCCGTTCCGGACGAACTCGACCTGTGTGCCGGAGGGCCCGCGTGA	MEHQPEPAARLFAAVQAADAAGARTALVEDASPAARDAHGWTPLHWAAGRGSTELVALLLEHGADPRAAADGRTPYDVALAAGHVTVARALARFRDGGTWQPYCRAYPLGELRRFPGWQDSTGEDDSAVVYLHDDLTVTASVIPGDRSVFAGDTPGWSDFCRDALDFAVPDELDLCAGGPA	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELEHSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ	61.99	gnl|BL_ORD_ID|4913|hsp_num:0	5906			369	594	ceftazidime; meropenem
BGC0001058.1|Zorbamycin_35 # 65090 # 66439 # 1 # ID=1_35;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.716	BGC0001058.1|Zorbamycin_35 	65090	66439	+	Loose	550	28.1054	PJM-1	45.24	3007374	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	PJM beta-lactamase	GTGAACGTCCACGGCCTGGACGCACACCCCCTGACCGCCAACCAGGAATGGGAGTGGGACTTCGACCACAGCATCGGGTCCGCCGCCTATCACCGCCCCGTCCTGCTCCGCCTGCGCGGGCCGTTGCGGCCGTGTGCCCTGCGGGAAGCCGTCGCCGCGGCCGTGCGACGCCACCACAGCCTGCGTACCCGTTACCCACTGGTCGACGGCCGCCGTATGCAGGTCGTCGACCCGCCCGGGTCCCGGCCCCTGCCTCTCATCGACCTCACCTCGCTGCCCGCCCGCGCACGCGAGGACGCCCTGGTGCGTATCGGGCGCGACGATGCGGCCAGCCCTTTCGACATGGCCAGCGGTACGACGGTTCGCTGGGGCCTGGTGCGTCTGGCGGCCGACCACCACGCCCTGCTGGTCTCGCCTCACCATGTGGCCGTCGACCTGTGGTCCCTGTCGGTCCTCGCCGCCGACATCGCCGCCCACTACCGCCACGCCGCCGCCGGCGAACCCCTGCCCGCGCGCCCCGCGCCACTCCAGCCCTCCGAGTGGGCCCGTGCCGAACGGGAGCGCTGGACCTCCGATCACCTCGACGCCGCTCTGGCTCCCTGGCGGGAGGCCCTCGCACGCCTGCCCGCACTCGAGCTGCCCGCCGACCACCCCTCCACCCCGGGCCCGCCGTCCGAGGGGTGGCTGCTGAGCACCCACCTGGATGCCGGACTCAGCGACTCCGTGAGGGCACTGAGCCGACGGCACGGCGTCACCGTCTTCGTCACGCTGCTCGCGGCCTTCCACAGCATGCTCGCCCGCGTCTGCGACGTCGACCGGCTGGTCACCTACAGCCTGACTGCCCGCCGGCACAGCCGCGCCATGGAGGACGCCGTCGGTCTCTACTCCGACTATCTGCGCGTCTTCGCCGATCTGACCGGAGATCCACCGTTCGCCGAGGTGCTGGCCCGCACCGCGGACCGCGTGCTGGACGGTCAGGACACCCAGCGGCTGCCCAACGAACGGCTGTTGCGCGGTACCGACGACGGGACGCGACCACATCCGCTCGAACGAGTGGGGTTCACCATGCACAACACCCCGCCCGTCGGGTTCCCCCTGTCCGAAGGGATACGGGCGGCGGCGATCGACTTCGACGCGCACGGACAGGGGCCGGTCACCGCCTACTGGCGGGCCCACCTGTTCTTCGACACCTTCGACTTCGGCAGCGGACCCATCAGGACGGAGATCTTCACGGCCAAGGAGTTGTACGCGAGCACGGCACCGTCCGACTGGGCGCGACGGTTCTCCGCCGTACTCGCCCGGGTCGTCGAGGACGACCAAGTGCCGTTGTCCCGGCTGCCGGGACGATGA	MNVHGLDAHPLTANQEWEWDFDHSIGSAAYHRPVLLRLRGPLRPCALREAVAAAVRRHHSLRTRYPLVDGRRMQVVDPPGSRPLPLIDLTSLPARAREDALVRIGRDDAASPFDMASGTTVRWGLVRLAADHHALLVSPHHVAVDLWSLSVLAADIAAHYRHAAAGEPLPARPAPLQPSEWARAERERWTSDHLDAALAPWREALARLPALELPADHPSTPGPPSEGWLLSTHLDAGLSDSVRALSRRHGVTVFVTLLAAFHSMLARVCDVDRLVTYSLTARRHSRAMEDAVGLYSDYLRVFADLTGDPPFAEVLARTADRVLDGQDTQRLPNERLLRGTDDGTRPHPLERVGFTMHNTPPVGFPLSEGIRAAAIDFDAHGQGPVTAYWRAHLFFDTFDFGSGPIRTEIFTAKELYASTAPSDWARRFSAVLARVVEDDQVPLSRLPGR	MTLRSTLLSALVALVLPSAALASDATTAKACADDAGWNDPAMPLKVYGNTWYVGTCGISALLVTSDEGHILVDAATPQAGPQILANIRALGFKPEDVRAIVFSHEHFDHAGSLAELQQATGAPVYARSPAVATLKRGASDRSDPQHEVLDPFAPVQQVVVLDDDGVVRVGPLALQVVPTPGHTPGGTSWTWRSCEGDDCRQMVYADSLTAISDDVYRYSDDAAHPGYVAAFRETLARVAALECDILVTPHPSASQLWSRIGPRADRPLVDTSACRTYARTATQRLDKRLADEASKPPVPAP	149.17	gnl|BL_ORD_ID|4908|hsp_num:0	5901			657	774	cefoxitin; imipenem; ampicillin; cefotaxime; cefalotin
BGC0001058.1|Zorbamycin_36 # 66458 # 68233 # -1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.729	BGC0001058.1|Zorbamycin_36 	66458	68233	-	Loose	1000	92.8189	almE	25.14	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCCCACGGCCTTCGACGGTGTCCATGAGGCGGTCGGGCACTGGGCCCGTGTCACTCCCGATGCGGTGGCTGTGAGTTGGCGCGGTGGGCACCTGACGTACCGGACGTTGGAGCGCTGCGCGGACCGGCTGGCGGGATCGCTCCGGACGGCGGGGGTGCGCACCGGTGAAGTGGTCGGCGTCCTGCTGGAACGCTCCCCCGACACCGTGGTCGCACTGCTTGCGGTGCTGAAGAGTGGTGGCTGCTACGTGGCGTTGGACCCGCGTGCGCCGCTCACCCGGCGACGGGCCGTGCTCGACGCTGCGGACGTCTCGGTGCTCGTGACGGACGGTGACGAGGGTCTGGGCCGGCGCGCGGTGCCTCCGGAGGCGGCGCGCTGCCACGGATGGTCCGAGCGCACGGAGCGGGCGCCGAGGACGACGACACACCCCGAGGCGGCGGCCTACGTCGCCTTCACCTCCGGAACGAGCGGCATTCCCAAGGGAATTGTCGTGCCGCACCGTGCGGTGCTGCATCTGGTCGCCGATCCGGAAGCGGCCGGGGCCCGGCGTGACGACGTGGTGGTGCACGCCTCGTCACCGGCCTTCGACGCCTCCACGTTCGAGGTGTGGGCTCCCCTGGTCAACGGCGGCCGACTGGCGTTGCCCGACTGCGAGGAGCGCACGCCCCGGGAGCTGGGGCGGGTCGTCACCCGGGAGGGTGCGACGCTCCTGTGGCTCACCGCCGGACTGTTCCACCGTTTCTCGGACGCCGAGTTGGCGGGCCTGCGGGGACTGCGCAGACTACTGGCGGGCGGCGACGTGGTCTCGCCGCAGCAGGTGAACCGGGCGATCGCAGCGCTGCCGGGCGCCTCGCTGGTCAACGGCTACGGCCCCACGGAGAACACCACCTTCACGTGTCTGCACGCCGTGACCGAGCCCGTGTCAGGCCCCGCCGTGCCCATCGGAGCGGTCCTGCCGGGTGCAGGAGCGCGAGTTGTCGACGCGGCGCTGGCCCCGCTGCCGGCCGGGCGTACCGGCGAACTGCTGGCCTGGGGGCCCGGGGTGGCCTGGGGTTACCTCGGGGATCCCCGGCTGACCGCCGAGCGTTTCGTGCCGGCCCCTGACGCGGTGGGCGGCCGGGCGTACCGCACGGGGGACGCGGTGCGGGACCGCGGTGACGGTGTGCTGGAGTTCGAGGGCCGGATGGACCGGCAGGTCAAGATCCGCGGCTTCCGGGTGGAACCGGCCGAGGTGGAGGCCGTGCTGACACGGCTGCCCGGAGTGGGCGAAGCAGCGGTGGTGGCGCCCCGCCGGGACGACGGTGAGCGCGAACTGACCGCGTTCGTGGTGTACGAGGACCCTTTCAGCGACGGGTCGTTGGCGCTGAGACAGCAGTTGGCCGAGCGCCTGCCCGATTACGCGGTGCCGACCGCGGTGCGGGTGATGGACACCCTGCCGCTGACCGTCGGGGGGAAGGTGGACCGGGCGGCACTGGAGGCGTCGCCGCCCCTGCCGCGTCGCGCCGCTGGAACCACGTACACTCCGCCGGTGACCGGGCTGGAGAGGCTGCTGGCGGGGCTGTGGGCGGATCTCTTCGGTCTGGACGAGGTCGGTACGCACGACGACTTCTTCGAACTGGGCGGCAACTCACTGCTGGGCATGCGGCTGGCGGGAGAGATCCAGGACGTGTTCGGCGTCGAGGTGCCGGCCCGGCGGTTCTACGAGAAGCCTACGGTGGCCGCGCTCGCGGGGCTGGTGGAGGAGGCCGCGGGACGGGCCGGCGTCCCGAGGTGA	MPTAFDGVHEAVGHWARVTPDAVAVSWRGGHLTYRTLERCADRLAGSLRTAGVRTGEVVGVLLERSPDTVVALLAVLKSGGCYVALDPRAPLTRRRAVLDAADVSVLVTDGDEGLGRRAVPPEAARCHGWSERTERAPRTTTHPEAAAYVAFTSGTSGIPKGIVVPHRAVLHLVADPEAAGARRDDVVVHASSPAFDASTFEVWAPLVNGGRLALPDCEERTPRELGRVVTREGATLLWLTAGLFHRFSDAELAGLRGLRRLLAGGDVVSPQQVNRAIAALPGASLVNGYGPTENTTFTCLHAVTEPVSGPAVPIGAVLPGAGARVVDAALAPLPAGRTGELLAWGPGVAWGYLGDPRLTAERFVPAPDAVGGRAYRTGDAVRDRGDGVLEFEGRMDRQVKIRGFRVEPAEVEAVLTRLPGVGEAAVVAPRRDDGERELTAFVVYEDPFSDGSLALRQQLAERLPDYAVPTAVRVMDTLPLTVGGKVDRAALEASPPLPRRAAGTTYTPPVTGLERLLAGLWADLFGLDEVGTHDDFFELGGNSLLGMRLAGEIQDVFGVEVPARRFYEKPTVAALAGLVEEAAGRAGVPR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	106.29	gnl|BL_ORD_ID|4935|hsp_num:0	5928			168	1656	colistin A; colistin B
BGC0001058.1|Zorbamycin_37 # 68515 # 69459 # 1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.687	BGC0001058.1|Zorbamycin_37 	68515	69459	+	Loose	1050	26.9498	srmB	32.84	3002828	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGGCTGGGACGGCTCGCCCACATCACCGTGAACAGGTGCGCCGACGGTACGCCGACCTCATCGACGTCCTGCTGGCCGAGGGCGAGCCGCAGGCGGCCGCGGACTGTGCCCGGCTCGCCGTGGAGCAAGGTGTGTGGCGCGATCCCCTGCAGCGCCCCGTGCACTACCTGCCGTCGCTCGGCCCCGTGCCCGTGCACGACCCGGCCGACTTCTGGTTCGTGCCCTATCTGGAGGAGAACTCCCGGCTGATCCGGGCCGAACTGGAGCGTGTGCTCGGCGCGGACGACAATGGCTTCCTCCCCGTCGAGGAACCGCTCCTCGGCACCGGTGACTGGAAACAGGTCACCTTCTACGAAGGCGGCCAGCGTTTCGACGACGCCTGTGAGCGTTTCCCCGTCACCGCCGGGATCATCGAGGCCATCCCCGAGGCCACCCTCGCGGGACCCGGCGTCGTGACTCTCTCCCGCCTCCAGCCCGGCTCCCACATAGTGCCGCACTGCGGTGCCTCCAACGCCAGGCTCCGGGTGCATCTCGGCCTGCACGTGCCCCAAGGCCCTCGTATGCGGGTCGGCGACCGCACCCTGCACTGGCGTGAGGGCTCATGCCTGGTCTTCGACGACTCGTTCGAACACGAGGTGTGGCACACCGGAGACACCCCGCGCGTCGTACTGCTCATGGACGTCTGGCACCCACGCCTAGACCCCGCCGTGCAACGTCTGATTACCGAGGACCGGGGCTCCCTGGCCACCCGCGTGCGTGACTTCATGCGAGCTCAGGGCATCACTCGCGTCGAGGACACCGGTGACGCGATCCTGCTGCATCCGGACGAGCGCGTCGAAACCCTCGTCCGCCGCCACATGCGGCAGGCGGACACCCGTGTCATCGATCTCCACGACGAACAGACCGTGCGGCAGGAACCCGACGGACCGGATCATGACGGCTGA	MAGTARPHHREQVRRRYADLIDVLLAEGEPQAAADCARLAVEQGVWRDPLQRPVHYLPSLGPVPVHDPADFWFVPYLEENSRLIRAELERVLGADDNGFLPVEEPLLGTGDWKQVTFYEGGQRFDDACERFPVTAGIIEAIPEATLAGPGVVTLSRLQPGSHIVPHCGASNARLRVHLGLHVPQGPRMRVGDRTLHWREGSCLVFDDSFEHEVWHTGDTPRVVLLMDVWHPRLDPAVQRLITEDRGSLATRVRDFMRAQGITRVEDTGDAILLHPDERVETLVRRHMRQADTRVIDLHDEQTVRQEPDGPDHDG	MSIAQYALHDITKRYHDCVVLDRVGFSIKPGEKVGVIGDNGSGKSTLLKILAGRVEPDNGALTVVAPGGVGYLAQTLELPLDATVQDAVDLALSDLRELEAAMREAEAELGESDENGSERELSAGLQRYAALVEQYQARGGYEADVRVEVALHGLGLPSLDRDRKLGTLSGGERSRLALAATLASSPELLLLDEPTNDLDDRAMEWLEDHLAGHRGTVIAVTHDRVFLDRLTTTILEVDSGSVTRYGNGYEGYLTAKAVERERRLREYEEWRAELDRNRGLITSNVARMDGIPRKMSLSVFGHGAYRRRGRDHGAMVRIRNAKQRVAQLTENPVHAPADPLSFAARIDTAGPEAEEAVAELTDVRVAGRLAVDSLTIRPGERLLVTGPNGAGKSTLLRVLSGELEPDGGSVRVGCRVGHLRQDETPWAPGLTVLRAFAQGREGYLEDHAEKLLSLGLFSPSDLRRRVKDLSYGQRRRIEIARLVSDPMDLLLLDEPTNHLTPVLVEELEQALADYRGAVVVVTHDRRMRSRFTGARLTMGDGRIAEFSAG	57.09	gnl|BL_ORD_ID|110|hsp_num:0	128			1065	1266	spiramycin
BGC0001058.1|Zorbamycin_38 # 69449 # 71380 # 1 # ID=1_38;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.729	BGC0001058.1|Zorbamycin_38 	69449	71380	+	Loose	500	31.187	ESP-1	30.65	3003717	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ESP beta-lactamase	ATGACGGCTGACCCCGCCACCACCGTTCCCCTGCCCCGCGGACACTTCCACGCCGTCTACCACGCGGTAGACCTCCCGGAAGAGCAACGCCACACCCTCGTCGTGACGCTGTTCGCGCCGCTGCCGGACGGTCTCGCTCCGGACCTGGTCGACCAGGCGCTGCATCTGCTCGTCGCACGCCACGACGCCTTGCGCTCCCTACTTGTACCCCTCCCCGGAGGCAAGTGGGCCCATCATGTCCGCCCCCCGGACAGCCAGGCCTCCTTCCCCAGGGCGGAGCTGAGCGAGCTCGGTCCCGACGGCGTGATCAGCCTGTCGGTCGCCCTCGGCGAGGAACTGCGGGACTGGCACGGCACCACCCCGCTGCGCGCCGCCGTCCTCACCGACGCCGGCGCCGCCGTGTACGTGCTCGTCGCCCTTCACCACTGCATCGTGGACCTGGAGGCGCTGCGCCGGCTCCAGGACGAGTTCGGTCAGGTCCTGCTGAACATCGTCACGGGAGCCGACCCGCGGACAGGCCTGCGACCGGCGCTGCCGCTGGCCGCCCGCACCGCCCTGGAACAGTCCGAGCACGGACGACGCGCCGACGACGAGGCGCAGGCCCACTGGTCACGTCTGCTGAGCGACGCCGCCAACATCTCCTTCCCCTACCGTCGTGACGACCGCTCGCCGCGTACCGCCCGCGTCCTGTCCCTGACATCCCCGGCGATCGACCACGCGCTCGCCCGCCTGTCCGCCGACGCCGCCCTCACCCCCACGGCGCTCGTCCTCGCCGCCGCGCACATGATGCTCTCCGCCTACACCGGCGGTGCGATCACCTGGTCCGTCCTCATGGGCAAACCCGCGCCGCTGAGCGGGGCCACCCTGGTCGAATGCGCACTGGAAACCGTGCACGTCCTGCTCCCGGCCGTCCCGCCCGAGCCCGCTGACGAGCCGTCGCTTCCGGAGACCGCTCACGACGCGCTCACCCGTCTGCTGGAGGCGACCCGCCACCGCGACTACGACTACGCGCGCTTCCTGGAGTCCCGCGCCGCCCACGCCGTCGAGCGCGGTGCTCTCGTGCAGTGGGAGACCACGCTCAACAGCCGCCTCCAGCCCGCCCCCGTGCACCACCCCGTCGGCACGCCGTCCCGCACCTCCGCCGGTCTGCTTCCTCGCTCGCGCACCCGCTGGTCGCTTCAGCGCACCGCCCGGCCGACCGTCGGCGTCTCGGCCGGCTCCGACGGCCGGGCCACGACCCTCGACCTCGCCTGCGACACGGATCTGCTCGGCAAGGACACCATGACGGCCGTGCTGCGAGGTGTGGAAATCCTTCTCGTCGCCGCCGCCGACGGCGATCCCGCTCCGTTCCGCGGCAACGCCCGCTCCGCGGGCTGGCCCCGCCGTCCCGACTGGGTTCTCGTCGACGGCAGGACCTGGACCGATCTCACCGCCTCCCGCGATCTGCTCGCCTCCCACCCCGGGGTGTGCGCCGTCGACCTGACGGTCACATCGGAGGAGGTCCCCGCGCTGCACGCCGCCGTGCGCGCCCGCTCCGGCACGGTGACCGGAGAGGATCTGAGGCGGCACGCCCTGCAAGCCCTGGACCGTCCGGGCCTGACGGTGCCGCACACCATCGACGTGCGCCCGTGCGCACACCCCCGCTGCCCCCGGTGCGTCACCGGTCATGCCGTCGGAGATCCGCGCCCGCGGCAGCCGGACGCCGTCGCCGCGCTGATCCGTGCCGTTGCCGGTGTCCTGGGCCGCGACTCCGTCGTCGCCGAGGCCGGGTACCTGGAACAGGGCGGTCGGGCCGAGGCCTATCCGGAGGTCAAGGCTTCGCTGGAAAAAGCCGGGTGGTGCGGACTCACCGGCGAGGCACTCCTCGGACCTCGCTCCCTCGCTCATGTCGCGGTCTCACTGCACCGGGATCCCCGAGGGGGCTGCACATGA	MTADPATTVPLPRGHFHAVYHAVDLPEEQRHTLVVTLFAPLPDGLAPDLVDQALHLLVARHDALRSLLVPLPGGKWAHHVRPPDSQASFPRAELSELGPDGVISLSVALGEELRDWHGTTPLRAAVLTDAGAAVYVLVALHHCIVDLEALRRLQDEFGQVLLNIVTGADPRTGLRPALPLAARTALEQSEHGRRADDEAQAHWSRLLSDAANISFPYRRDDRSPRTARVLSLTSPAIDHALARLSADAALTPTALVLAAAHMMLSAYTGGAITWSVLMGKPAPLSGATLVECALETVHVLLPAVPPEPADEPSLPETAHDALTRLLEATRHRDYDYARFLESRAAHAVERGALVQWETTLNSRLQPAPVHHPVGTPSRTSAGLLPRSRTRWSLQRTARPTVGVSAGSDGRATTLDLACDTDLLGKDTMTAVLRGVEILLVAAADGDPAPFRGNARSAGWPRRPDWVLVDGRTWTDLTASRDLLASHPGVCAVDLTVTSEEVPALHAAVRARSGTVTGEDLRRHALQALDRPGLTVPHTIDVRPCAHPRCPRCVTGHAVGDPRPRQPDAVAALIRAVAGVLGRDSVVAEAGYLEQGGRAEAYPEVKASLEKAGWCGLTGEALLGPRSLAHVAVSLHRDPRGGCT	MKKLTLILSLIIAFFGYAQTVTEPTNHSAEWSQPYEPFRIVGNLYYVGTYDLASYLIVTEKGNILINTGLADSYPQIKANIEKLGFKYKDTKILTLTQAHFDHMGAMADIKAETGAKLYVDEADAAELKSGGKSDYELGKYGVTFKPLTPDFLLKNNGKIKLGNTTLTLLHHPGHTKGSCSFIFETKDENRKYKVVIANMPSIIIDHKFSDVKTYPSIQKDYAYTLEAMKKLDFDVWVASHASQFDLHKKRKEGDAYNPKLFMDKENYFKRLKDLEDDYLEKVKEENKPE	221.72	gnl|BL_ORD_ID|2029|hsp_num:0	2232			72	258	
BGC0001058.1|Zorbamycin_40 # 72645 # 72911 # 1 # ID=1_40;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.723	BGC0001058.1|Zorbamycin_40 	72645	72911	+	Loose	1000	22.7126	MCR-6.1	30.16	3004501	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	GTGAGCGAGACGGCGCAGACCATTGAGCGTCTGGTCCTGGAACAGTTCCGCACCTGCTCCGGCAACAACCGGATGACCGCGACCGACGACTTCTTCAACACCGGCGGTGACTCCTTCACCGCCGTCCAGGCCGCCACCGCCATCGCGGCCCTCACCGGCCGGGACCCCGACCCCTCCCTGCTGTTCGCCCACCGCACGGCCCGCGCACTCGCCTGCCGGCTCGTCGAGGACCCGCCGGCGACGGGCGCAGCCGGGGGGAACGGCTGA	MSETAQTIERLVLEQFRTCSGNNRMTATDDFFNTGGDSFTAVQAATAIAALTGRDPDPSLLFAHRTARALACRLVEDPPATGAAGGNG	MTQHSPWYRRPVNPYLLMSVVALFLSATANLTFFDKITNTYPMAQNAGFVISTALVLFGAMLLITVLLSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAESKDLMNMAFFVRIIGLGVLPSILVAWVKVDYPTLGKSLIQRAMTWGVAVVMALVPILAFSSHYASFFREHKPLRSYVNPVMPIYSVGKLASIEYKKATAPKDTIYHAKDAVQTTTPAERKPRLVVFVVGETARADHVQFNGYSRETFPQLAKIDNLANFSQVTSCGTSTAYSVPCMFSYLGQDDYDVDTAKYQENVLDTLDRLGVGILWRDNNSDSKGVMDKLPASQYFDYKSATNNTICNTNPYNECRDVGMLVGLDDYVSTNQGKDMLIMLHQMGNHGPAYFKRYDEQFAKYTPVCEGNELAKCEHQSLINAYDNALLATDDFIAKSIDWLKTHQANYDVAMLYVSDHGESLGENGVYLHGMPNAFAPKEQRAVPAFFWSNNPSFTPTASDTVLTHDAITPTLLKLFDVTADKVKDRTAFIR	16.36	gnl|BL_ORD_ID|2664|hsp_num:0	3129			1287	1476	colistin A; colistin B
BGC0001058.1|Zorbamycin_41 # 72914 # 74512 # 1 # ID=1_41;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=12bp;gc_cont=0.720	BGC0001058.1|Zorbamycin_41 	72914	74512	+	Loose	1000	42.743	almE	21.25	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCCCTTCGCATCCCGTGTGCTCCGAGCCGGCCTCAGCGATCCGGACAGCGTGGCGGTCGTCCTCGACGGCACGAGCACCACCTACCGAGAACTGGCCGGGCGAGGCGCCCGCGTCGCACGGGCCTTACGCGAGTTGCCTCGCAGGCCGCGTGCCCCCTTCGGCGACATCCACCTGCCGTCTCACCTAGTCGCCGTGCTCACCGACAACGCCCCCCAACTGCCCGAACTGCTGGTCGGTGCCACCTCCGGTGACGGGGCATGCGCCCTGCTCGACCCCAAGTGGTCGGCCGCCCAGACGGCCGAGGTACTGCGCCGTCTGGGACCCGACCTGCTTGTCACCCAGCGGGCCCGCAGCGCCGCGGCAGACGCCGCAACCGCCCTGCACATCCCCGTCGTCATGCTCGACGGCGATGCCTCGGCGCCGGACTCCTACGACGGCTGGCTCGCTGCGCACTGCGACGCCGATCCGGAGAGGGAACTGACCTCCGGCGACGACGACTCGGTGTTCTTCGTCGGGTTCACCTCCGGTACCACCTCCACCCCCAAAGCGTTCGCCATGGCGCGCGGATGCTGGCGCACCAGTCTCGCCCTCGGCGCCCCGTTCTTCGACACCGCCACCGCCCAGGTCTCCGCGGCCCCCGGTCCCCTCCAACACGGCGTCACCCTCTACGCCCTGGCCGAAGCCCTCGACGCCGGCACCACCTTCGTCGGCGCGCGTCGCTTCGAGGCGAGGGAACTGATGCGCGCAGTGCGCGCCCACCGGGTGCAGAGGCTCTCCCTGGTGCCCAGCATGCTGCACGCCCTGTGCCGAGACACCTCTCCCGGCCAACCGCCCCTGGAGACGGTCACCGTCTGCATCAGCAGTGGGGCCCGGCTGGATGCGGACCTCGTCACCAGGGCCGCCCGGTTGTTGCCCCGGGCCCGCTTCGTCGACTATTACGGCGCTTCCGAGACCGGATTCATCAGTGTTCTCCAGCACCCTCTCGGAGGCCGGGGCAAGGGCGTCGGGCATCCCTTCCCCCGCGTCGAGATCGAAGTGCGCGACCCCCGCGGCCGGGTGTGCGCTGCGGGTGTCCCCGGCGAGATCCACGTCCGCAGCCCTTATGTGAGCCGCGGCTACCTGTGGGCGGCCGACGAGACGCGGATGTTCGCTCCGGGCGGCTGGGTCACCGTCGGCGACCAGGGGCACCTCGACGCCGACGGCACCCTCCACCTCGTCGGCCGCAAGGGTCGCATGGTCATCACCGGTGGCTGGAACGTCTACCCCGACGAGGTCGAGGCCGTGCTGCGCACCATTCCCGGCATCGACGACGCAGTGGTCGCGGGAGTCCCCGACGCCTTCCTCGGCACCGCTCTGGTCGCCGTGACCGCTTGCTCCGGCCCCGGCGGTCCGCCCGCGTACCCCGACGTCGTGCGGAGCTGCCGCGCCGCGCTGCCGTCCTACAAGGTCCCCGTCCGGGTCTACACCGTGCCCGCCCTGCCGCGCACCACCAGCGGCAAGGTCGCCCGTGCCGAGGTGGACGACTGGCTCGCACGTGCGCACGGCGGTGACAGTCCCCTCACCGAGCTCGCGCCGCGACCGGGGAGGCCGTCATGA	MPFASRVLRAGLSDPDSVAVVLDGTSTTYRELAGRGARVARALRELPRRPRAPFGDIHLPSHLVAVLTDNAPQLPELLVGATSGDGACALLDPKWSAAQTAEVLRRLGPDLLVTQRARSAAADAATALHIPVVMLDGDASAPDSYDGWLAAHCDADPERELTSGDDDSVFFVGFTSGTTSTPKAFAMARGCWRTSLALGAPFFDTATAQVSAAPGPLQHGVTLYALAEALDAGTTFVGARRFEARELMRAVRAHRVQRLSLVPSMLHALCRDTSPGQPPLETVTVCISSGARLDADLVTRAARLLPRARFVDYYGASETGFISVLQHPLGGRGKGVGHPFPRVEIEVRDPRGRVCAAGVPGEIHVRSPYVSRGYLWAADETRMFAPGGWVTVGDQGHLDADGTLHLVGRKGRMVITGGWNVYPDEVEAVLRTIPGIDDAVVAGVPDAFLGTALVAVTACSGPGGPPAYPDVVRSCRAALPSYKVPVRVYTVPALPRTTSGKVARAEVDDWLARAHGGDSPLTELAPRPGRPS	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	95.68	gnl|BL_ORD_ID|4935|hsp_num:0	5928			573	1611	colistin A; colistin B
BGC0001058.1|Zorbamycin_42 # 74509 # 75288 # 1 # ID=1_42;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.738	BGC0001058.1|Zorbamycin_42 	74509	75288	+	Loose	450	27.7202	RanB	23.6	3005090	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACGGCCCGCGCGGTTGTCGTGCCGCTCAGCGACAGCCAGAGCGCCGACACGGCGCACTTCCTGCCCGGTGTCGACGGCGGGCTGCGTCCCGCCTGCTCCTTCGCCGACCTCGTACGGGGCCGACTCGCCGTGCACGGTGTGATGCTCACCGGTCCTGGCCGTCCCGCCGACCACGGCGTGGAGCGACATGCACGGCTGGCCCTCGACGAAGTGGTCCGCAAGACCGGCCGCGGGCCCGACCGGCTCATCGGATACTCCTACGGCGCGCTGGTGGCGGTGGAGATGGCGCACCAGGCCAAGGCCCGGGGCTTGCCCGCCCCACGGCTTCTGGTGCTCGACACCCCCATCGCTCCGGGACCCCAGAGCGCCCCCTCGCCCGTCACCATGTTCTGGTACATCGGCCGGGGCGCGGGACTGGACCTCACCCTGGCCCAGTTCGCCGCACTCGATCCGGAGCGCCGGGCTGCCGAGGTGGGCCGCTGGTGCGCCACCCGCTCCCCGGGGTTCGACCTGAACGCCGCCCGCACGGTGTACGCCACCGTCGAAGCCAACTGCGCCGCATGGGCGGGCCACGAGGCCCGCCCCTACCTCGGTCCGGCCGACGTGGTCGTCGCGGAGGAATCCGCGGAGACGAGCGGTGACCGGGCCGACTGGACCGCGATGTTCCCCGGCGGCTACCGCGTCCGAACCGTTCCCGGCGGACACCTCGACGTGCTCTCCGAAGCCGGCGCACCGGCCCTCGCCCGCGCGGTGTCCGACCTGACGGCGCTCGACTGA	MTARAVVVPLSDSQSADTAHFLPGVDGGLRPACSFADLVRGRLAVHGVMLTGPGRPADHGVERHARLALDEVVRKTGRGPDRLIGYSYGALVAVEMAHQAKARGLPAPRLLVLDTPIAPGPQSAPSPVTMFWYIGRGAGLDLTLAQFAALDPERRAAEVGRWCATRSPGFDLNAARTVYATVEANCAAWAGHEARPYLGPADVVVAEESAETSGDRADWTAMFPGGYRVRTVPGGHLDVLSEAGAPALARAVSDLTALD	MLKLSKRMLTSVGEYVLLLGKVIKRPQKHNIFFKLLMREINDLGVNSFGLVLFTSIFVGAVVAIQMYNNFKASTIPIPLYFIGYATKVVLILEFSPTIISLILAGKVGSYIASSIGTMRVTEQIDALDIMGVNSPNFLILPKIVANVIFNPLLIAISIVFGIYGGYLAGVATGNWTEADYITGIQRYIPDYFIWYAFFKTVVFAFLIATIPAYFGYNVKGGSLEVGRASTQAVVWTMVAIIIAELISTQLFLS	102.37	gnl|BL_ORD_ID|2807|hsp_num:0	3824			45	303	
BGC0001058.1|Zorbamycin_43 # 75352 # 75933 # 1 # ID=1_43;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.701	BGC0001058.1|Zorbamycin_43 	75352	75933	+	Loose	1000	25.7942	MCR-2.2	41.94	3004502	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	GTGAAGACGAAAGACCTCGTCTACATCGCCCTGTTCGCGGCGATAGTGGTCGCGCTCGGCCTGTTCCCCGCAATCGAAGTGCCTTTCAGCAAGGTGCCCATCACCGCTCAGTCCCTCGGCGTGATGCTGGCCGGCAGCATCCTCGGCTGGCGGCGCGGCGGCCTCGCGCTGCTGGTGTTCGTCCTCCTCGTCGCGGTCGGCCTCCCCGTGCTTCCCGGCGGGCGCGGCGGCATGGGCATCTTCTTCCTGCCCAGTGGCGGCTTCGTGCTGAGCTGGCCCCTTGCCGCCGTGGTGGTCGGCTATCTCACCGAGCGGCTCTGGGGCCGCTACAACCTGGCCGTTGCCCTCGTGCCCAACCTCGTCGGCGGCGTTCTTGTGGTCTACGCGATCGGGCTGCCGTTCATGGCCGCCGTGGCAAACATCAGCCTGGGCCAGGCGTTCACCATCATGTGGGCGTTCGTGCCGGGTGACGTCGCCAAGTGCGTCCTGGCCGCGTTGGCCGCCGTCGCCGTGCGCCGCACCCACCCGCTGCTCGCCCCGGTCGCGACGGCGTCCGGCCCCTCCCGTTCCGGCACCAGGTAG	MKTKDLVYIALFAAIVVALGLFPAIEVPFSKVPITAQSLGVMLAGSILGWRRGGLALLVFVLLVAVGLPVLPGGRGGMGIFFLPSGGFVLSWPLAAVVVGYLTERLWGRYNLAVALVPNLVGGVLVVYAIGLPFMAAVANISLGQAFTIMWAFVPGDVAKCVLAALAAVAVRRTHPLLAPVATASGPSRSGTR	MTSQHSWYRYSINPFVLMGLVALFLAATANLTFFEKAMAVYPVSDNLGFIISMAVALMGAMLLIVVLLSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNAMQTDQAESKDLMNLAFFVRIIGLGVLPSVLVAFAKVNYPTWGKGLIQRAMTWGVSLVLLLVPIGLFSSQYASFFRVHKPVRFYINPITPIYSVGKLASIEYKKATAPTDTIYHAKDAVQTTKPSERKPRLVVFVVGETARADHVQFNGYGRETFPQLAKVDGLANFSQVTSCGTSTAYSVPCMFSYLGQDDYDVDTAKYQENVLDTLDRLGVDILWRDNNSDSKGVMDKLPTTQYFDYKSATNNTICNTNPFNECRDVGMLVGLDDYVSANNGKDMLIMLHQMGNHGPAYFKRYDEQFAKFTPVCEGNELAKCEHQSLINAYDNALLATDDFIAKSIDWLKTHEANYDVAMLYVSDHGESLGENGVYLHGMPNAFAPKEQRAVPAFFWSNNTTFKPTASDTVLTHDAITPTLLKLFDVTADKVKDRTAFIQ	35.87	gnl|BL_ORD_ID|2665|hsp_num:0	3130			339	429	colistin A; colistin B
BGC0001058.1|Zorbamycin_44 # 75940 # 76620 # 1 # ID=1_44;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.671	BGC0001058.1|Zorbamycin_44 	75940	76620	+	Loose	1280	90.1225	macB	30.54	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTTCCGTATCGAGGAAGTCGAGCACCGCTACGGCGACCGCACCGTGCTGCGGGACGTCTCCGTCGAACTGACGGAACGCAGGGTGGCCGTAGTGGGAGCAAACGGCTCCGGCAAGAGTACGTTCGCCCGGCTGCTGAACGGGCTGGTCGTGCCCACGTCCGGGACGGTCACGGTGGACGGCCTGGACACGCGCAAGGACGGCCGCCGGATCAGGGCCAAGGTCGGCTTCGTCTTCCAGGACCCCGACCTTCAGATCGTCATGCCCACCGTCGCCGAGGACCTCGCGTTCGGCCTCAAGCACCGCGGTCTGAGCAAGGCCGACATCGACCAACGGGTCGAACAGGCCCTGGAGGACAACGGTCTTCGCGATGTGCGCGACCAGCCCGCCCATCTGCTCAGCGGTGGCCAGAAACAGCGGCTGGCGATTGCCTCGGTGCTGGCGACCGCACCCCGGTACGTCGTCTTCGACGAACCGACCACCATGCTCGACCTGCGAAGCAAGCGCCAGATCGCCCGTGTCATGGCGGAGTTGGAGCAGCCCGTGGTCGTCGTCTCCCACGACATGGACCTGCTGGAGGGGTTCGACCGGGTGCTGGTGTTCGACGAGGGGCGCCTCGTGGCCGATGGCCCGCCCGACGTCTCGATCGCCTTCTACCTGGAGCTGATGGGCGCATGCTGA	MFRIEEVEHRYGDRTVLRDVSVELTERRVAVVGANGSGKSTFARLLNGLVVPTSGTVTVDGLDTRKDGRRIRAKVGFVFQDPDLQIVMPTVAEDLAFGLKHRGLSKADIDQRVEQALEDNGLRDVRDQPAHLLSGGQKQRLAIASVLATAPRYVVFDEPTTMLDLRSKRQIARVMAELEQPVVVVSHDMDLLEGFDRVLVFDEGRLVADGPPDVSIAFYLELMGAC	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	35.09	gnl|BL_ORD_ID|446|hsp_num:0	487			63	669	erythromycin
BGC0001058.1|Zorbamycin_45 # 76614 # 77213 # 1 # ID=1_45;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.680	BGC0001058.1|Zorbamycin_45 	76614	77213	+	Loose	275	24.2534	AAC(6')-Iu	33.33	3002565	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGCTGAGCCTCTACCGCCCTGGTGACAGCGTCCTGCACCGCGCTCCTGCCGGGCCCAAGCTGGTCGTCCTGCTGGTCACCTGCCTCGCGGTGTTCCTGGTGGACGAGCTGTGGTTCACGGCTGTCTGCGGGACGGTCGTCCTCGTGCTGTGGAGGATCGCGCTGATCCCCTACCGGGAACTGGGCCGCCAGCTACGCGAGTTGTGGGTGATCGCACTGCTGCTGGCCGTTTTCCAGGTGTGGGCCAACGGGTGGCACGAGGCCGCGATGACCGTTCTGCGGCTGCTGGCCCTGCTGCTGCTCGCCAGTCTGGTGACGATGACCAGTCGTACCTCGCACATCGTGGACGCGCTGGAGAGCGCAGCGCGCCCCCTCGCGCTCGTCGGGATGCGCCCCGGCCGGATAGCCTTCCTGATCGGCCTGACCCTGAGGTTCATCCCTCTCATCCGGGAGAAGGCCGAGGAAATCCGCGCCGCCCAGCGAGCCCGGGGTGTCGAACGCCGGCCGCTGGCCCTGCTGCTGCCCCTGCTTCTCAAGACGTTGACCATGGCGGATGCCATATCGGAGGCGCTGGACGCCCGGGGTTTCGAGAGCACCTGA	MLSLYRPGDSVLHRAPAGPKLVVLLVTCLAVFLVDELWFTAVCGTVVLVLWRIALIPYRELGRQLRELWVIALLLAVFQVWANGWHEAAMTVLRLLALLLLASLVTMTSRTSHIVDALESAARPLALVGMRPGRIAFLIGLTLRFIPLIREKAEEIRAAQRARGVERRPLALLLPLLLKTLTMADAISEALDARGFEST	MNILPISESQLSDWLALRSLLWPDHEEAHLQEMRQLLKQTDTLQLLAYSETQHAIAMLEASIRHEYVNGTQTSPVAFLEGIYVLPEYRRSGIATQLVQCVEEWAKQFACTEFASDAALDNTISHAMHRALGFHETERVVYFKKNIS	136.30	gnl|BL_ORD_ID|95|hsp_num:0	110			144	243	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0001058.1|Zorbamycin_46 # 77344 # 77826 # 1 # ID=1_46;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.671	BGC0001058.1|Zorbamycin_46 	77344	77826	+	Loose	500	26.9498	blaS1	32.76	3005111	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	blaS	ATGGCCGTACTCGACGCCGGACCGCTCAAGAGCAAGGCGGTAGTGGCTGATGCGTTCGCCCTGTACGCGCTGGCGACGGAGCACACCGACCCGGCCGAGGAGATGCGCGCCAGTGTGGGCCGGGGGCGGCTCACCGTGACCGTCTCGGCCCTTGCCGTCGCCACCGCCAGCGGTATGCGCACCTGCTGGGACGAGTACTGCTCCCGAAACCACCGGCCGGACGTCGCCACCTTGGTGCGCCGCCTGTGTGCAGGGCCAGGCGTCGAGGTCGTCGAGATGGATTTGAACGCGTCCATAGCCGCCGGACGGCTCTACGCCTCCAGTTCCGCAGTCCGTGTCGAAGGCCCGGAGGTCCTGGCGGGCTGTCATTCCGCACTGATGGCACAAGAGTTGAGCTGCAGAGTGCTCACCGTGGCACGTGCCGCCTACTGTTACACCAGTCCAGCCGTGCGAGAACTCGGCTGTCGTCTCATGCTGCTCTGA	MAVLDAGPLKSKAVVADAFALYALATEHTDPAEEMRASVGRGRLTVTVSALAVATASGMRTCWDEYCSRNHRPDVATLVRRLCAGPGVEVVEMDLNASIAAGRLYASSSAVRVEGPEVLAGCHSALMAQELSCRVLTVARAAYCYTSPAVRELGCRLMLL	MTNLSRRSVLIGSLAVMAAAGVRMPTASAAPVDDRIADLERRNNASIGIYAVDLDSNRTVAHRADDSFAMCSTFKAYLAARILRGAERGELSLDDRVFVDPAALLSNSPITETHAGGEMTLAELCQAALQRSDNAAANLLLKQIGGPAEITAFARSIGDQRTRLDRWETELNSAVPGDPRDTSTPAALAGGFRAVLTGDVLAPPQRQLLDEWMRANETSSLRAGLPDGWTSADKTGSGDYGSTNDVGIAYGPQGQRILLALMVRTRGDDPNADGFRPLIGELTALVLPELGVH	54.61	gnl|BL_ORD_ID|2823|hsp_num:0	3839			15	183	cefoxitin; carbenicillin; oxacillin; ceftriaxone; piperacillin; ampicillin; mezlocillin; cefixime
BGC0001058.1|Zorbamycin_48 # 79218 # 80231 # -1 # ID=1_48;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.672	BGC0001058.1|Zorbamycin_48 	79218	80231	-	Loose	1900	26.1794	AcrF	25.0	3000502	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCTCGAAAACGGCGCTGATCACGGGTATCACCGGCCAAGACGGCTCCTATCTGGCGGAGTTGCTGCTCTCGAAGGGCTATACAGTGCACGGTGTGATCCGGCGCTCCTCCGGTTCCGGTCTCGGCCGTATCGCGCATCTGGTCGGTGACGAGCGCGACGAGGAGGTCCGGATGCGTCTGCACCACGGCGATCTCTCCGACGGAGCACGGCTGATCGCGCTGCTCGACCGGGTGGTACCCAGCGAGATCTACCACCTGGCGGCCCAGTCGGACGTTCATGTCTCCTTCGAGCAGCCCGAGTACACGGGCGCGATCACGGCGTTGGGCACCACGCGGCTGCTGGAGGCGCTGCGCATCACCGGTCTGCCGGCCCGGTACTACCAGGCGTCGAGTTCGGAGATGTTCGGGGCAACGCCTCCCCCTCAGGCCGAGGGGTCGCCCCTCCAGCCGCGTTCGCCGTACGCGGTGGCCAAGGCGTACGGCTACTGGATGGCCCGTAATTACCGGGAGTCCTACGCCCTGCACACCGTCAACGGAATCATGTTCAACCACGAGTCACCCCGGCGCGGCGAGGCTTTCGTGACCCGGAAGATAGCCCGGGCGGCCGCCCGCATTGCGTGCGGACAACAGCGCTTCCTGGACCTGGGCAACCTGGAGGCACGGCGGGACTGGGGGTATGCACCGGAGTACGTCGAGGCGATGTGGCGGATGCTCCAGCGCGACCGCGCCGACGACTACGTGGTGGCGACCGGAACCAGTTACAGCGTGCGGGACTTCGTGACGTTCTGCTTCGAGCACGTCGGGCTGGACTGGGAACGGCATGTGCGCATTGATGATCGCTATGTGCGGCCGGCGGACGTGGCGGAGCTGGTGGGTGACGCGTCGAAGGCACAGCGCGTTCTGGGCTGGAAGCCGGAGGTGTTCGCGCCCGAACTGGCACGGATCATGACTGACGCGGAGTTGGAGGCCGCAGGCCGCGGGAAGGGACCGCTCCCCGAGGAGCGGGAATGA	MTSKTALITGITGQDGSYLAELLLSKGYTVHGVIRRSSGSGLGRIAHLVGDERDEEVRMRLHHGDLSDGARLIALLDRVVPSEIYHLAAQSDVHVSFEQPEYTGAITALGTTRLLEALRITGLPARYYQASSSEMFGATPPPQAEGSPLQPRSPYAVAKAYGYWMARNYRESYALHTVNGIMFNHESPRRGEAFVTRKIARAAARIACGQQRFLDLGNLEARRDWGYAPEYVEAMWRMLQRDRADDYVVATGTSYSVRDFVTFCFEHVGLDWERHVRIDDRYVRPADVAELVGDASKAQRVLGWKPEVFAPELARIMTDAELEAAGRGKGPLPEERE	MANFFIRRPIFAWVLAIILMMAGALAILQLPVAQYPTIAPPAVSVSANYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSYLMVAGFVSDNPGTTQDDISDYVASNVKDTLSRLNGVGDVQLFGAQYAMRIWLDADLLNKYKLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRFKNPEEFGKVTLRVNSDGSVVRLKDVARVELGGENYNVIARINGKPAAGLGIKLATGANALDTAKAIKAKLAELQPFFPQGMKVLYPYDTTPFVQLSIHEVVKTLFEAIMLVFLVMYLFLQNMRATLIPTIAVPVVLLGTFAILAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMMEDKLPPKEATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATLLKPVSAEHHENKGGFFGWFNTTFDHSVNHYTNSVGKILGSTGRYLLIYALIVAGMVVLFLRLPSSFLPEEDQGVFLTMIQLPAGATQERTQKVLDQVTDYYLKNEKANVESVFTVNGFSFSGQAQNAGMAFVSLKPWEERNGDENSAEAVIHRAKMELGKIRDGFVIPFNMPAIVELGTATGFDFELIDQAGLGHDALTQARNQLLGMAAQHPASLVSVRPNGLEDTAQFKLEVDQEKAQALGVSLSDINQTISTALGGTYVNDFIDRGRVKKLYVQADAKFRMLPEDVDKLYVRSANGEMVPFSAFTTSHWVYGSPRLERYNGLPSMEIQGEAAPGTSSGDAMALMENLASKLPAGIGYDWTGMSYQERLSGNQAPALVAISFVVVFLCLAALYESWSIPVSVMLVVPLGIVGVLLAATLFNQKNDVYFMVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGVVEATLMAVRMRLRPILMTSLAFILGVLPLAISNGAGSGAQNAVGIGVMGGMVSATLLAIFFVPVFFVVIRRCFKG	32.59	gnl|BL_ORD_ID|1353|hsp_num:0	1437			1725	1893	ciprofloxacin
BGC0001058.1|Zorbamycin_49 # 80447 # 83659 # 1 # ID=1_49;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.710	BGC0001058.1|Zorbamycin_49 	80447	83659	+	Loose	1000	116.316	almE	25.05	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCAGGACCGCGATCCCATCGCCCCGTCCACCCACGCAACCCCCCGCGAACGTCCCGCACGTGCCGCAGAACGTGCCCTCTGGCTCCTGGACCGTGTCGCTCCTGAGCGCGCGGCGAGCAACATCGCTCTCGCGGTCCGCAGCGCCGCACCGCTGGACGTCGCGCACGTGCGCCGCGCCCTCGGGACGATCATTCGCCGCCACCCTGCCCTGCGCAGCCGGTTCGTTCTGGTCGACGACGTGCTGACACGCCGGGTCGACGCCGTCGGCGACGATCCCTCCATCGAGGTCCTCACCGTCGCGCAGGAGGATGCCGACGAGACCCTACGGCGCTTCGCCGAGCGTCCCTTCGCGTCTTCCCCCGACCAGCCGGCTGCGGGAAAGCTGCGGGAAACCGATGGCGAACCCCTCATTCGCGCCGTTCTCGTCGTCACCCCGGCAGCCGACACTTTCTGCGTCGTCTGTCACCACACGATCTTCGACGGCACCTCCGCGCTGCTGCTGACCGGAGAACTCGTCCGCGCCTACGCCGCGCTCTCCACAGACGGACAGGTCCCGCCCGACCTCCTGGCCGAAGCAGCCGACTTCACTCCGCCGCCTCCCGGTCCCGACAGCCTCGCCTACTGGCACGAACAACTGGCCGGAGTGAACATCCGCTCCATGGACCTGCGGTGCGACCGTACCCGGCCCGCCCAACCCACCTTCCGCGGTGAACAGCACATCCACCCGCTGTCCCAGGGCGCCCACGACCTCCTCGGCAACTCCGAAGCCGCACTCCAGGCCACGCGCAACATCATCTTCCTCGCCGCCTATCTCCTCGTGCTCGCCCGTCACGGCGCCGGACCCGACGTCACCGTCGGGGTACCCGTCGACGTGCGCGGCGGCCGGGGACGCGGAGCGATCGGCTACCACACGCATACCGTCGTCCTCCGGGTCGACATGGAACGTCCCGGAACGTTCCGGGAGCTGGTTACGCTCACACGCGACACGTTCCTCGCCGCCCTCGGGCACGCCGACGCCTCGATCGACGACGTGATCGACCGGTACGGCACATGCGGCGGCAGCGCGGAGAACCGGCACTTCCACCATATGTTCAACTACTTCGACTTCCACACCTCCGTGCAGAAGGCCAGCTGGACACCCGGCGGCGCCGACGTCGACATCGTGGAGGTCGCCCCCCGGCACAGCGTCGCCGACCTGGAGATCGTCGTACGCACCCGGCACGATCGCACCGAGCTCGTCGTTCACCACGGCACCGACGTGCTCGACCGCACCGACGCCCGTGCTCTGGCAGGCCGTTACGACGCCCTGCTGCACTCCGCCCTGCGGGCCCCCGACACCCCGCTCCCCGATCTCACCTGGCACACCGACCTCGATCGCCGGGCCCTCACCCCGTCCCCGGTACGCGCCACCCCGTGGCGCGGAGGCGTTGTTGCGGCGATCGCCGCCCACGCCCGCGGAAAGCCGGACGCGATCGCTGTCGTTGATGCCGACACCGGCCGCACCACCAGCTACGCCGCACTCGTCGACCGGGCCGCCCGCATCCGCGACGACCTCGGTGACGCCGGCATCGGTCCCGGAAAGATCGTCGCCCTCGACTCAGCCCGCACCGCCGCCACCCTTGCCGGTGCCCTCGCCGTCTGGTCACTGGGTGCCGCGTACCTGCCCGTCGACCATGCGCACCCCGCTCCGCTGACCGCCCGCCGTCTCGCGGGCGCGCGCATCGCGGCGGTTCTCGGTCGCCCGCTGGATCCGGCCACGCTCCCCGACGTGCCCACGATCCCTCTGCCCGTCCCCCGTGCCACGGGTCCCTGGCGAGACCTGCCCGACACCGGCACACTCACCGCCGGCACACTCGCCTTCGTGATCCACACCTCAGGATCTACCGGTTCGCCCAAGGGAGTCCGCCTCACGCAGGGCAACGTGCACCATGCCGTTACCACCCTCGCCGCCGGCCTGGGGCTCGACGCCGGTGCGAGCGCACTGTGGTTGACCACGTTCACCTTCGAGCCGTCGTCCTTGGAGGTCTTCACCCCCCTCGTACTCGGCGGACGAGTCGTCGCCGCCCCCGACGCGGTACGACACGACCCGGCTCGTCTGACGGCCCTGCTCGCCCGCCACCCCGTCGACCTCGTCCAGGCGACACCTACCGTGTGGAGCGTGCTCGCCCCGGCGCTGGAGGGACGATGCGAGGGCGTCCATCTCGTCACCGGCGGCGAGCTCCTGAGCGCAGCCACGGCTCGGGCCCTGCTGTCCACCGGTGGACGTGTCCTCAACGCCTACGGCTGCACCGAAACAGCCGGCTGGCCCGTGATGGGCGAGATATCCCCCGCCTGCGTCGCGAACCAGCCCCCTCGTATCGGCCGTCCCACCGGCGGGCACCGCGTTGACATCGTGGACGACACAGGCCGCCCCCTGCCCCCCGGCCTGCGCGGCAACATCCGCATTACCGGCCCCGCGGTCGCCGACGGGTACCTGAACGCCCCCTTGCGTCATCCCACCGACGACACAGGGCATCGCACCCACAGCACCGGCGACATCGGCCGTCTGTGCGCCGACGGAACACTCGAAGTCGTCGGCCGTGCCGACCGGCAGATCAAACTGCTCGGGCTCCGTGTCGAACCGGCCGAGGTCGAGGGCGTTCTGGAGGATCACCCGTCCGTCAGCCGCTGCGGCGTGATCACCGCCCGTGACGCGGAGTCCCCGTCACTCGTCGCTTTCGTAGAAACCACGGCAACCGTCCATCCGGCTACCCTGCGCGCGCACGCCGCCCGTCATCTTCCCGCGCCTGCCGTGCCCTCCCGCATCGTCGCCGTGTCGGCCCTGCCCCGTACCGACACGGGCAAGGTGGCCCACACAGCCCTGCACGGATTGCTCGACACGCTCCCTCCCGACACCGCTCCCGCAGACCCGCACCGACCGCAACTCCTCGACGGCCACGTCACCGGGGAGGCGCTCACCGAACGGCTCACCAGCGCATGGCGTGCCGTCCTGGCCGACGACACGGCCGACTCGTCCACCGACTTTTTCGCGGCCGGCGGCAACTCCCTGCTCGCCGTCCTGCTCAGCGAGCGTGTCGAGGACCTCACCGGTCACCGCGTCTCCCTGGGCACCCTTCTGATCCGGGTCACTCCCGCCGCCCTCGCCGCTCACCTTGCTGAGGCACCCTCGCCGGCGACACCACCATCGACGACGAAACCCGGCGCGTCGTAG	MQDRDPIAPSTHATPRERPARAAERALWLLDRVAPERAASNIALAVRSAAPLDVAHVRRALGTIIRRHPALRSRFVLVDDVLTRRVDAVGDDPSIEVLTVAQEDADETLRRFAERPFASSPDQPAAGKLRETDGEPLIRAVLVVTPAADTFCVVCHHTIFDGTSALLLTGELVRAYAALSTDGQVPPDLLAEAADFTPPPPGPDSLAYWHEQLAGVNIRSMDLRCDRTRPAQPTFRGEQHIHPLSQGAHDLLGNSEAALQATRNIIFLAAYLLVLARHGAGPDVTVGVPVDVRGGRGRGAIGYHTHTVVLRVDMERPGTFRELVTLTRDTFLAALGHADASIDDVIDRYGTCGGSAENRHFHHMFNYFDFHTSVQKASWTPGGADVDIVEVAPRHSVADLEIVVRTRHDRTELVVHHGTDVLDRTDARALAGRYDALLHSALRAPDTPLPDLTWHTDLDRRALTPSPVRATPWRGGVVAAIAAHARGKPDAIAVVDADTGRTTSYAALVDRAARIRDDLGDAGIGPGKIVALDSARTAATLAGALAVWSLGAAYLPVDHAHPAPLTARRLAGARIAAVLGRPLDPATLPDVPTIPLPVPRATGPWRDLPDTGTLTAGTLAFVIHTSGSTGSPKGVRLTQGNVHHAVTTLAAGLGLDAGASALWLTTFTFEPSSLEVFTPLVLGGRVVAAPDAVRHDPARLTALLARHPVDLVQATPTVWSVLAPALEGRCEGVHLVTGGELLSAATARALLSTGGRVLNAYGCTETAGWPVMGEISPACVANQPPRIGRPTGGHRVDIVDDTGRPLPPGLRGNIRITGPAVADGYLNAPLRHPTDDTGHRTHSTGDIGRLCADGTLEVVGRADRQIKLLGLRVEPAEVEGVLEDHPSVSRCGVITARDAESPSLVAFVETTATVHPATLRAHAARHLPAPAVPSRIVAVSALPRTDTGKVAHTALHGLLDTLPPDTAPADPHRPQLLDGHVTGEALTERLTSAWRAVLADDTADSSTDFFAAGGNSLLAVLLSERVEDLTGHRVSLGTLLIRVTPAALAAHLAEAPSPATPPSTTKPGAS	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	192.45	gnl|BL_ORD_ID|4935|hsp_num:0	5928			96	1665	colistin A; colistin B
BGC0001058.1|Zorbamycin_50 # 83596 # 84771 # -1 # ID=1_50;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.690	BGC0001058.1|Zorbamycin_50 	83596	84771	-	Loose	550	25.7942	OXA-308	24.24	3001763	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATCGTCACCGACGACGAGGGAGAACCCACCGGGCTGATCGAGGAGGGAGCCATCGACCTTGTTCGTGCTCTCACCTACCCGCATTCGACGGCAGAGCTCGCCGAGGCGATCGGCCGGGCGAATCGCGACTATGTGCAGGAGGGCATCACATCCTGTACGGAGGCAGGCGTCGGCACCGGCTGGGTGGGGCACTCCCCCATCGAGGTGGCGGCCTACCAGCAGGCGCGTACCACGGGTGCACTCGACGTGCGCATTCAGCTCATGGTGGCGCATGAGGCTCTGCACGTACTTGACGCTCACGCGGACGATCCCGCCGGCGCACGCTTGGACCTGGGACTTCACACCGGTTTCGGCGACAAGTGGCTGCGGCTGGGCGCAGTGAAGATCTTCGCCGACGGCTCACTGTCCGGACAGACCGCCGCACTGAGCCGGGACTACGCGGGCGCCCGAGCTCATCGCGGGGCGTTGCGCTTCACTGCCGGGGAACTCGCGCGACACGTCGTCCAGGCGCACGCCACGGGGTGGCAGGTGGCCGTCCACGCCCTCGGGGATCGCGCCATCGACGTCGTGCTGGACGCCTTTGAGGCCGCGCAGCACGCGTTCCCGCGAACCGATGTGCGTCCCCGCATCGAGCACTGCGGGCTCACCCGGCCCGACCAGTTGGCCAGACTGCGGGCCCTGGGCGTCGTGCCCGTGCCGCAGGCCGTATTCATCGAGCGGACGGGCGACGCCTTGGTCACGGCCTTGGGGCCCGAGCGGGCCGAGTGGGCCCACCGTCACCGGAGTTTCCTCGATGCGGGTCTGACGGTTCCCGGAAGTTCGGACCGTCCGATCGCACCGGGATCCCCGCTGCGTGGCGTCCACGCCATGGTGAACCGTACGACGGGCACCGGTGACGTGCTGGGGCCGGGCGAGGTCGTCTCGCCTTCGCAGGCCCTGTACGCGTACACCATGGGTTCCGCCCATGCCGGGTTCGACGAGCGGGTCAAAGGCAGCATCGAGCCGGGAAAGCTGGCGGATCTGGCGGTACTGGAGCGTGATCCGACGACCGTGCCGCCGGACACGATCAAGGACATCGCGGTGCTGGCGACCTTGGTGGGCGGTCGGTTCGTCTACGACGCGCCGGGTTTCGTCGTCGATGGTGGTGTCGCCGGCGAGGGTGCCTCAGCAAGGTGA	IVTDDEGEPTGLIEEGAIDLVRALTYPHSTAELAEAIGRANRDYVQEGITSCTEAGVGTGWVGHSPIEVAAYQQARTTGALDVRIQLMVAHEALHVLDAHADDPAGARLDLGLHTGFGDKWLRLGAVKIFADGSLSGQTAALSRDYAGARAHRGALRFTAGELARHVVQAHATGWQVAVHALGDRAIDVVLDAFEAAQHAFPRTDVRPRIEHCGLTRPDQLARLRALGVVPVPQAVFIERTGDALVTALGPERAEWAHRHRSFLDAGLTVPGSSDRPIAPGSPLRGVHAMVNRTTGTGDVLGPGEVVSPSQALYAYTMGSAHAGFDERVKGSIEPGKLADLAVLERDPTTVPPDTIKDIAVLATLVGGRFVYDAPGFVVDGGVAGEGASAR	MNKKLNLALLCFLSILCAACQSNQQLSANSHTENHNTRAAEISLLFDEMHTQAVFVTYDGQHFQSYGNALQRADTAYVPASTFKMLNALIGLQNHKATNTEVFKWDGQKRAMSIWEKDMTLSDAMKVSAVPVYQELARRIGLDLMQKEVTRVRYGNTDIGTVVDRFWLDGPLKITPKQEAQFAYQLATQQLPFDQNVQSQVKDMLYVESRGQSKLFAKSGLSMKNGQPDIGWYTGWVEQADGKIVAFSINMQMVQGLDVNSRQQATLDILDKLGIFFYL	140.14	gnl|BL_ORD_ID|2562|hsp_num:0	3470			507	606	cloxacillin; oxacillin; cefalotin
